var title_f17_14_17632="Approach to patient with ILD";
var content_f17_14_17632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 709px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PFT: pulmonary function tests; HRCT: high resolution computed tomography; ILD: interstitial lung disease; BAL: bronchoalveolar lavage; UIP: usual interstitial pneumonia; IPF: idiopathic pulmonary fibrosis; NSIP: nonspecific interstitial pneumonia; OP: organizing pneumonia; PLCH: pulmonary Langerhans cell histiocytosis; TBB: transbronchial lung biopsy.",
"     <br>",
"      * Serology as indicated by clinical findings: rheumatoid factor, anti-cyclic citrulinated peptide, antinuclear antibody, antisynthetase antibodies, creatine kinase, aldolase, Sj&ouml;gren's antibodies and scleroderma antibodies.",
"      <br>",
"       &Delta; Classic HRCT features of UIP:",
"       <br>",
"        <ol>",
"         <li>",
"          Reticular opacities in basal and peripheral distribution",
"         </li>",
"         <li>",
"          Traction bronchiectasis",
"         </li>",
"         <li>",
"          Honeycombing (clustered airspaces 3 to 10 mm diameter) in subpleural location",
"         </li>",
"         <li>",
"          Ground glass opacities may be present but are less extensive than reticular opacities",
"         </li>",
"        </ol>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Raghu G. Am J Respir Crit Care Med 1995; 151:909.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17632=[""].join("\n");
var outline_f17_14_17632=null;
var title_f17_14_17633="AML FAB M4";
var content_f17_14_17633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F58646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F58646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute myelomonocytic leukemia (M4)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgAX0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6JIyP8/nRtGChAKnIIPenD0P480dv5e9ZGxyOr+EBLK0+kuI2bkxHp+Fc3NY6nbyGOS1lJ9hnNeosBgnPPrS75OOTx0BquZmsa0o6Hmtp4b1a8I3xmND/AHq67QfDdtpZEs2JpxyPQGtwksfmJI+tJ6Ec5qd9xSrSloUvEdmdY0O6tM/vCN6fh0rzrTJnRDFMCsqHawPUYr1IZGCDyO4/nWD4i8OLqTm6sCsV7j5geA//ANeqWq5WOlUUdHsYCMD6EdeacxHORzVGSO+sXK3Vs6kccDINIJppsiOF2btxmp5WdWj1LFxcFYCM9B+db/gWzZI5b2TILDC5qjpPhm6uXEuoN5cPXaep/CuzjSOOJIYV2xRjAFHkYVaityoeOB1pT3K9R70lL15/E0zlF6DoCM8U3+VFIcKjPIwSNRyxPFAhNw464rjPG9s8GrwXqqfJmUIx9GrSuvF9nHKUtIXn2nBft+FSf2uNZspLb7Iqs3TceAaq1tzaEZQfNY51WYLhlxUokyATnAqGK8NvO1rexYkTjPtU11LE0JaJgQOw7VNjpuMnvN4W3K70JwFNdDL4YgeyijWZo2wDjsKy/C+kPdXH2y6BEUZyoP8AEa7Fm3Nkd+KDGrOztE5VPBsYkBlugVB7A10dpbw2dusFqhCD8z71MR1weTWV4i1yLRIVVF829kHyx+g9TRqzLmnU0NZlCJmV1jXrljiq51DTwChu4TuPI3DmvN7uW/1VjJf3LYPRFOAPwqL+yolHQ5657inobLD92eiNoOli4FytopLeh+U1oIqxrthVUXpha43w5rktjItpeEvAeBntXaMAAGU5jblTSZjUjKLsxO+e/SkJ6jr2pScDJoKnaWYhEHUk8YoMxM+3tQW4z2rHv/E2lWTlfMMzjtGM0218UaTdsFZpIiem4Yp8rL5Jb2NknjkUE4HA4BoXZIgeGRZIz3XtTQc8/lUkikn05A6+lID04xxSDB6H60Me/Q+tABu59uwpD6ZPBwKM4+769aaTgdeaAHE+n0oyPc88+9NBycAUZye9ADuOfQfzpRjOe/oe1NB44FAxxQArdB3HoaRuQVGeaATjr7UMcelADMdhyfWm/p71J268elMIGRQM4jxRYvYX/wBujXdBIfmwPun1q3p+pwiD7wPvXUTRpMjRzKGjYcqR1rlbzwowmJ02YRxNyUc9D7U0+jN4VE1aR23fP50dvbPNKOoH5e1J75JNIwDj0PPSjnp1z3o5zgUu3C5J56YoAO/pQOOBgdjSAAggnA6fWn4ZcZAagQmz5eOe1IF5J79qdjH3QcmgZ4z0pgB3YwwVv94ZpqIiHKRop9QoqTHtzSgYx696BDDknk0oU9utO29gKdjqB26UAMA96CPw9qcR69/wpD2x06UAMxuOPU1x/jG/kubwabbsVhjAMuD1J7V2cXDj1ANebBjJql68nLmVhn8aa0Vzegryux8FusaDCgVestyThkyBTVAWMkjJp9hJiQsRx+tQdEtjRvtOtr5Q02fMI/1g9PSk0LTLCK+aLmX5eAfWmXMgaPgkL7VS0e5ePXYcEkMcVWtjLlbi9TtTgKAqhVAwAKSpHXDn1B6Uw+o/Gg5RskiwQyzvwsSljXmYd9Rvpr2bJeQnbnsvpXc+KWZPDV6UOCRjP41xlgoEK47Ch6I6sOtGywsQK8jOKfswPapkHtx3qKeQIAq8k1BuVLqEFMAYrq/B1613p728h3PEeM9a5iVJ0QO6MEP5Vd8G3QXxEIV6SLyKpbWIqLmgztsoqNJKQI1G4k15/ruq3GszlEcxWKnCqp5f3rpPHM5g8NTqh2vNIEz7Zrj41WKFFHAUYqr2VzKhBW5mV2WCDACgt3pjrHImTHgH2rrPCui29wsl7dpvAOEU1s3el2ciMRCsfpgUi5VknY4XSNUu9EkEiFpbYn5kJ7V39ldwX9mt3anKNwy+lcnfWUaIVC5FN8IX7WWqtYMMwTDK+xqtyakVNcyO1yM89uppueMYH0pk8ghVi7YQetZU+oyurG2XjsxpKLZzpXNR3CDLkAfXpVKTUU3FYVLEc7u1ZTPI8Sl2MjZ5yeKllBV1IxsIzn0qlFFcpZe6nYD5gufSnB5iCwZiB2rmtQ8TaRprbbi+Uv8A3E+Y5qgnxA0g5WITlQOSRjNaKm30LVOT2R2kN46L8zbgO5q3Bexu+xjsfrz0rjNN8W6LqDARXqRuONj8V0CMhw4O6MjhlORUumTKLjujdBHrx2pe2T+FZtpdsj7ZOY+xrSXrlTkevrWTViBAOvUH1oOc89SO9OHT19Pc0mM85NICPGf8KT8M1JjI5xnvTSuTwOlAEw7AUAFjgA9e1BHynHbjmqus366VpMt1t+fog96FroNK7siDW9ds9GISTMtywyI15I+tYf8AwmdyWJXT1Ce55rBt7d5ma5uGMk0p3Fj29q0EgGOFyKptLRHVGjFLU3LHxdazSCO+tjCT/GORXRQmOSISQOJIm5DA5rz2a2XOCvWn6RqM+jXg2sTbOcPGTxS3JnQTXunoA4HGaf8ATnFNDI8aSxHKOMg0/wCh59qVzlYo46/T1oxjjv6+9AHPHrS/0/pTEN5+maX19PSlI449KDgfgeKAG5znjoc0h46Hil44596T73AHPtQIRTtYEnivP9ZtH07XpwR+7mPmIfXPWvQfLc9v1qpqumJqNp5Uq4kBzG/oaa7GtKfIzjYn4x1zVhUKoGxgVLaQBHZJU2yxnDL/AFqW4wsZwRjvmosdPNcqzODFnPzZ5qDRkNxrcAToDzioLmXc/lxDLnsK6rwxpTWEP2mdf38g+QegphOShE25OWYg55pmMj260uBx39aOp9ff2pnEU9XtTeaTd24wS6Ege4rz3TXPlhW4K5Vgexr04khgw/OuI8T6U9jePf2yFraY5kCj7h9aN1Y6KE7e6yIPhST0HvVvw9YC+vvMlB8pOcVkJcq8fBznvXRaDfQ29vgOA3v3qTapdR0NrVIY3tCpVVG04Fcf4PhA8Uq+PuAj6Vo65rQMZigJZ3GCfarXg7TXtI5LycFXkGFB9KpbGK9yDv1I/iErvoKlBkLNlvpXKkhoevFek3ttHe2U9rNgxyjGfT0/WvMZIJdNupLK6GGToT/EOxp7ovDyTXKdf4d1BYLcRyDMZ/Stea5iMRMb7uMCuJ066RBtbAH8q0Wv8japFLcU6WtxNRcJ8oPPesW3mS11SO7kOEj5NW55N3L4x9awtVDyKkKBsyNzx2rSnBykU2ox1OvF4+pt9p5KP9xO2PepAoHJY+wA6VnWDGOBY04CqAKreI9ctNIs/PnkUt0EYPJNbcl3oY21si9fX8FjamW7kWGFASM9TXlninx6+qym0sPMt7JCd79HbH8q5Pxf42m1y+SeLISEFUtgeAc9TXF3uoXEYkaUMrS/Ox/wrrpYe2rO6lh7ayNnTdQI19roAzRxtld461dn1Nw9ze/dG7Jh7AVzujzBrQyK7cnlsdKtOkUrs+4skg5X1NbOCvdnS2tjfsntrqdL4wFYHUkkHvXaeDfGs1mGghzJaBsMJO30ryPS9Ums1ljMJaIk4Q9BXT+Hni+xyS3EqAs3yoDzWdSnpqTKKkrM+k7K7gvLGO5gYNDJ6djWlYTFGMLnch+6a8p+F2vQR3j6NISwnGY+fumvTE547rXBVhZnl1IckrG2M9Ohpc7sY69u2KjgkEkCv0PQmpBjjAwD2/rXMzIaeT3A65ozjqSPpTvr9fxpp5OQAfr2pXsBLyT9OB7Vznj/AHNYWSDlWk5A+tb7ygHbGNxB5HtVTxFZNfaLKsYLSx/vEx1OO1VHR3Lg7SVzkIEKqqkc1uRLDtAxj6Vy9lqkMuEkcJKDgg8EGtmO6BAwRj2qWmnqdclc05reKRCVwe1YWpWbohLLitKOc7gf4afrt2s1rGiY4HJpx3IV4s0PB901xpTQsctC2Afat30yT3zXK+AwzG9Y/c/rXVccd+OaOtjnrK02O6k5owO/0zSjPIz1NAOcUGQlIckY70p9aQ5+nrTAaBwzM2FAyTXLat4mlkZoNIVQoO0zMO/tU/jLUGjSPTrdsSSDdIy9l9KwbeEIgCjge1P4UdFKmmuZkbTag53PeTFh33VraFrF/BL5F5N5sbcI7ckGqix475pssef6VPM2buKkrG3epLNcrKoUM3DEf1qb+w/tCCSS5+RudoH6VTtLosg3N84GM9K19GmMgeLuvIp3OeXNFaC6fpVnYtvhTfL/AHm5xV/OScng9TS49OKUDp+dBi23qxAOMHkc0mcjqfbHanAc460ccEDn+dIQw/XvTSFYFXAKngqec1LjHYZ6k0mMY7AUAc3qPhW1ndntJDbuf4Oq1lDwhqXmYF3GFHTmu3YZBzx7UmMngY9Kd2aRrTStcwNH8Mw2TCa7kM82emeBXQFiTwcAdPagLgdOP6UMOpxxQRKTk7shnlWGMvJ0Fcb4muvtypI9thF4SUferoL5/tEzx5PlrwfrVCWFZEII6A49BWsEuoJtao4iaUR4wwIH4VXfUTCA5LY25xmp/EuuaZpm6GKIXd0RgqgyAfesCbX/ALOoa6tYjGwGSD0GeldEYRXQ6k60ldFu48QSAoY4ieQTnnIroRevqM1tcxQiOPG0gjpXOL4o0SQoJ7Uwg/xAdPeur0HyprCRbSRZocbkYVcrJaKxjKNRO8w1fUItPsJLqTOFHQdzXi/i6C71CM3NxcSL5jAhAc4HavWPFkav4ZvVY4xgqe4rxfUAJHjjjuJnaNQzD1q6C1ujqwy3Zyl1NDDeiMLtaEfMR/FUd4ItWLyK/lxKNqJnvXZ2nhyHXI7tQ6JLGmck43GuIh0WexupAzEoDtUdc+9dkZRel9UdUpXHaTJPbTCxKYU8n/aq8mnXlxNIY3EWzhcH9BVOR7oSNvwzJ0YdqowXt5aXAkjkaQZyR6VTj1FzGhPb3VqhicESuAMnnB9TW/4e0SdbdJZyrAHk+nvWC081yjTnc8r8n2FdJpr6mBbkKEtiNpDH71ZzbtoaO9jrPD1zHp2uJJaYaSNwWfsBXvSsJoluUB8p0DA+lfOY3vujRFHIYle5zX0Do7THw9p0crYZogXAHFefXRxYtbM1NFlEkEqZ+ZTnFaAORj1rD0o7NS2KeGGDW6Mnt1OOPWuOasziBcseOuPyrLvdf0m0mMUt0WkH3tgzisnxnq0sbrpVi+xnGZpB1A9BWDa2EYjwEU+56mpvY3p0rq7PTEjUSNIq/O1LLLDZAy3lwkQ9GNUdf1WPRNLe7cZlPyxp6mvOHN1q9wbjUpGctyqdlqktLsmnSc9eh2Nzf+DriaRJli8x+sioefeq8ieH0wlvclAfukg4rFt7aOMYVF46e1XoYre8iNtMqjPQkVPMjf2aj1ZcubTyohJE4kjb+NaxpnluXEEKlnJxxV2ysbqwm8jzc2sh2lScge9djp2l2unAPEu+Vh9809iXUUPMTQ7Aadp4iAxI3L1f6ewFHc7upp3b2z+lI5W7u7EA659aMH9KUHgevWlJP49KCRvbqKEH7xfQdvWl/l0oi5kBx6/jQB53qE32rXr2U5wH2L9BUpkWNeSP8KozZg1e9jk4Pmk/nV7SLRdR1NI5yRCDk+9Oe536KNyJblnBKI23PXFTI24HI5Nd3HDDEojjt0Ea8cr1FctrcUMcrmIADPQUrGcavM7WM08AkHoK0vB0ryanMH5+Xg+grDuJ1CY6f0roPA0LLFcXZGAflGaCqmkGdOPalPTk+30pAe3TjAo7UHEKe/50v0/CkyOaTPp9aAF9OPpRQSM9/TNAOOwpgN5yc/gaM8dDilIzj68Vw5+KHhqLXr3Sb27ezubWVoDJMn7tmHBwwzjnI5x0q6dGdS/Ir2M51I07c7tc7f2HI4zUF0/lwu/GR0otrqC9t1ns7iO4hYZWSJwyn6EcVWv3zIqEAqOSKm2tmWtdimmEXLn3Jry7xv8AELZePpmkRyMyH97P2HsK7vxTdvbaJdzRxybQOXUZ2ivG7u6tjZgxQho2BPmE8++a6aSV7tHZh4J6s5JfEkJvZJykkUwJzv6OfWrlrfC7tpDMd8rnCJniq2pabDfRAAbd3EZrDtDJoWsrbXZzGxwh9/avRUISXu7nbJq10bd0LbZKbwmNLdcYHBLVsfDvxRd6XdCWUsbQkfuyf4fWuF8XXcs1ybdnAKfM3v8AWrfhW+Fxp8nmOEmj+UBuMinKF46icVOOp774mdrjTXa1cNbSxl19+OK8NaaX+zXl2hZGYoW9Mdq734f+IHubNtJv+Mf6ksOnt9K4vxPYXGmarPZgZhuH3gN0B74rKlHlbiznoNwm4SOdt76/guJGllKq/wAquDipNOvi1w0d84yDwa1tQtrY27GIBplXBXoPwrkogZbmQnKqp6V0JJq52uPMdJNahd8qRqxYfKBWbKkiQgC12hurYpDJPcxhVmOR6cYFdPp9/FNpkcLKWlXgkj+tJycfMy5WjjljmilIt42QHgkg1e0m7v5dQWC8fMYOFx0Fe7fDPQbK/wBBuW1G3SYO+0ZGePY10cPgnQISGi05IyhyMnOfrXPPExu1Yh4qMG4tHnngDwvc6jfCa6YrbKQxkxwfYV7ITGiqnKhRwR0ApsMUdvbrHHGqIo4VR0qOVWkkiijHD8CuKc3N3ZxVarqO7L+hW/Ety4yWO1M+lXdRivJLGZNPdY7s/ddui1YjiWKJYwPlXAPuaeygh1J4IwSOozXO3rcyZ5gnmT6lM9zKs1yp2SOvRmFairgDbn8KpPa/2Tq91A7blc7lY9wavoQVyTjNRLc7k7pEnxNcnUNNg/g64z7VnWw+X+veuk8faW+oaRDc2ozPaHcQByVrjbC+EiDBwauWsVYVF3hZGwMgAAdKa+c5B2moRKpwc9KbJOqqef8A69ZGliSbVHiKrJzg8E16JZyeZZW0meWQGvJTbzatOtvbZDE9R2r1axga0sLa2c7njQKTVdjnxCSsi0Ovrx+NL/DnpTVzg9805famcgvTj07Uc84pCeG+lIenPAoAXJ9KQHqc446+lGevJzjNMzkY5Ipgcp420iRn/tSyBZgAsyAdh3rndG1hbaQFuM969OyVJwDj3FYWqeF9N1BjIE+zzMckp0NO6e5vTqpLllsUJfEwZAA369awL7VBM2d3etRvAkhkPl3o2djg1e0/wbaW7h7uYzkdQBRaxop0o6ow9F0y51i5U7SsCnLOa9DtoYra3jtoBhEHUdzRGqRRCOBBHGBgAU5f19KRhUqOY8Z+U/rQDwf7pGaaTxn0oGTwOvQUGYpOMHr70hfHcZrJ1nxBpukfJcy+ZMf+WaHJrEfx5GXzFpspjx3Ip26lxpSktEdlnjjsKyvEmjf27YpanUtS07ZIJPO06fyZGwCNpOD8vOceoFV9H8U6dqcghYNbTMcKH7mt0oUPzdD0PanGTg7rcidN/DJHDf8ACvP+pw8Zcf8AUT/+xrxXUPhn4mv/ABZqtvZ2dzLbpdSAXt4+PMUtkOznG4kEEkA85r6i7cnvzmhgc89e9d1DMq1G7WtzirYGlVstrHk/gP4Tz+H7hLq88QXiTdWhsGMaH2Yn7w/AV6FL+9kdlBPzda1HHDe3SsldwiPbJPPeueriKmIlz1HdnRRoQox5YLQyvE15Jb+ENSjjCkspUr1PNfPWoSx22lwwIsnBy2emPSvorUIRPbyQ4GXBUZr598dF9FWWwvB86ksrKOGU9K2w29j0cLLoUm1WGK3Z8LIEXgD+E1jazJb6jZrOG3TQnzFbsDWN4YlN1LJbTjbECX571fuBaWtlMI1+c5OzPXiu9QUHodctDkX1RrqZ5Jsb5GwWatLTk86ZlV+SOMcA1hQwxCHzNzMS/wBz0rpNBUJC11GihVOK3lsEG7HURahM1mZrQLDeW4ACHqQK9J8IGx8d6Iy6pEEvF+RsfeT3rytYzbvJcLCZnYAtIP4RXY+CbyC28RWckLHyLlNj+5965KkVa6Ma9O65luiLxL8PdU0/VFl05jcwYxgdT9ax9W8P3tulu50yRFQ/vGC9a+grB8u8d2oyOh9KuRoBu3xLLE33cjisfrEluYxxU476nzdbaavmM0UErt3TZxXc+GvAF1eyxy6iptbHghcAM1epRWtum7ZDGvOchRVxNodMncMY+lROvJ7DlipP4dBunWFrp1ilraJ5cMY+Uf1NTAhicEkn16CmsAx+U8L1ApkhjT5zkM3AXrXNucvqSyShI9oXPrjrWhptuVHnuuHPC+wqvp9gzSC4uOAPup/jXivifX/EPw08Yz2ljP52jy/v7a1uMvGsbH7q912nIwD2BrahhniW4Qev5nPiMSsOlKS0PoFRjn9aXpkYrg/h78SdO8XXIsvs1xa6kEMjRkb4yB1IYf1A69673b/jz3rmrUZ0ZclRWZdKrCrHmg7owvE2j/2lAstuFF1FyP8AaHpXJRzPDmOVWR1OCpHSvSe+c/pVa5sbW5k3z2ySN6nrWR006vKrPYNP1WwvJmSzuFkcfeU96xdc8HWt/O09hKLS4PJT+EmuStrUW7h4GaJx0K10VlrN5GoE6iVcde9O9nobOk4O8GY1x4Y1+0Zl8pZ0HRkNPs/Cmr3Ug+0osKdznmumHiBo1CqWUHrk10CSG4gjlycOM9aL+QpVakVqZui6NbaPH+7IkmPBf0rR5JwTzigjg+mPzpY0yQo4pHM23qxTntyamWN+SVP19q5bxT4sh0eQWVggub8/wg8IPU1xlxf6ze5e81F4w38EZwAKq1tzWFCU1fY9bEbN0IJPoaa6yJwVOfSvHB9riIMF/cI2Ou4mt7wx4o1Oz1CG11N/tVlJx5n8SUipYZpXTPQppIreB7i7kWKFRksTgVyj+OI5rl4dOtsxg4ErdD74rG8bXU+t3TCJ2XTYjt2A/e9zVHTIEDoExjpgU3ZDhRVryOsg8R3aN+/jV0PbGK27DVLe/bagMUnoehrITTlaBWIyMVyPi2PUIJ7eXRboxXtu29IWOI5h3R/6N2P4iluS4Rlsj1LyizEAfdpshhgUtPNEiryRurymPxzf6tpFpp1i8sFxCBDdvcH9+jKuDv8AVj1z0OcitLTdHaaINczzSE9SzGnZLcSo6XkzvbXUNPvJDHa3kTyA4255NW2Vl4cd+vrXAXvhmJlElszRTDkFTg1b8L+J5o9SXRtVO5j8scp6n2ot1QpUtLxZ2XbGOKo65qC6Vot5fNwVX5c+vStB1Icqecelc78QIGuPCN0qZypBx6jiiO9mZRV5I8+0y3Nw7XE6l55jvLNzjPat2PTiwGc9Kh8MxLtTeecDrXdQQRGABUy386Td2dlSpy6HBXun7OoIPY9xXR+C9ZYltN1CQs//ACyc9T7Ve1SyRIiwGTXJWeI/EFnjp5nWnuK6qRaZ6WVIIUryDig8njJ/wp8mPNbng803qPqM1JxjHHysPbtWVEAUxnuc+3tWuwwvtnNZTrsklT0OcVSBEExRFO7p61418dbFbzS7SC3iPmySD94f4a9lnQMCQMcce9ec/FRytnZkhcBuT3rpoS5ZJo3o/Gj5wu7K60l1jvCVlJyGHQ1ejuYrrT7h2iAkiTAz610PibTf7ZvFALdAAp6j3rk9YsrrT7OVYELRK2GevWhNTir7not3MuKJGtGL7QW7Zwa2NFV7Sza2MRYsclj2Fc9HcCchWTawIP1rudHlXVwYYNoTbtYHhhVTdlfoNIl05prj7RFuMcC8F1H36lt/Mt7y1VFkRmkG1h6fStPw/bw6esvmK0kUZ6di1SGxbUtXs9zBSX3RqvWud1LNroS9bo91MY+zW7O4+aNckdc4FOgkmiGQQ8fXaT2p1pDGURJDlkQL+OKkFuhhaMqwOeW9K8+T1PNt3M2+1SOEgyboSxwu77prTt7PU5ViciMxHncvcVV1TT7d7EGZfMjHRmrp/DiNHotsp3AY+UH0qZTstBTirXRUi0qco+5wpPQDtV6z02K32kjzJAPvN2NaIGRk/kaQ/rWLm2Zjcc5PJrg/i74Km8XaPbDTxCNStpQY2c4BRuGBP5N/wH3rve+P1o+lVRqyozVSG6M6tONWDhLZnj3h7RJ/hNdrd3oS/wBHvVSK7vIoiHtHzxkckxknr/8AWB9cgkjuII5YXWSF1Dq6NuDA9CD3FPmgW5geGaJZIZFKsrgFWB6gg9RXnZW6+Gt3yJbjwZcP7u+mux/Mxkn8Pr97onJ4t3fx/n/wfz9d8YxWGVl8H5f8D8vTb0TBBz3pMkcgAk9aIZEmgjlgkWSJ1DI6nIZTyCD3BpSC3QniuPyOrc86AwM571qW0HmRArgf1NY7SDbwea2dOuENsMkBunWpPRntoUdSXygM9jXV+GLsXOmhAeY64nW7pTKUByOmRXU+CIXjsJJGGFbp705dDKqvc1Oh9D1qrrF9/ZmiXt5jLohx9as1l+LLZrzwpqEMeS+3cMe1OO6OaO6ueXaUjOJLucmS4mJdmY81uaXZfbJRuGcnpWDpswezUjggenetLSdcOnTqzoGAOaJ35mei07e6dlL4bC242pk4zgda4/VbeSwnRwv3G3D8O1ekaV4i0vVVVre42y7fmRuCK57xPBHc+Y0YGDkinHU5adSSlaRzmm3CNq0sCkGG6USIPQ45H51JZL9nv3jY/wAX51z+n3Ai1aG2mBEnmfuZB2Poa3ddZ7TVQG6sASaVnex0vsd1bXCtZYGPkri9QmD6+pkJKqM1PBqZhgYE9awZrkS3EsjnoOB601sZU6dmZ2tafNc6++oaKyR6jCMYc4S4X/nm/wDQ9R9Mirnhv4qaLqPijT9Cit54pZ1KPJIQFjmH/LPjO7kEZBxnGM54XS44rxbhZi2yVTGWRipweOCOQa8+134OX9jOuoeEb8SPC4lSGdgkiMDkbX6E59cVOl7MVdNfCfSbhQnGOnFec+MwbW/hvIMrNG4YYqW58eLD4ctZryBrS+eIefFIMFHHDADuMg4PcYNeaeIfifaWsEkj/wCkTHOxccKfU1pShObtBXJguRc8tEfTNnci50u1umwN6AmotSns5rK4t5p4z5iY69K+ObD4leI9RmV7i+KWan5Io/lJFehaDq9vfI7TXkryNhQNx+Umux4P2avJnMqdR+9y2R6RbQS2T7eHCdCvIIrettXaNMuduOo9q8ykuNT0hQIJvOjP8Lnn866Gx161uI47bV0e0kZciQD5T9TSlRXqaKqpfEjotT1rzoQsbcd/eofC9o9/qsc20+XHzuI4q7Y+E0kSOZbpJLduQQeorrbaKG2gWGBAiAY4HJrnlCPQqVWKVokr/MWI79qD1OfpScfTvSj+lYnOJjv171m3qFLoSDncOtaQ7kDHFVr2IyxHbgOORTQIpSLnkZznNed/Fywubrw81xZpulgcPtx1Fegxv8y88CotQiWZGQjcrDkYzmtYS5ZXNIS5ZKSPnB0vEEN9KU2MnJA+5XPa3566VNLKn7kHKk969P8AFuhjTr0QhHWxdtwfqoPo1cdqthc30RWaEmDJZQOAcV30qqvqelGSlZo4bw/pxkcXMqLGX6Kw6iukj0K3CfaLXetyn8anGfar2lQpDbqLhV3LliWP8PoPetawttQv45ZLDT5HiJxGMYH1zWlSrK+hUmluUrOKK2mQzBn3J/qyfvH1rt/h/oEf2ptYu4GVeVhRvWrHh7wM0LQX2tyrNdr9yKM8L7E13s0YVYhsG5R91egFcs6mujOWrWT92I5VjXLqwyeoFLHlnLlsr02H0qQ2yZQNhQRnI4NL5TZYgdO+egrnuc62HBPto+yGLbGxz1rpI4wkaoowqDaMVl6JBhnnPTGFJ71rDoR/KspPoZyfQXA/AfrSc/pxRnGOgx60fnmpIIriQw2sswj8wxqWCr1OBXGW3jm6uoQYtMWN8kbXIyK7hCAeP5V53qtslp4ju41BVGO8D60G9FRk7SRLPqOsXZLSXRjB/gj4AqvPHevC0ct5LJG6lXjfBVgeoI9K07VVZc46Gp5oRt7UuZo391aWG+EtTj062g0maKOK2iXZFsGAorrmG0+oPINefX0IxkfeHSu48PzG50yJn5KjFNvm1ZjVgopOJxGteFNQtJ5ZbD99bnnaOq1hLb6mF+W0lz9DXrJY79y/hTtzdyPXpT5rrUpYiS0OB0Xwrc3bx3F8RHGDnDdTXdQxxwwJDAuI0AwKcSWyW69RRj8efSpepnOo57gDz0+v1p8Q3FuhQjDA+lMAOeuc+1c1428Qf2Yiadati6m++R/CtNK5MYuTsjkvE2hWkOsTjRLhirnc6D7qnuK517O+RiJ7FbiPPzHJBxXY6XaRsocE7upOa25Y1twpZUYEZwRVOpc7FLl0PL1MmnyeZbo8XOQvOB7GtZfFpezaOUHzsHHHWulljt7qQiSJSOnFa+iaFo81vvezV5lPWi66hOolq0cJ4E0afXtcW7ukkS0jbduYYya9K1TQbW6lLx53YwAfStKJI7ePy4I1ijHG1R1p+T7Zz09aTld3RzSqyk7nEXfhO8YjyiOORVV/B181vKiqGkIyo9a9ByeeuaUMwbgjinzB7aZ8+LqM+jXMtteRtFIjH5WBGaTUvGUyWDyb9kS9SeOa9v1rQNL10D+0LVPMz99Rz+NfLH7SL2una5DpGmO6KqjcqnAPrmuihRp152tYt4pJaq7OH8Y+LZtSuXjikYrng5rmUjlvHGdzsTnYO1Fvab4SY8lweord0a3e3uizqwcLkV7KShHljsaU8O6suaoNtEaziaG5QxswyCetej/Ci/V4r0bAsuNqMwzuNcDqg+0RvPlmKetSeFddm0PU7ebdugY4dM8YqJR54NHXXprltE9902JIrfF/cNLIw+b2NOnkKhZY7jNuHAaORQflHUVQjvorpMxph7iMOjqeD7GrsEcsEYmniw5UKEJyGA61w8vc8xzs7nSeC/F6WNzFb3e9bOY7ck8J6V6ujA4YHKkZBHcV4CRY31vJbSSmGRnwgQY2nGeTXo3wx1yWeCTRdUbF9a8oG6unYisZx6hOKtdHddRwO/50dvp0pecdz/npQeDjPNc00YiHOSSefSmkHHOOlP8ApjPNJnOB0JqAMq/t9hMsSkqfvLVOOUMuU6dB9K6AgYJIz7nvWPfWJVzLbDg/eQVcX0Y7mdfRxMDHIEkjIyQwyDXM3eh6PcTEtkN/dB+Wt7Ure6uLcps8mPux9K5i7uLe0vVgiQSlhy2a3iaQcvsj7LwnpIIeOBZJAeC54rftYwF8pFWPZ0AGBWDpK3VxE08Csjq+3Y/Ga3YJjIw8xfKmUYIaqlcbbejLQXJyq5JGMVNawYm+Y5JHyrUIfB3o4L4xt9KniZpc+Sj7+mcVkw6Elw2ZF5BUce+adYwveKQxKop5bH3varEOns7K04wo7Z6mtVECoERQFHQelZuVtiXLohEVURUUbUUcU7t29M0f1peMZwOelQZiZ6nHfihjj60hJz70g9+lAw/lXHeNrdoby3vl+6R5bfXtXZkcc8mq17aw3tq8FwoZG9un0oKpy5Xc4y1mIUc8+1WhMcY61SvdJvtMYhUMlvn5XHJ/Goo5ZmARY33emKXKdmktUTXjDGBzXZ+Hozb6XEr8EjOK57R9FlnkE14pSIHoeprqiBgADAAwKeysYVpJ+6hMcn1JpcDvQhDKrDgEU7afwpGI3HB4rF8UalfaPDBe21l9ssImP21I8mZI/wC/GB97b1K9SOnIwd0du9IR1/nQBX0u7t9Rt7a7spkuLaZRJFIjZV1PTBryHxH51x4ovrqbd9/aAfSut1dW8BXFxrliB/wjzv5uo2WceQxPM8I+p+ZO/Uc5B8/sPG2meMdZ1eTSreaOGBgw83G50PG/A6DPGPp64rSHVG1CSUtTr9Ak464zWrq14kUALYMmNuBXG2l43mbYW4/2TRrOrW2m27XF5IPMHqamFNuVkdM0viZtWZclpSdufXtXW6Nd2sdoztNGin1bqa+XfF/xXmeJ4tJyrZIDE/yrz19f8R3skbTancZPRQ+BXoQwDavN2OablV0pq595R6hZyttju4Wb0DdKso2eVwfpXwQL3Xbe6jlGp3aOv3CJDjNdj4f+K/izRCge7+2ov3kkznHpTngP5WL6vWSu4n2OWHTseOvWgk59cD9K8i8L/GSyvrW2k1SIW3mnG/PFeo2F/b6jbLPaTLLE3dSDXHUoSp/Ejm9or2LQOHBNfF37QLO/xIuGyWCqOowB9K+zdwPQ8Dua+Sf2kNKFl4tF6VfEi7SuPl5rrwC99ryKbSlFva55/oUKSQyRrIqFuQCetdRcWziGNkhwpXJfOfwrzyym2uhUkHPAPat6w1G6j3RGVngbqCelelqz2qM1OKsXhbLuljbd5cg3Bvp2rnWBAePaeuATXZmXbaxRzRBYSCVc96xb22t5I1kjkxnqfQ0lct6nX/DPxNGYDpmpOqvEMQyMccelehPcS3bQxXNwBErfLtNfO9zbyQTjGemVZf511/hzxvNbJb2+pAzbTgSnr7ZrOVNN3R5dfDyT0PbLMW0MxjcB3PQEdT9as3VwbbUdP1K1laO8ibDEjqnda5PTta0yWZVe5AJYMGJ4Q+1b2rmGRC+/dvHDqeDXLJO5koOPus94sbpLy2huIvuSjOAelTFhjpmuI+EOsx6z4YWNHzLbSNG2Tz14rrr+/srAE3c6qfQGuKpFxujKOunUsbhikz09a5K98dQxAm0tvMUHGW71Ug+I0T3Cx3FntjP8QrGzN1Rm+h3GaO9Q2N3b6jbiezcMp6jPIqwE+XLEKo7k4pGbVtzM1oBrXa+7aeDiuGv9PEUySJGFkHKA+nrXoztBMjJ5qMR6HNc5qemMjFljklck+V6KT/StacrFwdjl9PMl1qAb7UWRflwvGG969AhsIZbSL7RGHkA5bpWR4Z8NCwima5wZJHy2Oma6bAAAXoOlFSd9EKcrvQrQWVtB/q4lHueTVkAAcYA/2aceucH8PWgDHUe9ZXuQJ2JzS8Ek0HgHI9uKRvTNAhCeBSf1oYfIzMyqg5Yt0Fc/qHi/SrSQxReZcyg4OztQXGLlsjoKKwtM8WaZfzCKQPayHpv6Gt9l29wQeQR0NASi47iZ/IUhBxwadwTnjB9KUDI5H40EjBwMdvQ96AAMHZHu9dopzDA6Y9x3ox0JBxSATk/eJNBOenFKQQfp1owPXBoAUck4penQdT+VIPSl+hPPagoD6AZOeaQ9Rz+lO4yR2phOc560COf8deFbHxjoEuk6nLcRwM4kDwPtYMOmexHsRj9K8Q0z4X+IPh54xtdW03/id6Lu8q6SBcTGBuGBj/iI4YbSSSo4FfRrHjiq9zKIIXmPIRSfqapMLHkfxSfTvDAQaWjPdTHBjUfNXzt4y1bVNUgmluGkEAO0Z+Xn0xXtHim5l1HVJ74qQ4bEffgf41xPjHTzL4dudmwyk7zGo717GHlGmkra9x+ylUd5S07Hj0FsHUSylsZwWA6fSum06ztI1LFn55UsKzLKScRSKI1Xb94e9d/4TtI9T0+STZHuIxz/AJ611VJKMeZnqUoxgtDHsVjA++u8ON24ZBFbl2tj+7UQxtCw4ePg/QisbxBaPBMhhjCvE2HUfxCtLQxCsHn7fMZRkqO1ZTtujXfU5e+iSO/mjhkdUbgA9FPaup+E/wAQdT8N+IrfTrty9kz/ADA8isnVGi1CeR4YgiYyxPUmsvwRozax4xgtwxKI28H1I7VatKNpbHFmEFKnzdVsfZmpeI7Ow06K4lbiRQwUf4V5l41v9J8YbbS+tZPOYHDFflwPWs/xAPsOivqdxLJIkY8tY2PcCuC0zxbq8CzOPIl81D8mM7BXFSpW96PQ5aeHc42Zlaj8LbtWafQL22ukQkiBm+b6VyWpw3+ku9vqtk9u7dcjjPrmtNJbiyn+12txcK7SGRirHrn0rpbXxksyva+JbFdQ09xtEjDEimu7mmvM3p0qlL4WcRDqsssMUE53QIPlB7+9X5PJmtw7chRyo71q614Nsr6xbUfBty12sZG+zc4kT6DvXHS3ksbeVco0bxHayYww+tOMk1odNLEJ6T0ZrwlFmiDOdnTaR29aW90hlu2RMPEw3AimadNBdDzGIUpjrWoL37PKzQwh17MGzik076HWmmijaSLbW7RXcRVQ3DAda6TQvFCafcfZZpWlsGwQGHKCuXvNUjlgmMiEsx3ADoKyLWR7xjaWcTzXVwQqBRkr60+VS0ZzYmVOEPePpn4K6vFb2euXlsmPOcldhwOOBxWlNcSXl28txIzkmmeDfDH/AAjHgq2s5WQ38qbnUHn8agtWMc5WTIweuK8nFNSm3E4cFDljd7s3bazWS3xgVBLp6BSrqPxq1p9/CyN5bBsdcdqZc3O4nHf1ri1OvUk8I6oNP1+1so9xaVtuB0xWl8TZ9UTVUjDNHp3AG3+I+9N+HGkmbW5tWuYzsiGIyR1PtWn8SLgOlraDHmO/mH1Ap7MxbTqqxzGlXd3p8iyRsXU9jXWQeJlMSl1aNhgn0Nc5DHgA49qtrGgUtIoPoPeoTuaTjGW539leW+oRLJbSckYKng1KflODgfUV54kk0J3wExt7HpUsOvavaD94yzJ/tCqRzSw76HejnHWjr2rH0HXrfVF2SD7Pc91PRvpW0Vx1oMJRcXZjR2H40g79vr2p3oDx9O9VtSlMOn3UoxlYzg/hQJa6HF+LtWm1K6NhYuVs4v8AWMON59KqWumRJAAozkelRadbEQBy+WY7j+NbunuiDEnGeAaTZ3pckbI528sMc7eQc5967TwbfNeac0ExzJF90mszVEQQkgjNO8DE/bph2xTRNT3oXZ12Bz0+tBA49vxzRjP0B5pe/HT+lI4xBjIwcUA84Gc4p20Z/Gk6A4yBQIQYHPaj659sGl6dulAOO/X0GaAGEgc0uT3/ABpo4+npQT8uQKBin60m7rgU05JAAz/WsPxV4jXRQlvbBJbyTqp/g9zTSuOKcnZG4wIxkNXF/EzW30nRhDAwFxOdq5PSs218Z6taXWboJcQk8gDBFcJ8adbe91jT54xiywN0Z4GfXNdOFpqdVRYq8ZUo8xQheS4mAuDtlA++PukelVbyxhm0+5iuSEYsSjZ6irc13LLDawwxQtb4A3q2W/8A1Vn6lbv9uFmxB+XcrHoPwrti2t9C7c0r3PGRci0v7uDB8tnKgnrXSeD7saU5ubiTnd9wcAjtXPeIYPsfiO4VDvRm3Dvz/Sp/ONxbF5l2qDj5en4V2tKUbM9CjrHXobmsaxFPqTSQyKzt827+4fSq2n3xSOWSOcIRnI96zPsscFuZVB8wY9+Ka7Kmnu7Io3HHTp9alRVrG7aRUuLsi4kxM6c8MOhr274BaNbafoOo65fyIFkO1HI5HHY14RJt8qXjdwNv419I6HZjTPg3GCEZ0j8xI+zE4qMQ7Qt3OOv70lE4bx/4jfU9dawsmd9OhyG9HauSQCOMyRHLl9rA8cVvw2FvmKZ7oxyzKWAbufSkg0pNryyMkqEEYHAU+9EXGKsjeKUEkjLvXitLWBprdQzHoCMj3rL1txOn7kqCSAdvf3qzdXlsbmdLlQ0cYwoJ6GsPSZVk1Ys0W6JQQoHQVpFW1BzJYJLq2vEa1mkiaMDDLxmrE09j4gn26p/ot39xbnGMn/a9alllV5mQgoQQQSO1QXsEM1sSiPIzjJGOAfaqdr3M6lPnTSMHVNP1DQ7poLlGAPRhyrj1FVVvpQhjViEbkrnrXsvw8u7C+srOHUUW6YOIjFKMOB6A96PHmhaLH4uFjpWjLBGwDFmH5/SkpqUuVnmynVo6X0PLLKxu9QEaFvLhc9AOTXq3gfwZ/Z1xHcW6MZwv+sYcIT3FV7fWtK0Vxb2Wmi4dF2+c3IU+ma0YPEN1dW7LNdiCJh+5ES8N7E1lUnLaKOv2FSurvRfj/wAA6trDV7e7Mi6p9sI6qz8j2FTRaoN2L5djdD9frXlsetzWF+8LyM3mjcrE4IPvXTeA9aS6voItTCTWtw/llW5ZT61hKF1eRo8HOlFyps7Dw1LHea61rYy7i3QZ616jY+ESQhvSFUdh3ripPCdrZXZk0sSQzq27du6V6D4O1iS+tWtrz/j4i457iuSrFPWJyuvPZ6HQW0EdlaGC0QBY1OB6nFeVTXc17q88l2T5iEqAe1ero20+neuF8aaC8MzalZqWiY5kUdQfWuS19C6E0pa9SpbLwMVOFDSccCqWnSebGeDwKvQcpnqTWdrHUyTblQOnNGxZBKjjBZcqfQ1JnvTR945HPrQSZk0LQv51ucOOeK77Qb8anpqOT+/T5WHqK5Bl3/Koye1avh+N9Mn3zOFjccr3H4VSM6yUo+Z0/pgZFU9Xw9lcQZBkdfuis3U/EIX91psZZzx5jjAFVNFl/wBMIuXLyuMkt3pnOqb+JmXDbtHEoPAA/WkDYOBz71f1exubKWRwPMtWG5WHVfY1hJexhev61LTOyL5lcuXE7YZX6Y4FbXge3ISe5wdvSsGx0671WbbbqQneQ9K6m71W10GOLT4E865Vcsq9PxNVayM6juuRbm11AwfejpyfzrkpPEeoyNmOOKJewxk1NbeJLpHX7bCjp3KjBxQY+xkdOCV/wp2cDnmoLW4hu4RNasGXup6rUgPBxx/WkZWtoOJOcdD1z6Uxh9ad3Pc05TxycfjigRApwPccc0FvfNNHHGO3egk8ZHJ/SgojvbqPTtPuL2cjbEpP415BDJcarqdxqE4IedsgdcL2FegfEZ3j8K5Vf3ZfD4rkfDkIaPLDB61e0bnTQVouRVmh2N97nsK4T4j/AL+zKOQNsZIHvmvXbqwJieRV49fSvMfHmmm50+XK8qD0rfDNRqRky6n7yEo+Rw3hK/hntIZy7RumYmQHOceldNfxwQW/nySFp1UnJPIB7V5x4BhSx1q50+7LmQNuXPTr/Ou98Uziz02TzIU2sNpJ7k9K9WcLS9TgjPnfKuh47f3DXerSPKFJDEZQ8davcIoiR04GdpNUIbCR7mUSHA3ZqWaz/eskLEuhHBHNbX6Hr0o2iTS3LQtE2AWJ+8emKfq0qfZkjhKu5ALbehFOuYnuLdd4xtIViOMUoSO2gOwFnXhWPQikaWdjG1FF+1RiMh4jtG1Tz9K+q9S0aCbwDptyTJEYbUBUJwDkDnFfKF4DbXayBCFVhID645r7FuXi1XwJo8v/AD2tghOcYyB29a5sW3Zep51R8tY8UntpftSCdYXCqQGJxtHqKxryzktLYQxXbTGZjuC9xUniC4istQurW6SQXK/IgfjPPWs+9vo4ntshQY1G4g5BNaRTdmdvNpc5rWo2EhhPzO7YQDqR71uaHp8NtoNwX5usdO4qB7F9Qu/twjJijO4J0GParTiSJX8sSQ+ZwvGcj0zWj1MVG7uU/OafybV1TavJwefxrY024ifz7e3h8yNeCAOh9QaxbXQb5r/MiNlsYJPau5uPI02xtoLaAAL98gZJNTOSVkjoWxyD293bXqXNpA8RSUMDnBJzXdfEa/gh0mPUZZGW8miCKAeQe9ctNPPNqTlAwZOST0zVb4k3a3GqaVbTyFoooRI4HY/SlZtpnLiYc0kv6/rUyrm9hi0mC2tXYSuN0ufU02S4dIUs1ZgqnOB3JqrHEt1cnyxtU9M1pX0cOmWCwMVe8lwxdTnA9Kt7noxtBWJILYNdpHJKC6Ln5+x+taOlWOrxazaSQKsMfmKdxI2nmuYa7lk4jiwP7xHJ/GpJbnUQBCJJBGOdoNS1cbbtofYEF9aXKIVu4ZZ0UCRVbo3pVO01NtN1yJ5CAjOFP0NfJEHiDVNNlVre4ljKtknJ6+9euWXjtNW06ynb5rkEJIvf61y/VneyPGrxVFN7o+qlAZPMDAJjduPSsy78RaJa747i8STjBVecivO9U8RahqlrbWcDGK1jQAlT9/iqthYqrAkc968uejKpYfmXNI6iBdNeeVtNlIik+6j9qjjV4nZHUjHTPce1U4oVA7jsMVetY2vSbbzCswGUb1qL3Nrco8Enk9BS/exGuTmsyWO/tZ/LubeUEH72Dg1saKrqs9zdJtihXd8w6mjlaBtJXLUjJpturld9zIMKvp71Wt1ZiZbli0h4x2FVRO93I11N95zwP7oqyrFm+ZifrS2JsNbBIAGMGorreih4iVkX5gattyQOmKrXLboySOBxigaOu0e9XUdLjn2gsPllU881FLpGmb2le1RTnJ7CsvwQxEF5x+79PeoPGN87XEemRFlDL5kpHGR6VWq2OfkfPyovaj4jtLGJrXSlElxjA2D5U+tc3axMS8k7F55DlnPeltYUiUBVGO1XAPbGPSpubxiobDVRQMYFK6Bl5HHcVKBngnBx+dIwAXn/APXSHcTRLprDU1A/1LnDCuxYbTlSORkVwdwcOh967aBy9tAx+8UHBquhhWXUk/zilQkDGfzpvagso+9+HFBiVbO5ivbOO5izsfk+1S4xnPf1rA8CuzaIwbOFbiug/Un/ACaUdrGk1yyaM/xLYHVPD13bISHC7lGOpFeZaDfmJ/Ll+WRTh19DXr0beWQV/IVwvjnwxILw6vpSZJ/1qKP1rSNmuVmlGaXus1YblHtWBI2svFcXrlujs6ldyHgin6bqDrFhzgjg5pl7NvDHgjPNCvHRm8Y2dzyHxVoM9hqS3tsuUT5mPUsP/rVD4ovbrVPDtu626CB24k3fNwa9l03w+fENnPbN8q4JDYry/W/Cl9o8dxpmpwSrAWLwyKDtH/669bD11Vioy+JHDUUaNfm+y9/I4K3tsyfapTGIwNpTPJPrUBiLTxSxH96DkDHX61bgLRFYfJLTxk8NwCtK4YECJd0hb5Nnb2robdz2oWa0ZozS2pt2ieFVc4LE8c1kvaNMS1lGHUD5h2pUnZmktrhI96nJbP6U6bWDYNH5UO6FODjjePekk1sU1Y47V55Xd47pgrJnCj1r6d8A351jwtosDI/k28IMjsMHIA5r5rv4pde18W+mQvNLM2FRFyQK+nvDthc+F9K0zTL8pFGYxkEc5x0qMTbkXc8erK9ey1sYXxi8If2zpsOq27RrdRnll6kYrxeMoshhuUxIONxHBx7V9RxWVrODGCwhZM+UeQ9eJfEbwrLYXkeoQwvHbySbArj7tZ4er9hnRSn9k5xbiMwsjO23GMKMYqPTb+eWVLGLLxg55GWqxLbSiNzCgk2kb1TqPer9qlhBZRagEIkI2jnDLW7kjpUOpqXkxVYvJjZ5MY3niqp+120pRdsiuuW3j7lVn1NQ0Xmy7Vx8qjt9a3fDlpqPia88jT4H+zoP392wwij0rH4V5Fv3VdmJoNg15NHFas00Al3zOe3PSuX8URSaz4vv2iOYoiEBUdhXuUeiWmj2QstPRnLMWmlH8R9B7V5fotnbvd3wzy9wwd/QZ6VcKid5HLGXtat+iMOPT5FXEcLB1Xk+3rVfTdJe5upHG6cx8uCK7XV57awtUaL95yY9wHArA0lLxfNltrkRxy5GMcn2qua6ud0Xpdl6aCL7Mt2EijGNhT1PsKpXLWE9rGu8RXbcbsVVZJI5I7cxtO0bF8knGfSq72q3DRBx5eXyR3FNRE31uZriSMyLcFHhUkbu+e1M8NS/ZPE9owYtETg7e2avXVuq3jzQFZI4+qE9TVTSUlk1jzkRUK/O/oBW8NTzswu6bufUOlwqLWIoRkKAccjpW1BGMA4/xrlPAcsk2koZSS4AGW6/jXYwYA5HNfOYiPLVaLoz5qUX5DwpJx0XoKuaO6WmqebIVKMMZPaq+A3JHAPSqt3biRGVSV+lZIbV9D0osSq52upGRkZrH8YKZPDN6FUfKN3yDFYXhvxK9qY7DU/ni6Ry9x9a7GeFJInhlw0Uy446EGq2OOUXTlqee2EgkiQjpjtV1GIORjPp6VmXFpNot89rcK3l5/dOBwy/WrqSoy5yPzpSVjs31RYLEnPYcVSu5doIzTpZgOFO4nsKv6Vocl7J5t4CkK+tCXVktqOrNjwvB9n0hiT80rZPvXP+KMp4pZnP34uM12CKsZCIMIowKzPEejnU4Ultztu4R8uf4h6U92c8J+/zPqYMZ4FTqcLuBGBVGMTwMUnhdGHqKvRLvALEKvvUuLOhjsljhQSAKGSTYvGOKvwrbxj5JUZvQHvVlLR5zkqSp60WRm52MO1tJLmZRgY3CuwwFVEwflGMioILeO25Vfm6VKOvXmmYznzMcSOeeKNxB+Vc/U0gHQdD70AA9ciggo6VZLpunR2q/eHLn3q32wST680Z3e5/lQBkgKM/T+dBTd3dijJbAzk1HdXlppqb7+4jhRuqsev4VheLfEn9k4sbFQ9/IMlu0YrhmtJb2Rpb+Rp5DzlzmqtZamtOi56vY7LzPB2qCTEyRPnk/dzUSeDdPmYPY6mkkX9zdk1x8+jQSD/VqT6gVQeznsn3200iBTnAPNO76M6FS/lkewWenw6ZD5NuDk/eJ6mi9tILyIxXUSSxEdGFYXgnxC2qQmzvDm5QfK56sPeulIIyOc1Kk7+Zxzi4uzPPPE/wr0PWrZ4ot1mW7x8EfjXm2vfAvWreEjw1qSuCclJj19xX0ZjNNcA46jvx2rphiqkeoRnKHwux8vWv7PviRn3y6nbI3U5BPNdHYfs9CSKL+1tckZgPnWLIU178VyOv50EAn0HpVPGVe43Um9Ls4zwd8OvDvhJQ2m2aNcd5X5Y/jWj4s0gapYNtVfPj+aMnsa6EjoeKPszOuSMDOcnisXVk5c0nqZq0djzOCWWe1CSPJDdQjaRjr+FHijRbfW/DLQXMoWVBvRs8lhXdahpltcvuEkSzngYPNc/ceFLqOcSRyhwp4B5FaRqxeqdi1No+Zr+KTw3qEcl8JVjVjxjlqoajr1jMwZYWdXbLDpgfSvpfUvA76rK41EQywnGMgZB9qbafCvw7DdrcyWqNIvbtXYsVDeW52LGJdDxrwX4Ki8QSDUrwCDSYyHKP1IFexQxeZZx2mmRiz0sdVVcGQe9avibSoYRZxQQiOzU/6tBgE+mKvpuXygI0XgKFNYVK3PZmE6kqjuzHXTY/3TyA7EG0Ka8f1nQ10TxBqlv5Q23H76INwCDya+hWiwfmAYY9K4j4p6PHd+Hvt0ak3ViQ4I67O4qaVVp27lYefLP1PE/9Lt7ae3VI57SUbimOR9KxZ5zaoz2UIDj5QH6iu21Qm3sY5beNWmnXEEgPAHfI+ua42705mmaJ5xv27zJnj6V305KSbPTjruUbLVZLW5S4lQF1bLJjgjvWltXUpZ7tIysI5IFUls5GsHlnChlOFbpkVqaKsUumMNspDH5lj6getW7LVBJLdHJ/Y5JFnIj2kvwc81d8KwyTXt1E0QVYgCz4yc11uoaXZw29u2lq80zsMM5xz6YrrH8Nx6RaRiOLF7dFWmPp7VSrLQ87HSTptdzrfB1qLLw1aRFf3pHzH3rprfPHNZFoPIMcBONqgAGteHcTgdK8PES5qjY6MeWmkWlUsBxx71M0WEBwST19KlswiHMp/OrctxABhWBrHQTk76HM6hbBlbsev0rtvCd093oa+Y254jtyeuK5XUpVPOMD+dbFveN4d8KG42B7i4fEMZ9aa2CquaKXU6DVHsks9uq+X5OPuv8Ae/CuQ83w6rkQw3zrnI7AVR2TXUpuNQk86duTn7q+wFXVXaMDgUXsTGnyrc0dLvdBScboJYmPRpeRmulJ3KrIVeIjIKHjFcHPCJVww4+lS6Nqc+kXAR8yWjcMh7e9PcU6V9Udp05B+nFMmlSCNppXEcS8sxqUkOqSxHdG4ypzXJeK7g3OpJYg/uYRvYf3jSMYR5nYs3HieSZttjbI6A8PMvWq0l4bgl7q1hLeiDAqrDHsH+PapyNvbIFI6FCK2RPFJbCP5LNfM/vZ6VE97fwS+dHMwUH/AFfbFWLSHdHnHWkuYfXIz+lMWlzZ0zUodTjIH7udfvIe9WsYyPTt61xUjPa3STxZV0Oa7K1uBeWcdwmMuOfrTMakOXVbEpPHqcU0nnv+ApcHpjr0NRySRxkB5UQ+jNikZjz39jikaUW8M07DIhQt+NL3z3H+c1DqMfm6PfRjO5ozjFC3KR5fas9/dz3szFnlcnJ7Ctm1g808Dj0rJ0eRWgVAMMCR+tdZpaJgE4zVVPiO2TstCsdPwuQOKydTgwjYHIrsbjy1TC4965XV5Byc9qSIpybZk+Fw0HiOBgSAW5wPWvTtXu7TTUaa9mWNWOFHc1yvg63gsba816+wILdSEB7muOk1G+1/UWv9RbKs/wC4iXpGvYn3pqPUJw9pPyR6FL4p04MBEkki9jUlp4hs7mYIytGTxzXK2tt8oVgM1Wu8QTArwO9Fri9lHY9LxwDkEHpijpyeprI8K3jXVo8LnJXoa1ri5t7K2kur6QR28fUnvSRzSjZ2M3xFrdtoFiLidPNlY/JGOpryfWPFGva1cMVne1gJ4ReOK09c1uTxBqckqREWynbFkYwKgSBxHgoCPpVNqOnU66NFRV3uc+i6kk4k+2zM/XljXXeGPFl7aSrFfO00RP8AEeRVNYIpHCfdY+vFJLYGM8jB7NUt82jNZRi1Zo9WtJ4L2MS2rBlbn6VLtxjpj3ri/Bcssd4ik/L0I9a7ojG78unSlqcNSHK7FS7tUuYSjjAI+U+hrJUPbSCOcc5wHx1roCP5YqOSNJV2OAy1SlYhOxmxnOc8g1DJCsy7JEV0kBVkI4ZasyaeyEtbyEjP3WqmskySkXEZRR901a8ikeO694WudAuJVlJlsBITbtgkIp5I/Wuf1jRLG/ska2kInRvu9Nwr36eeGZGWQI8f91hkVkNpGkzn59PjRiMblGCBW8ask7nbDEtL3keAax4euZNNeO2K+XCyu6pk7RV7wTD9lkuC2wNGn7wuOvHYV7PBpWk6PHObeEM7D94X5JHpXMXVik95LcQ2cFqHPdc5/Ct/bc0WpDli7rlSuZ3hLSlDC71S1QQKSYYzwSfWuy0zSZNa1FGCEwIwZnI/Ssq2to4MSXDyXRH8LdK7LS/G2lW8cdtLp8tog/iUZFYVKyXwnJOFWo+aSI/GmgTLNHqGmoXQKFkjUcj3rJ066LfIVbeOvHSvStOu7bUIVuNOnSZG6gHkfWuO8V3UA1f7NYQohQZndRjLGuW6ktS6VSXwNC2+maheLuRoYo+xZuac3h/VAvyyRSr1wjDmsp4PMGWlkx3ANNSCSFibe5niI7h6lM2s+jOg0rw1LKfN1JiqL/D61V8YO3/CRWcB4tYId0S++etXvC/iFriYadqsgMuP3M543expnj60ZVs9QHDwN5Uq/wCyec1Sd9DFOSqJSM1emSKlHU1WgkBUkHPHNTZ71Bqx6jfwB17VBeQYQ7uMCtbTEQoWPX3pNSjUoduCQOppkc+tiz4PuxPpksDN+8gfIB9Kxdf/AHfiq7/20DAflWh4LixLczfw7SCfWk8XadLI6ajbLuZE2yqOuM9aq2pKajUZQD8HFSBsqRWPHeBwCAf61ZW7IbAVsHvilys1sdDpk0e3axwV4q1OoKZ4rm0uV3gq21h71cW+ITDdO9K1jKUHe6IdQwFwB19K6bRI2h0mMNwWOQK5qwU6lqSKBlFOW+ldXqFylnavKRhYVwoHrTeiJqPaJla3rDW8ptbMAzkfM+eEH+Nc9Jb+a2+5dnkPUkmn24MhaWTl5CWarOcD1pbGsUo7HY9RwOPU0RsI2Bb7p4P0pc89c9qjcnPvQch5/wCItNfRtWeaNCbO4O5WHQGprC/AVdrDFdo6JNE0FzGssLdVYfyrBuvB9tI5awuDDnnaat2ludMKqtaRRn1Dcp5wKxir39/FaQhneQ4469a6BPB0+799eKF6cVt6ZpFpolrdTWaiS88skSMOlKyXUr2sY/Ccv47uoobW18OWZBihAecjuew/OsqxtDHGH27R0xUuiWD6ne+fdHc8jbnY9zXZ3ekRG2MUX3vYU3Ze6xuap+6c3ESqZ74rE1SXexC9a3r60ntkYNk4rm5oZbm6EceSzHAFFrFwaep1vw8ErNcM6kJtwG7Zqh8TLprrU7XSUP7mMeZKB3Ndro1rDo+lJHL8qwp5sp98V5XHcvq+pXmpysWNxIfL9lB6fpQtLsyp+/UcuxYitREVOMKe3pV0Rjb+PWp7RElUxTD5CMH1X3FJLE1qoViXVej47Vnub3KElsGkDAcryDU0UgnikSUfvE7+tSb18vcDVXTbeW8vJEgz74poT2uzT8L28txqqPEThTyO1d+xBckc89aytC0pdJt8ZzO4yfatLt7Z4FNnFVlzS0Fx+XfPrQBznj/E0Z5Jzgmkzx/OkZjSOBjj2prgEYdcj0NOY4HJzTXdI4mllcRxJ95mPFMCjcabazZDRbT6g1GNIt2YFpHx6Vgap46RHaLRrVp9pwZH6H6VDD431CKIy32nI8S8sV61V5GypTsbevQ2umaLJOkIaRjtXee9cvY25ufnk+Yn8q6XxJEPE3hS2v8AT23RI3mlM88dRXOeGrgLdGN2yoOAaL6XNKStF9y1c6e6Q/cwPYVmtCki7WUE5xg16HBHHNCUYAjGa5nWNHmt5S8Cbl65FJa7DhV1syh4YiXTdSnvIGZFiiJKKflb8KmWIXVqL+MZMrFm9cml0xC080T5TfGV5qPw+TE5tycoR93tmk/Mt7tokHSl2tL9wEk1KIGE7IR36V0FhapFANyjce+KVhSmonEalakEOwKspyGHGDXoWlzLqegxG7VZCy+XJnvXJeJJI2YhOgHNdD4UyNDwx/i4p9DOq7wTMPU9EudNkL226a1JypHJUe9UVuhty3H4V6ECyk7eh/Kqlzp1jc7jPbLk91p3T3JjW7nGJfhFKq/Bp8CXeoyiOFW2nqfauoTRdNjYOLck+hq/GFhUrCiRj/ZFGg3WXRENhZpY2iwR4z1c1OGI5GPQg9KTt170c5696Rg3fcqzWunxhp54YkC8s+cCst/FOlrlbWyadBwSqcfnWX4mvnvdRazQn7PB94A/eaq0ahQFUAUX7nRCkmryNSfV9GvSBd6XcRAdHQYxRbaFZajIG0zVN8f8ULgblqhsO3t/jVadJbeRbi2YxyocqV4596ak0XyW+F2O306xg02NkgBLt95yOtYfi6ZvMtLQcKxLtWroOq/2vaOXVVvIh84Hf3FYni0eXq9jJn5XXFLW+pjBPn94gToMDipASOmKiU4wTmpM0mbnZHGemRj8BTCARnGfpzSF2H07AU0HFByWHbfmoOBwMGmljn5T16+9NLA5/Me1AWH4XvinKRgpJ91htNRbsYpwIxz+NMLHF31vc6DfM6ozW7NuRgMjHoa2rXxDaTRhmco4HNbW9im2VVZT1VhkVTfStMdtxtAD1OKbaer3NOZP4kY2o6guofJaoXJOCcVo6NocdgRcXIDXBGQv92tGJIoE228McY9hzTixySeSaL9EJydrIZfwm802+tskvNGVFeV6SDCPszgo8RKYPbmvVSzA7l+9XOeJvDg1FmvtMYLefxxD+P3FUrWsyqM1F2ZjI20kg4I9KkNzInRh688g/WsZp7i0by7mF0YdQaBqO87Y4i5J6VLps67XLV9cIqHCBTnOAMc11ngm0FtpjXMiYmmY7c+lYGg+Hbm9Zbi/ysIO7J7j0ruPlUKiABFGEA9KLW0OetNfCiXPOM9ec+tIT1J5qItn7pzUN/eQafZyXd6+y3j657n0FI5rXLRbPTr0pckH5sivOb3xxqd2xGlwxwW56O/3qZa+MdatXzdJFcJ/EDwT9KLM2WHnY9HPJwcHPtXE/EK9e4vodIifECKHmx39BXQ+H9fs9ZwkWYrpRloj3HtXI+L7KW28TzTOS0c6KVb8OlOOo6ULTtIgsbRC6xqMADgVuR2aPC0RVeR3rFQkGNumD611FowlijmUg5GCKRvUbRnfDS6XTdSvNEuD+6mJkgBPHuPzrN8VaRJ4f1h5Yv8AjwuG3RN/cbupo8SW7xXMd5asY5o23K3oRXZ6TfReItCH2+FHI+WZD646irvZ36Mzd4vnW3U53R9eCIFkbpXQWuvW8kDCZgD71jah4LDNnTLkKM/cfsKrjwdfZG64XHfmlyLoxP2ctbk97eWzTEoRz0xVfT7WVLs3bRt9mHIYCtiw8L2ls2+4kMjD+Gt8yfuvKVVWIDG3HFGiJdRLSJxcupJJOzIw9qkbV5FjxvzmrWr+FormRpdNl8mU9Y26ZrKTwtqpkCO6qCODS5E+palBopzyNdzqifM7nFei6db/AGXT4YejAZasrw9ocWnFnkIe49xwK2i4z1yaHZaIyqz5tEKeeP8A9VBBA4+ppuSfp0o3HnJ4FIysO9+31pBwTwfTFJluOOvSkL8YpALxj3pq/eGPc00ue59qaDyPamFjz9WP9pXuevnNmrq96h8TW7afrbTYxBc8qffuKit5icknOelDR3R96KZpKx7cj0pJgNvSq6zHGM4pJLj5cdveiwcrHaRctYazDNH0Y7WX1FdB40s2lsY54BlrdvMAH90iuY0oNd6vEq8hTk130jAsUIyuNpHtVWtYxqvlkmcTazrIgZe45qwrA55qLWNFuLGV57DMtuTu2d1/+tWSNScE5jNHI3saq0tUf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow smear from a patient with acute myelomonocytic leukemia (FAB classification M4). (Wright-Giemsa stain). The two promyelocytes on the left (black arrows) with basophilic cytoplasm containing coarse azurophilic granules contrast with the two promonocytes on the right (blue arrows) which have abundant pale cytoplasm and delicate nuclear folds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17633=[""].join("\n");
var outline_f17_14_17633=null;
var title_f17_14_17634="Patient information: Achilles tendinopathy (The Basics)";
var content_f17_14_17634=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16716\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/53/39765\">",
"         Achilles tendon",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?39/15/40178\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/13/2262\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Achilles tendinopathy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/achilles-tendinopathy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25517848\">",
"      <span class=\"h1\">",
"       What is Achilles tendinopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Achilles tendinopathy (sometimes called Achilles tendinitis) is a condition that causes pain in the back of the leg, just above the heel. It happens when people hurt their Achilles tendon. Tendons are strong bands of tissue that connect muscles to bones. The Achilles tendon connects the calf muscles to the heel bone (",
"      <a class=\"graphic graphic_figure graphicRef53890 \" href=\"UTD.htm?38/53/39765\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      You use your Achilles tendon when you walk, run, and jump.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517879\">",
"      <span class=\"h1\">",
"       What causes Achilles tendinopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Achilles tendinopathy can happen when people:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Suddenly increase their exercise or activity (such as running)",
"       </li>",
"       <li>",
"        Do the same exercises or activities (such as jumping) over and over",
"       </li>",
"       <li>",
"        Don&rsquo;t warm up their calf muscles before exercising",
"       </li>",
"       <li>",
"        Exercise in shoes or sneakers that are worn-out or not made for exercise",
"       </li>",
"       <li>",
"        Have arthritis or a bone growth on the back of their heel bone &ndash; This can rub against the tendon and hurt it.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517894\">",
"      <span class=\"h1\">",
"       What are the symptoms of Achilles tendinopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common symptoms are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain in the back of the leg, just above the heel &ndash; The pain usually gets worse with exercise and better with rest.",
"       </li>",
"       <li>",
"        Stiffness or soreness in the back of the leg, especially in the morning",
"       </li>",
"       <li>",
"        Swelling of the skin over the Achilles tendon",
"       </li>",
"       <li>",
"        Trouble standing on tiptoe",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sometimes, an Achilles tendon tears. Doctors call this a &ldquo;rupture.&rdquo; Symptoms of an Achilles tendon rupture can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Sudden, severe pain in the back of the leg",
"       </li>",
"       <li>",
"        Trouble putting weight on the foot or walking normally",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517909\">",
"      <span class=\"h1\">",
"       Is there a test for Achilles tendinopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. But your doctor or nurse should be able to tell if you have it by learning about your symptoms and doing an exam. Your doctor or nurse might order an X-ray or other test to check if another condition is causing your symptoms.",
"     </p>",
"     <p>",
"      If your doctor or nurse thinks that you tore your Achilles tendon, you might have an imaging test called an MRI. This test can create pictures of the tendon.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517924\">",
"      <span class=\"h1\">",
"       How is Achilles tendinopathy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Achilles tendinopathy usually gets better on its own, but it can take months to heal completely. To help your symptoms get better, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Rest your Achilles tendon and avoid activities that cause pain",
"       </li>",
"       <li>",
"        Ice the area &ndash; Put a cold gel pack, bag of ice, or bag of frozen vegetables on the injured area every 1 to 2 hours, for 15 minutes each time. Put a thin towel between the ice (or other cold object) and your skin.",
"       </li>",
"       <li>",
"        Wrap your ankle with an elastic bandage (or other wrap) &ndash; This can help keep your tendon from moving too much. Your doctor or nurse will show you how to wrap your ankle correctly. &nbsp;",
"       </li>",
"       <li>",
"        Take medicine to reduce the pain and swelling &ndash; Your doctor might recommend that you take a &ldquo;nonsteroidal anti-inflammatory drug&rdquo; or &ldquo;NSAID.&rdquo; NSAIDs are a group of medicines that includes",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;) and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sample brand names: Aleve&reg;, Naprosyn&reg;).",
"       </li>",
"       <li>",
"        Do exercises to make your calf muscles stronger &ndash; Your doctor or physical therapist (exercise expert) will show you which exercises to do.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517939\">",
"      <span class=\"h1\">",
"       What if my symptoms don&rsquo;t get better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your symptoms don&rsquo;t get better, your doctor might suggest other possible treatments. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A device to wear in your shoe or around your ankle to keep your foot in a position where it can heal properly",
"       </li>",
"       <li>",
"        Surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517954\">",
"      <span class=\"h1\">",
"       How is an Achilles tendon rupture treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A tendon rupture is usually treated with surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517969\">",
"      <span class=\"h1\">",
"       Is there anything I can do to keep from getting tendinopathy again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To lower the chance of getting Achilles tendinopathy again, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Warm up your muscles before you exercise. For example, if you run, you can warm up your muscles by jogging slowly and then slowly increasing your pace.",
"       </li>",
"       <li>",
"        Avoid sudden increases in your exercise or activity. When you begin a sport or activity, start off slowly. Over time, you can exercise harder and for longer periods of time.",
"       </li>",
"       <li>",
"        Avoid running or exercising outside in cold weather. If you need to be outside, wear warm clothes.",
"       </li>",
"       <li>",
"        Wear the correct sneakers or shoes for your sport or activity.",
"       </li>",
"       <li>",
"        Replace worn-out sneakers or shoes.",
"       </li>",
"       <li>",
"        Avoid running on hard surfaces.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25517984\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?17/14/17634?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16716 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-221.179.173.170-4115C7D097-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17634=[""].join("\n");
var outline_f17_14_17634=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517848\">",
"      What is Achilles tendinopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517879\">",
"      What causes Achilles tendinopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517894\">",
"      What are the symptoms of Achilles tendinopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517909\">",
"      Is there a test for Achilles tendinopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517924\">",
"      How is Achilles tendinopathy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517939\">",
"      What if my symptoms don&rsquo;t get better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517954\">",
"      How is an Achilles tendon rupture treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517969\">",
"      Is there anything I can do to keep from getting tendinopathy again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25517984\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16716\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/53/39765\">",
"      Achilles tendon",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17635="Subcutaneous fat necrosis of the newborn";
var content_f17_14_17635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subcutaneous fat necrosis of the newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDycamo7/rTzqSg/ernCx7nmmFmJ612NGep066mvrS/2on94VyxJ9aaSR0NLlDU6sakmPvCm/2mueW/WuW3N35pdx7HmjlQanWLqSno1KupKBjd+Vclub+8aAzZ6mjlQanYjUEHfrR/aCnuK5IM/wDeOPrTgJT0yaLIep1Jv1zndQL8HuK5jZN6tTtrp1eiyC50v29f71RNqIJ4bmuaeXaeWJ+lRtc7erUWQanUC/GeSM1Ol8D0ri2vgOjU06iQD8xosg1O9TUAOpApx1FR3H5154+qMP4jUD6tJngmldIdmegXWoqVzu/CsC8vQ7EZ4rmW1OQj7xqs95I2eTS5kPlOgkulBzkCq8l+gH3smsMzO3c0qo78k4o5gsaZv89Kie+Y9OagjjU8ZJNBt2B449KLsdhJbqQ+1V3uJDxk0+RHzzjNM2c8ipbYWIjIx703J71Myc0wr7VOoEZOaKk2UbPpSsBHRUgQZ5NSrGpHNNRuBWqeJcip0iQkAAVq2VshI4FXGNhN2MpLcv2OfpWpp+nbyCy/pWtDZjstadrblOMYrRKxDlcrW2nAAfLWna2S8ZFTIpAHNSoD2PNMmxKttHGOwrNvljBIq+4bbzWfPExJ4oYygWUDgU1ZAT90Z9am8licYPNOW3C8kikMdE5APFOLt1PSnrGpHc0Y7BM0mCIs5NOAz1FSiJz0UClFq2eWpDIjGpHPSq7xBTwK1EtQByacsCtwFLH2FFwM2EBiMir0YUDkVfg0qV+RCAPc097CSM/NGMUagZ5OBwTTPNI9a0DbH+4KPspPYflS1GUkmb0oVywyVI+orTj025cbo4HK+u2rdvoOo3B+S2b8aWoGFkn+E06KOSRwscbMx9BXeaP4D1C4KmdQF9q9I0LwPbWsaloxuHtSbSEeTeHfCF1qEqmdCkfpjmvUNF8F2VoqkxgkdjXX2+kx26gIgX6CraW6oQalz7AZtrpkUIHlxgY6cVaMJFaO3nIFOMYI5qOZhYzltt4yKkjg2HkVO52DjNM+ZjkE0XAcQmOlFMKZ6miiwHw8w9qZ3qRmUd6jaRAPeusQhGaQp2/Wmm5QdTzUMl6o6GgZPtNLt+lZzX49aifUPSk2FjXwuetODIPSsFr80z7c/alzIdjpY5EDcAVaS4QjHArj/tkpIwalF1PtOGxRzBynUTvIIGmUfulPJzWPPqajI3ZNdZb2aJ8LJrqcfvXyQT7mvMyp5zUSbQ0i/LqBfocVWa6Y1EImPQGnLAzfSpcmxjTMxpC5PentCUGWpFjyam7AbhjTljz1NP2Y6mnAYPShDDbGAByTS4A4A5qRInbkLxnGTUgiCt85yatWAjiiZzxwKsRxRA4dufak2tjGCopuVGAg570c1h2La7BgRKfrinSbAMsfmq/4f8O6xrr7NMs5Zh3IHA/GvTvCXwO1bUQx1fNqOwByfrS5gaSPGlXLE7SalhspLuZYoYmeRuiqMmvr3wn8FtB0cBrhDdS9zJyK7Ky8F6HY3KywWECuOQQgqXUQHwpe+HtTtN3n2U6ADOSpxish0IOMc96/RG/0LT7iNlltomVhg/KK+NvjX4dh0TxjPFax7IJF3qAKIy5thPQ8zbIpmT2q2It3bmmNBt5xVNCK/NLk1KkJdgoUk+wrSstIllwTGx/CiKYGbEjuflzXQaPEykb81pWWiSZA8vA78Vt22iMuPlwa0SsS9Qs7QSKDk1oJaACpbaykiGD0q+kSqPmPNXcmxSjtkA+apBEi9BmrDqmKi8wL0A/GlcLDGQMMAfjVV4zkg1ZaUDq1V3nHQZNJsCrJal+pxTVskXqSatDzGPC09Y3zk0hldYFUfKtSCMY6AVOITn5jxT4rYu4VFLE9qQrldYl7804ICcIua1dI0i61O/W1tkO/PJx0Fer6F8OLW3jVrv8AeSd80NqO4zx+2055sFlZgeyit2x8P37kC2stp7Fq9tt/DllaIu2FcD2oupre2TEaDcO2KnnT2A8avfDmr2yhpCik9Aoq5pPg7UtRAaY4HsK9Ogs5dRlDzrtjHQVvQW6W6gIAKHUtoJI4Gw+HtqoHnjc3fJrZh8HadbqP3KfiK6wsMds00neMGs3UY7GJHoNmEwsS1YttMtoGwsYxV9o8cg8Uix5Oc0uZjJ4oYwuEAwPSrCKBVVAy0/ziuM1LQy0YwajKKM5qP7TnpjNMcu/epsFyTcBkUKd3TpUQByAadHw2M1QkOkUAdqhDAHpirW3PWopIc/d5NFwYwkZopPLI60UxH58Sagx6E1Xa7kOeah8tj2ppBHBreUpFWHtO5PJppdj3NNorO7GLknuaKADViC3L9wKerAhxTgCegqcQgPgnJrc0rw3e3flskarG5ADPxgetDdtylFvYxIIzwD1r1L4T+CdP8RJNNqzGONThSx2g1Bpng61tyHmBuJfU9Bz6CurtrNURY0+Uf3BwKzdeK2N44aT3M/4j6cpt4NF0AK9lFje4YEcdBXH2/gSRk3TXKIe4254r0mKyVAQFyevIqYWiBcgZz0wetZSrtmscNFbnCReB7IDmSZjnqAOatReCrARIpMuck545FdtHbtjONqk9O/51IYFIO3G0dKz9sy/YROKbwTpzgYEgOf72KkfwNpTKVaFwMdmwfzrtEtBwWI4/GnmEfwgkZ5pe3Y/q8UcUPAmjLED9mO85BBc9PWpofBejQuG+xK5xjDMSPr1rtFiA/gP1IpTEpGCuBnkEUvat9QVGKOZh8Paei7BZwmPpgrwKkPh7TREY2sYgnddo5FdAUDY4OaTyuQcYYDkEUe0fcr2cexy7+F9GbltPTPqpIpmm+FtAs7pZZtMFyoOdjSEA11JiUq24YFRmLHUgDuaarNB7GLR6T4R8W+EbG2W2js30zA43IGXP1Fehaff2F/GJNPu7edT3jYH9OtfN5iJww5Hc4p0Rkt5Q8EjRt1DRkg1XtU9zOWD/AJT6Zzt7cUyTp1rw7SPH+v6eBHLKl5EpxtmHzAezV22geP8AR9QdU1SV7KU8jeMxn8f8apSTOedGcN0dfPMixkGTmvBvjr4aXWZIr2BwHj4J9q+gYlsLiDzLdop42GQ8bbhj8K87+IWlSTWU8kCYTB4xWtJ6mElY+ZrbwraRf62Un6VeTRNOQY2bsetWp3MLsNnKnBFQC7OewrqsZtksVjZRHKW6/iKmVo0OERB+FUXleTgE/hURt7hn+UHHvRYDWFzjpgUv2ok8tVa10+Vhh81fj0wDkkfjTQaELXOOmTTUmlY8KQK0Ps0UYxjJpNq5woApiKrCQrz1NQrbyE5ZjWgUwc5ppYZxSArC1GeefrUiWpJIjj3H2Ga1tK02fUbqOG3iZ8sATjgfjXtvhbwZZ6faI0kSvK3LE1MpKK1Dc8E/s+7C7jbyAeu00kVnNISEickdcCvpyXSLR49hgTHpiqNv4cso5CVgQZOelQqqHynj3hbwPe6m6STx+XD6Hqa7HWPDthoGjySrGpmYbV9SfSvRYrVLZAsagD2rjvF8ZvPEGk2Q5j3+Yw9cUlU5pBawngXw2NMsPtMqD7TN87cdM11hk8sEucVch2rEF4AArEv/ADbq4McfCA8kVnfmeo3psOuLs3K+XADu6ZqK30kI++b5m960NOtktlAxz61omPdS5rbAl3KMShUwABTipboKs+UO/wCVOWMKTjFTcaRS8k5FTpb8dKsYA60qMPWhsdiHyR6VC8ew5UVeJz0ppTdwc0rgUBuOeKcsO7rVvygpwBQAFancRTa2IOcVJEvODVkkUxnVT6UXAj2BunTtSGHPOf0odiTwaVZGOeaNQFRcj5jQJBGflPNV7m4itUMlxKsaDqWOK4nxH8TNH09HS0Jupx/c6A/Wj1GouWx3BOW/rRXz5rXxJ1vUWZLdxbxnjCDmii8TZYebPEJNLVUztFYl1bKshDnaK7aUAxniuU1lPnJr0JLQ5IMyWjQthG4qRYQByaWCIsQAB1rUislb7xJPoKxUTUylh5PetTTdLub2RYoEbnv/APX7Vu6Jof2mVS6ssY+8SK7fT7COCNYo1ITHbqfxrGpUjHQ3pUnN+RjaF4agtRvlQSSJzgjIBrqobMHaerdzVq2tQseMHOeQKvR2+QMjG3gAdq4p1Wz0YUVEhggjAXCfMBgnsamWL5sIue5yMCrkcQCBTT1jwwCx/lWfMW0ip5UzPyMZ5x71YihAJ3FiT+GKsCJz0B+hHanrC20HJH48Uri5SFoYxhQeRSJGFGMA9e/WrXkb26/N2zTlhIx19ht4/OpHYqbBuwGwe+BTyhPPFXDCdvKjn8KidPXhfSgNGRJFhOfXr6VKUyOBzj65qaJMHgDHoasRRFsEcKDn60XE0UBGdnzA9O9J5JAHHIPcVpOu5WwOPWoxBkEjnJ5ouCRmsgzhQST0yOMU3ywMYXp2rRMWGOFBPqelROg4DAZouaxiZvlDIwCD+VI8TA88NjNXztGc49qgmxgn+HpyeRSudEYmVJGdxJHI9OM1DJEcEAn1rRcguT0Gagk5I259BTUrDdNMistSv9Hl83TruWA56xnCn6jpXSx/Ee9mtTFq1olwpGDJF8rfl0rm5YyQdoAPfiqMkQWTCHvW8Krjqjkq4SM9zP1W2hu76SW1fEch3bW4IqJNFxgvV6e2BXJ+uKZCZUTaspAPY85rshil9o86rgJR+ESOxhjxkDP0qQeUmQFFNKuwOTggZyOlUrqO5iySAV7HNdCqxexyTo1IboumVR04qN7hQPvVksbo4G05NSW2najeTeXDBIzH0FPmM7PqWpLtAOtQPfJtyCMiuk0/4b6veW/mOpjY9Aa6LQfhRMbhXvXBUHO3pQ5WEjzq1F3fS+XawO7H2r0Twd8Or25nWfUxtTGQtesaN4VsdOjQRwruA64roU8uNcKoAAxxWLq22KSuY2jeHrLS4lWGJFI9q2Y2UcYo+Zm46U4RgHpzWLbZSVtgddxGO1MMZzkVOq8cnb79Kjnv7GHPnXlsmOzSqKm7KSuEabiAa5LUIwnj+yDD5TA2PzrXvfFeg2fzS6nbfRHDE/lXnHizxxZTa7a32lAyNbqVJfgNmrg0nqP2blokeia1M8UipEOWqW2e1tYs3M8UfHJZgK8P13xrqeqSbjc+SnQLFx+tc5PcSTMWmmkkY/xO5NS5JKxrDCyerPoe68T6FBxJqNvkf3TmoIvHHh0cHUIx9Qa+eGGSArMPenBTx82QfU1POjZYO59E/wDCaeH25GoRD68UDxhoT8DUYQfrXzyqg5GeKaw+Xb8ueoz1pc6G8E+jPpCLX9KmXCX9uxP+1VuO6gkUeVLG49VbNfMGJBkrkZ9+lOgvL22bdFcypj0cin7SJnLByWx9ReYQMjpSi429eK+boPFWvQAeXqU4Huc1o2/xA8Rw4H2pJQP76U+eDIeEqI+gGuOelQNKzH2ryXS/irdRnGoWCyj+9GcGuv0z4i+HrwKJ5ZLVz2kXgfjTTT2MnTnHdHWJI2MYpCGc9Kfp2oabqCBrG8t5v9xwf0q80YAzjGOc07kWM4wNjOa47xf41tNDVobdvtF7j7o6L9arfEPxo1q0mm6TIPNxiSUc7Pp715LJlmaSUl3Y5JJyTUynY6KOHc/eexPr2u6prcm69uG8s9I1OFFYElsM/McD0rUOHYAD5afFaLIW3Z24rByb3PQjSUdEYOUUFRn2xRWNrEN7Y3chjWQKDle4NFVq9iJaPVFRxlMVlato16LP7bJbyLanpIRwa2ouHViMhTkj1r0m0f8A4T7Sf7NPl2djbqBIwxukx0VfQepr24RUtz52rVdOzS06nzwgIPpXXeF9He8IlkLKg/i7N7VDc6FE/ieWxs3861hkKmUcjA6816DZ26W0EcEShUjHy8dK8/EVPZ6I9TDU/a+90JLe2EaKsaYQHGBWraWvIJAx0pLOAld3XvmtiythtBbAA6D3rzZTb3PXhTUVsEVqBjA4xVpYNoBI/KpkjIYcfnVyGMHhsfjSCRVWJRkPz6GpYrbPLYwKvRWobJ4IxmrcVruGT07gigzbSM6O2UAY69ATUr24LZwOD68VqxWwBwSNxpxgAOD1Hr2+tOzI5jHNuTg8AnuaGt3HVeMZ3Z+99BW8sQKdRvPOexFVptkSFi+I/u5HPPtT5Rc5lSWxkjUsOOoJHSo4rZ1JDKQo6Z5zWqHjOEcgAjPIpFyFPyL2xnmnyk85QFt85AVj6KPSpAhVcKpGf73arjebtJ4C5ADdD9KrSREEHO4f7PFJxGqhBKSMHKjJx1zmmSOAjBSM4xwccU2c/OxyOf4eOB61AyrkAlc9qXIzWMkNd+pPO0daC67egXPXPWoFO1iONn0pvzbs7lbA4BpOJ0ppkM0gV/kHHvVZ3ZwSufT6VakQSHJByO+O1UpFK9AcZPO6ptY3iQmRsfMob6UrMPlOSeemKbJGcfKzLkfWkc7cluFGDkUy2rEjEEHcfoe9U5VLMMEZByKkDrlgQetNkX5wcdDQIaQ2356rlArBlwCOue9W2yV3fw9SMZwKjGC2COQOSe4q0yXHQTyyCNpx3Oeab5fmxkEexq1CQAynGQc/UVDICjbux649afMZ+yvqZ8lsY/8AVn6gjNS2ss1u6vbyyQSDnKNjFaDKrgkHIPvzVR48GqjNoznhovWx0ll8Q/EFhEYw1tOvQGWLn9KsL8U9dWQbrSxPPI2kZrkJFynXj0qu8eM8HP8AKtPas5pYKn2PTbT4vXC8Xmjxk45MUpH86nl+LcTp+6054yf7zZzXlPl4HUkH19acAU4xn60e1ZP1Gmz0Wb4o6oxxbRwKSejA8Vj3/j/xLO5X7aIF6fukArkc8E7SfYVIkgwA34g0Oq2OODjHoW7rV9TvCTdahdyA+spFVWUlvmZmyMkk5pzICuRzTArKMAjioc7nQsOktEB2DGBwOKf+7KHjr+lR7tp+YHOepo3lgS2C2c8dKV7ouMGtLCsq+mR3yKjOBnCc+tSdQCO/v0pyL83Oahtm0YLqV8MTnb1/Sgs2OntxVvYrZPORSMn1x60uZo0VGL2Kykk4elJzznmnyRsvQnPXmo+nbHrRzCdJIljJB5P1FS4Qj5jyKgBUnPUmnAnAzSuxciY8oGJwCRQqDBPNM5B4/PNSAnOePzpczQOimtBPKRhkZB/OopIwB/8AWp+7Yx2kgHp9KHKtyoNPmMnRWzRBG7QMrxSPHIO6MR/Ktq08ZeIrKAwxapO0ZGCsuGx9D1rIx9KPKz0q41pLqYzwkX0IG1G43s8qeYzklmz1qWLUYWIEymM+/NNMecgdPSj7OpPK89zQ6glQa2NW0EEyb4nVvpU4HIwAK59rLad8JZD6qafFqFxbHbcgun9/uKnmT2Ks47m3LbxyjZKQQetFYd1qRbBRgc+hooUGZykmzlFi3Ke+ahWWaNJ44bqa3LDaBH/F7Gu98KfDPxN4gm3rbNZWqnmWf5VP0HU17Pp3gLQvB/hye91CGK+ntImmMkiAAtjj9cV7kq8ILU+dVNzdrHzx4f0oabHh0PmkAyE8/QVvWsReQkYyTzTFYyyNI5+eQl2+p5q9aw4PJ9zXiVqjm2z6LDUeWKSNK2QKORwPTvWnbqQwB+6BzVC3BLYz8uK04QGU5B9QPSseY6pR0LUSKcE8ewq9EFUHGM4zVQHaMk9eaJbyG3TM0gQk5CjrimpHPKJtRBcHOB6VICwBOM/SuUm198sLaEkf3nOAPwqs+oX84+a4dV/upxmqMeU7VyCeAAAcnPGKrzXUMUZLzIAfvZYZxXJrbSS4Z3kb1DMT+FSpYxg5CqfXPeq5rEuBttqtmFzJPuB48sDP4mqd5ryOu1BI4zj7vIGOxqBLNdwwFU49KkS2jyCOB3z1NNTJ9miKXVpmYeTblMcZPNQm5vXbcSgBIYjGckVdeFFPTIpoXDEDvRzsapXM+U3EoJlmkPPrxS+RlADI4I9/5VafmT2zTTgHvntmlzM3jRSK7Qbdu129cjnmnlCg2nG7OeadJhQRnGeOKZyQSCf60+YtUkMlAKkAcjuTUSLuBV23DsehNDZJ65P97NRIfnAJyOoIp8xooW2JmQoF8sEACmyRqwyV2+xFSCXgAgkng0rkn5eg7ZpS1NoaFNowqKAfmHGDzioJYwykAAnsPWr5USEn+QqF0AUjkE9+lRY2Zm7WQqRnA4G3v9alJ3Rg4xjk4+vWppIiTkL09DwaQxnHyggY4HagbSGxBlXjJ3cevFRvD82Rgg+vftxT8n7pzyPpinswz82CeAaEQRbSUzjJz0x+tPWIuwKY46Z61KjsPukfN0H0p6AHAYEMPSmPcrmFl3tgEHnGenvTJIhj2IzmrbryTnGRkY9aAASQQA2M4wMUCsrmXKCjDKjkY5qNk5YnIb8KvzIUbDYBJ6AcGoQism/I3dRTUhSgimY+FXOV9u1P8k43KePSpguxmycDGemT9aXyyv8AFye3r709yUiuYnbJUAgelNktshSQNx4xVokAdRn2pDkPxyOv1pXGolJVaP7v3T1x2NSsMpuwd3fFPZS3O0devpTSCcdz6incfI1sQkfMB296ZtIzt7c9KtJGMk5wo5OaUA7SWGSfSpv2LUebcqKpBB7GrCgEkY5xx6inPDnBBBUfpSkZI39O9K41TsRugzuRscfjSqxABbOP51KcDGQTjoaiMZGcdPrQXy9iVhvz06daqTxAcrg98VKodDtYZU9qeBuBByG9+9Fh3voyiHGR8ozUivninTRY5QHj1qBCVb396fkZSjy7EwUgjjBNLvx1PFIjEoecYpJFyAWJ/ChopajtwOTnIxTAdrD+72qP7ox1okbjHekTJkj/ADHoM09RjA6GoYsMQABj37VP904znPrUsqNmBXceBS7cEbvpxSxjsTj0NTInQ4yO9SVyoaI8g54pskKlSCox6HvV2OHcSD0qY2pOOQfrSTZnOKZyc9qsE2cfuyefait2/styn5en60VvGppqcE6Ouh9U9B6AdhXB/Gi88jwYbdSVa7mWPg/wj5jXeV5p8bf3lnpcfbe7EfgK6JbHk0VeaR4zCm04HT3rStkIXIJ5qOKIZxir0CgYBPNcLPfgkkW4AABjHSrPnLCjSSsFQDkk1mz3KWkfmSE47AdW+lZDyzX0oaUkKPuoOg/xpKNyZztojXudYec7LUbU6byOT9PSmQxNJySWY9S3OaitrbbjjpWpaxH1wf51Sstjmab3I4bYnqK0YLRVG4g5PT6U+KL5Rkce1XY4Co7cjrTJI0iwuADg9T3p4iXaeCAKtJEQ208Z7GpGjUjCJ1PBz3piuiiQvBVcjpTQM8YGRzkjpVortAU5z69KcYWLDcc44Jp2HGzM2RmX7p49cUEk9MH2q46JjaFIOeD61EYGRgoHXtTN42sV25X27dqhdOPm+nA6VeePnDjaR29RSOmPlAzkcj0pDTM4Kc4wTximyADjrjtVuSIjByAOpxUTRgrtLe+aRqkii4+bGCVPqKjZMFtyk45q8647ZYfpULg4x3pXNErlYKMgAZI556YoViGI6j+dSlBjPTnpTHBA5GDTUjT2YK4BXkkemae7B19ieg7VC2CcbR6ZHFMG5Txz7d6pakSTQ5l25z09umaZxtX2PXFTkKwOGJ4/iHNRupHAHPc0mVF3IZIhtJUgE8/L3pACYui5HU45qXlFJJ4B6ZoiU4OMkEcimSyJY/XBwARUgBToR9RzSxIWYOuQFxx39qndTkjHzDqMetAkVC3UFeSc4xinRqrsFUYJ6jGacACVJHHp6GnpH83JyOgqblWsQyptXDDPUY6YquV4yAQR/KtMgsCMEj0IzUBUouyTkZzg96EDTK00CqASuNwxz1FQMpygXIJ4I9xV0R+bESG2kchfX2qrHhcArk554+7VBHzKqO287lB9frUh6sedy96l2rliACvHPvUgUYVkCnJ249fegbsVoyu0DB+b8iKCoGQv1PFSGNFjYlsKO3vTkQEDBOM5FOwN2IhGGw+OCOPenBdqkgHJwCOlSqFDnJwTyMdKbIuDhTgmk1YaZFtIGMZHvQFLDHQD1HSpXYFlAxkd8dKNxI7dMHJ4NIdyEKoI2sSRweKDgE7sHHcdqVslWAwB/KmlWIyMY70xpg5Tn0qJyEBG3pyMUwsdx/UCm5OOufegHIk3KevHrVeSIHLAfL1JqTYdpC8kVDuwOecnHWghyGBgDgdDyCakBOCWII9D1qN16557ikGeHB5qrXM+aw9gCDkcdMVC6nJAPHYipnflccrim5JzxzjtSsHPdajVByeKsAs2QcAH161EGZep56jipAwIPGSe9HKTGdmToNoGVPHT61ZhP944Y9zUSnon8Q5yKmByc7s4/OoaNue+paiwHGMc9KtRgMSeCPp0rOgIADcqR2q/DIoPyZB64Y5z7UuUiTLFzb7ofu4HY+tFWoD5nXdkjhRRRZmTZ78DxXnfxhj32unPjoXH8q9CXpXHfFKDzdAhlAz5U2CfQEf/AFq7HseBTdpo8XCASc96fNKsEZkk+6OmO9D/AOswDWZfuZpNgPyL/OuJxvue7zWS8yJ3ku7jzXGF/hXstX7VMYGOR2pllCeh65rWtYAzZxxSchcqS1H28e5QWI5rSt0G44AI702O3Axj8quwoAAf5ChMyehJEvIY7QcdTVlMnaSTjrnsaSJBjGMDOeasFM4Y4I+tWkZMcgHGPqCB1pFQDORuPanhxjpx2PpT0G49APpTJITGHBwvHc9Kj8t8gqOMZPbFW0XdjbkkHPPapSvqM80IpOxRSNS4znI6nOOKfJGDktnPqPSrQiyeex61I0ZfovJ564qrDczOaNefkzkYz6moynDcADH61ovEwHAYf73eozEjAZ7nAA7UmjSMjJlBAY/LgetVSQRjAI5ya25oRGwYAEZwcfxe1VjartZnwQSenUVNjaNRWMm4A2DaGC7RwepPrVR48884HPBrUuIum3oe/U4qoVwG3DJ/pSZvB6FNsE5HQVGCFJHQng5qdgARgcGmNHzhRjPOKk6o2ZBjJwOn9agcZ/PrVwoRnBOPp0qKRCFyuP8AGqTCURkZLLg454pSCGG3OB3qMMY2GRwD+VS579Mj86q9zFRsyNSeuPXinYIJ28jP6UyTj6mpYgcgggEdDQiGtQAOSV+XOQfcetSIGADZySACc9f8aBxypyehqRUHlKFOCCBnr3oHypakDINxPQe/FSIDgqemOKsSJ5hZoxgAc9+fao4485CfN6Aj8ake6Gq+SVYYDDANNlC7vvZI/H60LwxAJ59utDKc5UDjAGDnI6UxECoisN3A5x9aZLEJHYrlWAyQRUuz924PKk5x6UyMlZGxkuc4JGady0isI2jjG0ghe/eliywPA+Y55HSr1uiSNtByGBwD6+lVHiMch2knZ69KLlct0MG5QpyPm5zjP4VHKhDkg4HfB5FWokC8spwOSB3qOFSmVXLKOenPNMVisc85ZT3py5YDoee/apnTkDnPQ+lN2fL82Pr2pXLUSHYMqeQR70wrkHIBHarIBGRjg88dqFT5Tk8Z6mpNOVFRcfQ9xSlWbsOO2amMZHKgkDpTOpBPB9+9FwdJELoGUt39RUXlZ44GOasAfPt/hHGRUnRc9ccZouS4IpmPtz+H86Y0KE5GRVt0OD8pHcHrmozGMcj5vY07kuCKwiwuc5HpULJtJ4xg+nFXiBvyQeeMDvUbj14GehNHMS6aK4UbScD0+lMA2n3qwVweDnvg0hjHXIouSoJFV+vFMQjn07/WrMkZC8dKquh5JyDVqVjGpTfQuwsQBh8j361bVgCucgnpgVjRs6Z2nA64q0ku4bhnIqtHqZRbWjNWIEKcnlT1xVtThAABzycVj210VcBucevFadtIAcOMDII9qXKPmNFZAGGdw24zn0opsbfIwOCGPQ9/Silysl6s+hkNZ3iqyF/4evoMAkx7hn1HNaCVzXxA1uTStFENmwF/eP5EHGdufvMfoMmuk+fW54rdr5MTOV5YkLn9ayUTMhP3mPPNa+ruJ7napyqfKD6471BbwKXGR+VctR9Ee1Qu1eQ61QjBJ+uK1oFJxt+tJDbr8o2j1FaEEScdq53ubtoIomOWNXbdNmNw606JFKHOATVtAhUA8GmrGMgVdp+boe1PYBQMYJqRACDnORUWzJyOtaoysOg+Y43Z96kZcAIvRqII+cHoOc1Y8o55PTnJFBD0GRxAgZIUnnA6j2qfyx5YIO7uKfGoGSTu+gqwke5CF6+1XFEOQ2NeWU4z156A0nlnIOAQe9TrHtIDY6HpxU6xLgAg8jnPFXYjm1KDx7UBbDEH1zxTWt3coYwAMHgDt61eMY2hex4Oe1JKp2AKcFvlJHcUWKUzGu4GVuMHI471W2sBt44PPv3rYkjDsQD1yCR3qtPbjAeI5UjJ9qTidEJ9GY00WGyD16mqc0eQONvc+9brQblHoe/pVW5t/m2r6YB7YrOSsdMJmCYgBwBuHemshBGBnI9OlaTQ8ANye+KZLCMHcWPcfSpaOuMzNZN3Tk+hqGRRjgHI6e1aLRcZAXJPWo3jzEe5HTjnFI05jHmj55BOaTlvujFWJ4sODnnOMVEqAc4yOtNFNJjHXIzjGKkjBZemCeeOmaa2QSF4x3qWAblIyTyBTM5ICpC5GPUdhU6wnCBVGMjknsaRgRgdV6YpYlBkAXgN0FBMth8Rw2xg3TBB4J96VFO1kLcqMqT1OPep2UAoucvnn6VEigEbh82OnYdqQtyFRmXcwGHAyfQ/0zUMoKdundeo5qyEAjcgjG4DH4c1GwQhRgYHXAxTJICBlgc5OeMe9Qcq456Dr05q45+TJBJ2nn6c0wpvlIJPz5OCOV46/nSNIkKoxTKrjryDUbzGSf5sLjvjjkcir6q8UQbaMMdjfT61msvlysjAHDEYx79aGaRSZKYTj5Ru4yOc4qs0jK7Bfl7Fat2r7Y2U7QR8uOuahaNMnqA3Y9c96CrdyHoC3IzTkfKlcZ69en1pTlVHPA7+1KuFGflyO3emNEOSpGBjPalY5xtHQ81K+0EMD2/yKYW+YjGABwB3HrSHcR1LfdJXjgZ6VAQSAOPpVwFCBuGD2weajlUBgpxgYHHf3pGkXYpqmW+UkgHkVKcYxg56fhT1A/hOQe9BX3znuaAbuyJclD+ozSEYOCRzz9KVlwdx7fpQFHTPymgTRFICR3GO9RsuMDn3NWZBkDP0qOQEEkjHPSkS0RMMEZximEsCeMBuKs7Qc5xgVHIm8kYJNO5LRWK555w3HFRMjEEHBBq4IgBgD5v5U0RnHIwfX1p3MpIz2XJAOQKcIzjIxxUzpk5IIpyxg4wd2KpMwlAjB+X1+pq5Z3AQ7Xz0yMn9KhEe18bc9AB61b1Gwgs9QjgmuyVXAnZI8+WfQeuBWkWYTVi/GSB87Oj4Bw4xx9KKy75p7TUHhu5ftBCqVmY/eUj5fwxjiirsZKS7n1GvArxPxJqx1nxLqV8sm60sR9it8dCx5dv6V13xW8VjRtK/s6xf/iZ3i7EC9VXu3tXnYthYaFaW5zuI3uSeWY9zVt2PLowv7zM3h2OT9auQLgjBx68VWiX94e9X448nge9cM3qetBWRbt1yw/nV9Uxj0NVYFGQKvwp0yeDWW43oOjPzDg5q2hwvvTFjAIGMmrCop7YqkJtMcDkAZOfWpY4h82QR/KmxrjJAUjHXFTRcBs9atGTJI41OPT1qdd3AIxiol4HDYI4xViBMgghs+lUkZSJY4GOCfToKnjQq4yMj9c06FS2VHAHvmpAoHUdM81qtDFsjcMzleD6elTqi7cknHXGfu1HtLAMckjnNOYrwwBz69KdyGhrjKZXp37kU04KbVXHHGexqWRzuIGApHIPH/wCuoc7lxwB6k8/WjmGkRpCgzkgn9DUUsZB6KB229vwqyvy4ye2cgZJFLyOWOMdT1J9OadzSLsZ8qsrY6krhgOg9KqOrInIDHtgcYrVmJ2AlUQhucen0qo8LLJtJJGPXsaTSZ0Rn3MuSNoixPrwR/Sqk8RDKR1HXPGa2HQgFgc98AdqpSDLgDrjg9aho6YVDOlTlR1GcdO+elIVO0MMZHQGtNoSvPGwc8VBLGAT8uFOMY/rUtGiqX0MS4hBJLY5OelVPLBb5sc5GPStmaE7skjbjP61RaBvNwD1pG6noU5IxgEnGByKETEg9/T0q08WC2RnpkelNtUG4hsDJH400KUtBNm5GBA29Mg9PeoAPnByQFxj1rQdQFdenUntVWFPn/wBvOGyeo9qLC5tC1sLKxXAwfX1OP503axLE7fm3L/8AXqzEylVJ25OO3QAj/wDXTSnzjkbuSCfTkihozTKki7IyRhjgEr64qHC/dAyCMA9xmrEvzKSo6MQefbNIF4bI+6QRjocCkWiCTAj2kABl5PemqhWQFsbgecdj0/KrjpGVBGSdoGD71EnzMGYDGMbj/WgpSQy4d9jocDuR2NVZkLoHcMCfUd+hq3LH+7EbAAHDB+uR6U1VO1A2Xx1TPb2NBaZmRqw3IPvMPSnKAQVYHLHIIqwVPU8kEY459M0mFPl7AAPuMCP1FCNG7kRiAwDwSOcc81VYEkqRgDv3PvWmAUG8HBFU5Q25sYBwM+9BUHcrNtGcjGf0pduduFywpXXjI6AY/GpFR92ST06d6RQ0jAw3UHionye3A/IVZdGRgByRyD61E6EA/NnnkH+dA0EiovtxwBxzTXy3I5Hp6VKAWjA44/OnEDaBjhh3oE3qUWBLEke5IpqDrhsnHftU8i8r1J9qYF/ujp1oKuJ94DoaYQMZx07VNweMEY7Yp3lMV3MAOcHHeiwiuU+UHGKRV+Yj+VWgPl9T78UzZgfwjnPpmlYRAw44XqelG0dSAalYHcSvAIyAecUiqcHPSlsRJFZkGT6+1MEe1uAw71cK7VG3r6mo2TIzzn607mbViCRQdzjjoQQO9dAbSW9AurzQppJ3AJZJgiyejEHkZrGUbdhQDIP5fWtjWbaC8vXnGr2q+ZyVLN8px0HtVxOSrujl/Ef2l9Sla9hEE+F/dA8IuPlA9sUU7VIEinaNJo7hAB+8QkhuPf0oq+Yx5EdBZm51jWbjWNS+aVz8oPRR6CtDXSDHGB/Co4qnY3saw7MgHoBirGpFZ0gkVgVKAEg96tNu9ziaSsjMhPJrSt1DD9aqQQguMCtSCLAx1PtXJM7U1YnhGCAB71oeYNgAHI61UAG4enqKsQAh8DjNShMuRfM2RnJ5qcA55HH8qiiG0nP0qwMAcnn3qkQ2x6AgZ6LU0YDEgEe9MQbkwMAdyO9TrFt7e9WjNsVAdwBPGcZHOauxJtfk8dcegpkcRUqeOegHr71PHEQGyApz69atGMnckj7qSBnPzAVJnOEIdXx1zxUbOUwAVwOCM96SA5BBcgbeQKq5FhxcmPHPXj0FRkkkrjk8D6UrSBcBRx056VWLFOny47jvSGlclG7DfN0Hp1PtTQ2WBwSev1FJvMwPPy/3SP0okKoRjDY7eh/wpFWHoxfAPUdz0pvmBVBHP+038sUsDAjBx04wcc/4U1VbbnKg478ZqkwAZL4dhuIzxyDxSzYyAFJY8dPvHPehX+XcyqG7qe3pT5T8mC4UY3fPjJJPQVQ09SnK6kvHsYuygAkY/OqsqKsuUADj26CrkseBsOMt03VQkVlyAVC565wc+lJm8WMlVzgjOzGQcdRimMrHoORzzT3lJVVzg5zyfT0pMb1BPG84PNZ7mt7FVlVwx5+UYqlJGWO+NMDGzn1rUlAQhVI8zGCAOKquCrEkAg9QD/nmg0jMoXAAwQCeOfrTbSAmUEDGXHBH0NWFVuEyTlSSeuc1YtlAuEZicrljx7U0U5WRBNbh4mwSUyOD1qtHEwmkfG0hiAMdBjFbZUITnkEBVOKqtH8h2nBZcsSOmTQyFU0M6IEuMj51Pr9KmcM52tGG3HGQeRxVko3mMcDAcBSB6DP9KryIGkC5PykDb0OWHH5CmXe5UMCgjcThnOB7en5VY8ravABUHjNSwpul3bWbD4XjsT1x+FTmHYuW5JII4ODzyaVhuZlsNpUEFg3Uegz2pyfNLjAOMc/hU8y7nIYdF2gjqM9M/nSGLbLuYHIPYe2KixVys8TBWymVHO7tUWFDfNkEeh4/Gti3VZFYqcHb8vHA4xWRIAZNqjgA8e9MuErkdwAP4cLywPWq7AOeV2kY4x1q88QJC5J+UgYPbOKhAZ2DHqT0/Sg0UtAABTAGN3bHJ+lUpgAykg8njnt9a0IwuMsBgDHvmoJoywJCDGAce3rQVB2ZSZN2ScjsQB2pYYwOMkHH61dZA2NwyWGRxUTbtzBwSFHGBSNOa5Xk6fKQCOOR19qrynA2j8z1q5KqkhsHoVOf51VdTJnAXg0FodAjBlx15B9M0sgwAMD1qeCL92AwOOO/fNDRAqdpwcYAoJvqUmBDgkdhSAnGzg/1qRwFJ4OOlMkXJ3AZPcZplDV+UEnlhzilyWUjJ5GdpPT6UjgKQMDgYJApyg7RnjPv0oED4K7hnI4oHIGeCalK4ABz68U0jb95eR+OaQxvlD05pqKwYYIAqYsdykEkLzSBTjg9+KAZGyZOeoPtUMind8vpn1qzjPzZBHpUL8ZHTJzkUiHEdZXgtS5NvBMGXH71c4qaXWQVJ/s7TyR/0zqjcDbzjgcGqNx3x25yaLs5p0k9Rmpzi7nMxiihBA/dxDCjFFR3sdvFt+z3XnMcZHl7eo7fTpRVGDfY6H4i65p8+s3EeiW0MUNudnmJw0zHq3sBUOlIqeH7FnUMzKznPux5rhLyY7pXOMn/ADmu/UGLTdPQcqIE6/SuyrpE8WkveVyxbBNwYDn2rTt2xnaSayoSNoPOKu2+Q+M59TXnSZ6kYmohDKGBx2wRVlX+7nGaqQgAYIOP61NENzZxx3GKSBl9ASCNxHPapwrbduc453VUhG1h1I/Wrg5BA7mqRmyQEqORgnrir0TKzoCOlVYxvAUkZ9j0xVmJRuydze+cVpEymWiqFh024+tTbfmHKhunXmqsfTJPB61NyQvJ3DuDiqMmiQodxYKeuB70zOwdvYdBTXkwpEmfqR1/KhWVmJIOB0pgEjNtACjBOQQc81WfLBRgADtjrT55N0fyDA9eN1RQyYAGSp7MRSLSsrj7fMO8NyW4yf6U9cs77SxHQj0PtUUuRuGWx+XNNSV2jCKeB0b0FFx2bLXJIJwQF6E9TS5O7nnd1IOT9KhSVuMgDJOT70ksuxSGYK3qKCeVljapTA5RSchvWoJRGrvw7cHkHpxTPtG6MKXI5xzUDygEMT2HQ5ouVGLAyEhAz/KcMDwcH3qpNISx8xjnGeg4HvSu2AxVSRnoe9QSuCxYd+eRUtnRBClv9ZkYI9T2/wAaVJQFwT0+br3qtKAoAVSSfvH09aQNjHGEHAJ/rSuatEjTEvncckknjmoLmXEJwQB7inOwZuvLf5xUbEkHC5HvRcWwyLer7o+DgY9quxjyg/Azt4/+tVTJEi7frj0q3FjarcYzk49aYpNkwZSBk4IzyP5U/wDd7yQAed208Dpx/WoVkXaThRjj36UxWbhiecZ9z6CmRYkd12qAQwALFscliP8A6+KaYsEybgCNzMwGP9nH607+MHHAO859ajkJDxh1643A8jaOf1NMrYdbKIp2KrzGDjHqBj/GpnjIBVcqT8px+tLBGVuYVkY5DfhySSf0qaUsqISoYHkj6tnPt2pkt6me8QdgNy5Ykkeo3D/CmyQsjBZCwYgHGenXFX3hCZRCjr8oyOSB3/XNR3BXfmRWCgsdw74PFTylqbbKbnyZCExgHaRnjA//AF1nwqWkGV4xuOauT585gwLOOSP7x7/ypiIVmbjG1SOvUDqKVjaLsio43wRhiQ5wQT9aaEPyYb7pzjvx0FSSHbwF3DaMA9gBTymV4VgMAYJ5z/nFBdyNYxuJDYGSox065FRPEzEBiRnrj9KvMjfMoI+XDHvxjioXychBnaMeuc0DUiBImA3Jxnk5qC4QjJ5AJ7DqK1cbY8KwyMHkVWnQAux5ICnj+Hn1osVGepjTKVfdyB2wfXrSbFZgWHJ4PvVqZVdmb+Isc+3OaaByMDAUE5P8qRu5Bt2p8ozyOg/SoiCBIMkDODntVuRCY8hfmGOc+9VpOSd3HJpihqVJM7flPHP5UyMHGRjcB/WnuCOMnOSCPWnKMYJHHX60GpCYugI6UpUAZOf8asmLJI6HuM0/ySeSp+gphzFZA3AHft/hUs0ZC9MDpVlYgv3f0HWkYYOM5/XikHMU9mR3z/Ohcse3r9KtOnOcnk1FJHtA+nSkO9yBsKNuOP51WkzyWzj+VTzDAI5JHNQyNk9cZ/GpB6FaVsY3MeTjPt61sXdsLCS9uY7FDsCW9mrrvErHkvjvWHMPnABBYnC81p6ha29raTb5bqSewljV38zAGeoQdvrVxRxV3qjE8TQpBq0iRRiMlEd41HCOVBZR+Paim65brZ37IsjyRuqyxu/3trDIz70VTWpzpqxyEgaboWRgMY9T/wDqr01xttbM56Qp/IV5yVMrb4lwEX5h/e/+vXoykTWNnIAQDAvBHtXTVXunlUviHwHjPT2rQtyAeRxWQj46Vo28mduR9CTXAz1VHQ102nHOKlh4bnO2qUchUe2asQMzSYJGPQUiOU1YsMc9fap1AwTnC9xVOJjtBxmrIOSDtIHpVIxe5egVSMAFvTORVtU44PX2qnC5AAJP+NWUYDgkYHODVrQykTJgNtyPoO9KMFxknOPbFRrKnr8xpzbXRio+UjGD/SqI6jCTv+Q8tnO04qGQhE+85B6E0kjBflON3r6VCX3N97g9qDRRLG8McbgQOPrSv8oYABmPP/6qrkhQSCAMdahkm5HPHp7UilEsKVfaGJxnGen/AOqon2sW5wP4famlyTjAwMZqQjefmOMn5SaB7DYyojJcgkdiepp3EhVGIJHHSnHbyMDBGCcVGpDHJzkZ5ApBe4rtjcQOueM1VMirgLk9gSOasuchQRyT19aqEDeQDjB70mXAbuLMwUgHPU1GykHMeCDxzT3GwckZzjgU1wFRuQMHg5zmkaJpEE7qV2g7do5HXNIznZjPyjk4FIQBCSC2W9utRA/MA3ORyaC7iF8ljzkdMU61ODk9B1yabxu57cY9qlRSibmwB1GO9BLfQHYB2CqQT1qYvjhWOOnTrUK7tuXPvnvU0WxvmGRgZ/HtQQPYkrtBGBx9T1NIiZfcDg4Jx14pAjfU7epHFS4YsNqBm6c8Y9qYXHLE0jKEGMnAz3pTG6AAjcqjaMnkDrQhAO5SeO56Ad6mWNWZhghcbgM/TqatCbGwMVmHUk5AyO2B/WrC5DKZP9WfnL+vXApEHmXC7QNv3cg8cYz/AFqXBeMFu53Yz2xgD8qu2hLZFFujLuP3ZCHPOcYBJP5mo7oN5JxkEDGPQnHU1bZJHkc7AAw2rxwBnJqN1aM4kO9uwzxknJJotZE3VzKljKtcbGIBYDj646/iaWVEcOd4X5yR7Dnn8cVYkgEcwaQg4ycdh7fqKhKhQI43BIAJGO+P8is7G3NcqEMAquB0Jx+Of6CplhaIyscNtCqcjvgEkVHGivLCwD7HHmAZ7DIH5nmrUQ3QqQo+ZSM9zyACfyNBTZWaE8r/ALW3+YpvlNIpkHAzwF6kdKvMBuG1wQQcg8nHXmjYQoiZgCNpIA4Ht9aClJoomM5OQR/Cp/Sq1wpCISoJwQFB44xWlNEfKUlvfJ6DHWoJwNzFRksMKTxjv+dIuMrGTJGRyNueT7UQxAfMwG0D86vyW4lC9NpO3aOo9TThDh8AYDH5fw4zRY29p0KTA5cMpH9D6VSm4dm2knHT1rWljIXaw4DY+pqnMm7ZnJB6/wD1vfNA4SM/ZwN33gc0ix44HPQirjRnBIzk8fnSiL7ojHXoPfH+TTSuaOdhkS5bgDP0qxswygkFuhH4VChCsGxyOnXn0qVyOSoPpz2qhXbEYbVA7dyOtRHKkkA+lLuy27OCOefX1NRScALg8/NjNSyooYSQVPZgSMdDzTZ8EfK2RinOBt5GB1wOwquj8kE8daRqQzHIOB+tVmUY5z61acegyPcVXcgcY5qbEuWhTkG4EZA7cGuhaO/eF0utHt7iaXYS5nC+Zt+6SM81z80gHzZz833cYzVjVYLbVb1ruHVLe3V8N5cxYSRcfdAHUemK2hHqcFeVylrtpqPntd6hBgu20lSCq4HC8dOKKl1K6ieLV5I7jcLkRQpE2QWKYzKfTNFacqONSfU5OB4WkKFCp7BuGBx2/Gu/thu0uyZmJbygCc154DMQd0MbKONx5Iz3/Cu90k7/AA3ZMAAQu3g5GATWtX4ThpN8yHHHIPJFWIjtxwce1U8k5ye9Woc4HOTXns9uGqNKMqcf1q1DnPHHvVG3fnIHHvV1ZFC5xihIlpmnE+cAnHrir0LAjsfSsmBw5GCR+taMA2gc96aOecbF1AeDU6HIz/EKrxtkKRnOanzuJAOPrVGNhiE7uhDZ7GiSYqQcnH1pJjggAfNkYPpUUjEgcgAcfWmUo9RJZyHwrE8ZpFbliT82KgdznGfrikeYbSQeew70GnKK8oJGWIA69xSxvhhuYke9Vmk3AkDj0piSsHBB60GihpY1IJFwAe3r0NWeCoEbEN7joPr71kRy7m55Hrmr1pcYVlH3DwR7UXMJwtqPGDjGQOnNRr149SRUm8Ek5xwaqyPggKMn1pXCOpZkbKAE7scDiqhAQDI7VYWQMM5HYE1BKCXxnI74pAuwjANgnJquWAfJDY9DVh1AAIIz2qrLhWw3Xr9aY1IGG4FiCFHUVHJgAHGCOR9KkPKZzkZ6io+WB9elFg5rjCqlsZ3YGcYqxLGVYK3BA5Ge1JCPIV24LHgZpIuHO4ZDHJz2FMrcFHC43BjyeKkQEll53Z65/kKYck9+p6VMqruGVye+TUgxXYMCASFyMAmplUA7mDHb+VRIMtuBUAdj0zV1WBiXzuv8I9aYmyMKZB1C8fjio43djk/w8/jmpRuRfl4bHQ9qYiOS2ADn3xx607i3LSAZBBBQnaNozu9c/wCNSEkNJtIUMcDP93PX6cVUjYPJtUYftzn8KtqPnwIznB4z19T+FaRZm9BWcxWzLKWw/XHUg9TVSX5puuUz82e3HQ1buQ7MMKiKvzAkZPPb61VwsrFnJXO4kL1Jx1NMcdNSORI2RRIdnQ9Dh2PQVWllLEvGwDAsA4Hcen51ZuFTYBNMYo1YnLL1bp061UkaOQbYAVjX7oGBvH9786mVjWNmCAhl43DGRtPAPQdOnerJIWABWOfKBBHpn/8AXVXyjFuABAYIAB364H4CiIusZUBuwODwcdF+n+FSXa5JKVYbVYcBUHy8bjx+OBU8jIGIjz5X3lzjO3/69VB8hVl+8oLj69P60ryKZJNy/OMdPUf09KVx2FQK27euRt+8eR06fU8VDKzGRScnkjnkZ/zgU+5LmMBcEvwfrntTE+TgcnJIx0IH/wBekWl1JMgOcA7Y8pjpk4yf1pqoqqrPzJjgHqO/HvUpYLGgHzuB85GDuPXFMZSG3NgkfMCD+n0qhIa0eUA5JBwPc/8A6+M1UaEgoQwbkgD1PoKuFz5hJ2sBwpB4qJyCFU8hR8oXoPegpNooxR7sbR1BwB+tJGBuHzcDJGP5VexiMhM7iByRVOVtg3DHfnGOapI05rsgCq7ZJ4AwAP61E7nJAHHv1PpU6rjrkZ5wfWopsBOfvZ4yaTNIjHO1RjOeOM9frUMnUdM9KfIGVdrc454qvI+COOeuPSpZtEbM5xjPy5z9ag3EFT096HkJPOOajkf5WJ7/AM6RbY6STKscDPY1UmfaCvbjvmkeQZO44BqvM5VuTxVJXMJuw0n5jkkKeD9M11VxPLbf2jFBZW/+jKjwqYQS8fQnPf61yYcNIApBJwBk8V0M72WnXvlyXeotcwDy/NQgADGcDPbmtFoclRczMjxNCx1WZ2AQyRowXaB5YK8Lx6UUag8M9zJLDLK6Nhi0xy5PfOKKBKGmpxLqTglHBORndkZ6jiu58OSvN4eUP8zLIwYnjnjrXCnAADbcDIKqTk/U12XguTdok0YKN5cpHydgR0PvXVUXuni037yLzDDcflUyHBXGcelQ5AcDtU0WOxP4mvPkj3aT0LkTEr1qcB8jHf8AlVNGJA9OxFXoXzgdPwqTRlm0OAc5/wAK0raQZAfj361mI2AAcHnrU0T4bAzjqKZlKPMb0DqFxn8R3qZiGGV59cd6zrYhhkHkdQatFsDadx/lTOSSsyRm+YcHFROcDGRj1zSu/wAu7oOnWqs0g7Z5PQdKZcESMwUFgOPXqaqSTBzwO/YUskvyZJ/+vVEvhsZNI6KcSVZOMcj0pisdwXrn1OaYBy2T9KfGozndQa2sW48LxjjHXPSrEc2wkZ/Sqig7e5FWY0+UFmBH50HPUsXFkPl4yAT3pnl5ycdPve9MIRTzwaiDEEjcRkc4oOd+RY3bcFiFyOOOlISpBYnjPpg1CsmflDDp3od2GVdCB0z2xVJXIbGXUgyAPu+lVmmMjqqrx1wKxr/XrFZhFHP5rDgiMbse1W9PuJJl3qhjHv1o2DpoaLKW4UZHfHGamjh5U474B6AetELfJ7dCcVKzBQEjBbvkn+VJjV0QXGN7YHGfrSMw2Hy+VH60srEISF60xPujd6Z+tS2arYcn8J/lU6FlOFJqIdAeAPanq2Bu5BPYUgJlwDhcge9OZ8jJyMcDvUSnAOQfqaCyk9OO+KYrEyuN2F4U8sQKV2z91ShbkZPamDBxwvPpSeYkR2OGIIzgHn2poTLaARrzEFY9zzj/APXT45VClscsT82eCKpQHMrO6tzxxU8sxnUAbVjHUqOcD0FWZtXdhhaSVm8tflBJwOAB9akJi4bzf3i4Cvtxgn+8O5pqBjFth3MOAT0CjPX1zS4iLYzt6kArkuT2x6UXK0K907E7VAeSPo7AnJP+FQNIkRVGQuwI2ev4/jzUkxkjJUfNtBHyk8k1HH9rRlmnUzE8hjyEz2H4dqTNFsNSUE4K7zyAzHJPvj8KRpcJuLHdnHA7UtxNuG1DnqOgyT3OahLbh80YAAycelS2aR9BzSAszHcc9sdh2/OlZyqg/wAZOcnqDUbsqDaOo5z7+9V3Y7c52t0BPFK5okSO4WRgcjI2nHOPYf570qPtVdrhWxgZ5z/9aqgOWPzcglcCpcs+MjnPG3pRcq1y9EFXDNkkcflSSSlQVPU9j2FUw8ijPBIOTn1pJZx5YzknH60XG4Fh5MKc/eNIXB2knI5xxjPvVGRtrYUgjpQzsVGO3SmmPkLRkYknnnHU1CSPMIOSBycfTv7VH53zEjBYfdPpTlGA3Oc8nHeqTFaxKVGw5YcY6nJqq+0ITg8etTNNhcMAO4xVV2/hJHznJx2FDNYIikfhWxjBzVSeXqBjmpXcgfMCvbJqjOxC+oPPHepN1ZDHcFwRwPSopZeCCcVBPKFyC2O30rOvL2OEZZgT2A5JqkrkTnYsyy564AFUp7jcxUNwec1EtvfX6fu4TFGefMk+Xj2FWrbQ44fmnuJHf0AAFaJJHJOcpbIda4faWyIz7da7DUpb6C5222kxzW6KBE7wFyVx3PrWPptlp5kb7XcvAABtyCwNajyWO0Ea5cKF9A/P609DCXtb/D+Zz2pSztduZrVbeXA3RKmwAY9KKn1N4muX8udrlMD962cnjpg+lFSV+8OJPy5UFUDEZGOT+Vdf4QeT7LdmZgSzK/GMAYx0rm9Qj+x3Zwn7zPVugHetLwVJm8uUCn5oicD2Nds9meLD4kdEw5YdQTnNC8NgA+tKUO7rweTigoxOc5PrXmvc92i9CaJyF74JqzG56+lUlXGM1dhBweBx70joLsHTk8/Wra5LZIPtVOJQGB7AVdQZwDyeuRQZyL1q/r1q0GOACQQTySaoqwCkqASanRgx5GTVHNKNyWQgYVemearSyAJ8qqSTipJGBBycYPUVUeQ5+XhaCoIZIxyc59siq/fnNK0mHwevbAphY5JUfjUnVFEiLkkHtz9KPm3fKT7+lQhmHIJPrT0Ylw3INMTui/bNtAB3AHuauQsQ2AAQ3YVmJICNrfjkVYWRwdoO0GmjmqF9trLhgBjqRVXcGGFIJzz7VG07Etk4Xp9KjaUKRxj39qZztWHzOcZGMHjH0rk/FOsTxxizgl2NIuXZT8wX0robqcBSqKOTjnua841CcXuvzBcuVbYMe1U3oRFXepq6BYB2G37oPYV2sDBEAOFVRWLpMUkcSqqKnHIHU1rRx5cF/mx6Vkastq24DGQM9M1OT8pORk1XVuOgGfSnlmAHegQ9skYPFCR5HNEbZByOlWPugHAJosNvoQsCoGSM5oByefTGaJGAxjGaYCQpOOKC0WS4K7CePftTOFxjPt71CBkY704ANgMT1pBZEwkJ+UDjHSpEXdjfjA5I6H86h2ZGD+NSrHnGOMdKpGbLCpvI2OpY9OD0pGQhedoboAowKQuEVQ2fYVG0jOMqh47Af1q0LcmVmlkAbc+MkAAr+v8AWomMnQoqooyPmwFp5nUQlJm+U87e5qvcMH+Uxb16nHGKoS3I0lzPjHqAB2/+vTEuHid9jkEgg4PQn9Kjxje8nyqBgBTgn2FOlMHlLlWQH+Enms9TXS+xGjxr+6ySe5DYGKYcxyElQfT6U3eoTawUqBjA6j8e9MeZFBA3D0A7mpZabWiFkJLdAv8AL/69QTfMeGO4eoqGW7jhPLc9MGnRTRyY2nLdeKOV2vYpTSdrjk4XuT39hUkfAIHQfpUh27SeB3AqE4ABXp6ZpFqVx0jEEhuuOg61Xz0J6+vXFKzhSzZJJ/IVXkk+YNnkUjaOuhIW4Xg9KYjHPDEDrk1C7ksT2pu8sMd+1Mq2hcVlI3Lg49O9PMqqAzZJ6cdqqK3lMoH4VBcznd1+amTa7LUk2FKhuQM9KqyTrg4BGefeqc1yoXLN0rP+2yXMjR2kTTSdPl6D6mmjTRGvJNkbmxxxisi9vxkJCPMkPGE5P/1quW+jXF0B9tnMa/xIn9TW3a6fb2abIIQD3IXk/jQQ5rocvDo97dKHuZBbxn+EcsRWhb6TZWv+qjBk/vtyfzrXmGATnOR1FZ0+ckgZGfWm5W2LjT5tyKUpjk89KhDZY8DApZQCTjrVbPIAPf8AOp5jdQSRp2lnPeF1t49+zk8gY/Opm0C/b/lgvr/rF4/WstWZtqg8k4HPrXQyW+lQC8Dw3EjWZRZWEuN2eCQPrVLUzneO35f8E5+7sntZWiuECyAAn5gevSirWtRJBfSRQptg2q0fOSQRnOf6UVL3EldXKPizwxqWmymC/tZY1dj5cxGU9duaxPB8MkHiQiTdgxOAO2a+ttT0y31C0eC6jDRt1B5xXlHinwU2kSSahbBHtUDAsByufWvTlK6PkKcrSVzjHHBCgZpUTjAB/GnY+bb6d+lOUHJxXmt6n0FHRAiHkHp7VPGDjGDj6VEAckH73UDNT2+WztOR1xmkdN9C5BglTjB7D1q9GnOfy5qjDliFXgj0rQTcVRc5IpmM2KU3BSqkZ6896egOD8xz6+lPKBG3Y3Y7ZpQSU3bMAfkPwpmTkI6sOSGHtVSZiqnGeetW9xbB5UdsmomXeTkYKgjP9KkcHYp8EArnPf0qPYQevPpU7KMYx1qEtxz69KDdSECkE8U4Lkkjt6Gmsc45HHHA609CCTk9Oc+1UO5Igz0OG9zxU+cnklsDoDgioFBwQT06c1Nt4Ug5I4IoOeoNL/w7TjH5VG5IH06c04qQ2QAcdfao8q2cZ+XpjtRcwZR1CbybaaU4XYp9+1cf4ag82ZpXGSTnJ7mug8WSFNMdQQWkYLz+dUvDkSraqTwfWhiR0MQxgDJPf2q9BwAD0qrbgABvvetWlAJJ6H0qbDbJmyeB07U5Vyu3v60qgkDJ4pdgwcdKYhRxjB56U/Jx0GB61ECccVIoGAKRVwdQe2B6CjyuRzx/Kgqc5yM+lPwT0HNId7DQoVCFJ69qQMV4A6VMQoBLEZ/hA4zUZXI6jHvTsFxYwQuSOT1py4JADHn+GkQHOcimFhkg/iaaJbJmY5ztwW6Z5p2XVMKCv+8eBUKsACMFj2LHgU47gSzZwvGc9KpCJfMnGMnPGDuHGPamTSlY2C8KeSy8AVG04bbtGccZfjNRPL8pUoUQE7gR/WrEQBMyBmP3RnH9aV1b78oY7sYxwT7+9PiWFEzMZF54wOR/9akuWULkOzN22jgfjUWL5rPQrMoB+ZSDnpn/ADzWZq14kSlIVPmFcnJztH+NWrqXG8Zb3bNctrE8hti8WfOuJNq9z6A1rRpqTu9kZYiq4xSW7Iob2CO8kS83SDG35T90+ue9ayBtiyQSZXOUYHkH0IqtaeGUS3BeQtKeST61UZJdNnKNzGfxFUq7UvIX1eMo2jv+p1Frdi6tt/SQHDAdjUjY6k8nrxWLazrFdJKrYhnwGx2960pGG4Fc8dfesq9NQlps9TbD1nUhZ7rRjsk4AAPfmq0rAEqBk+tSF2LdOB1FVZZAAQvbofasTsi7Cs20HH6miOQHJdsEVWaYDr25BPes++v0VdqEs56Ack/ShGjloaF5dhVJXjnqT1rMN5NdSFLOMyOeM5+UfU1JaaVcXx3XuUUnPlA9R7101lp8VuANgCZwAo4FVYz9oY9h4caYibUJPOI5ManCj2966S3023hASNQsYGSAKvQQqFwAuD0561LHjYSeGzzxinYyc2ys0AReMkHnn+lV5RsJznK8mrzkIRuIOegrPmGSSSBzndik9CoSKE+PvfKBjtWfM3zYIznoRV25BRdy8jPasudzzvGCevNSdtORDNk/d5FVZD7Zz0FPkkK/KMjI7VWeUspXvnGfWg157CrISOnQ/jXSNcXUGpxpeyWhkmiWOcMMqB28zHfp0rlUEm1nRGKoQSQOFOeM108qWt7M1zc2mpxSyAGRI4cqxx1B7Zq0jKpUTepU1pbhtQl+1BBMABiPhduOMe2KKj1e7ea8ZmiaBAqqkbcFVAwM0VLWooy0R9R4yMjpWJ4tsmvPDeoxIPmaFiPcjmvJPD3jHV/DhWMs19p4wDbytyo/2G7fyr17w34j03xJZefp824AYmhfh4/Zh/XpXbGakrI+TnRlSd2eAwNvAXqMdalRQrEcHtmpNatRpviC/s1IxDMwH+6TkfzqJcsCcCuOWjPco+8k0TMSUVWJYDkY45p0S4PB56ntTI2KngZPbjpVhUJQbepOaSOlFm1bcSrKFHX/ACa0IQDjB96oW6lWG5sD88VeiY5UZG0ds9vemYzLSDG3BCg8gelKwUqTwT6ZzSIwIXIHA4Hp/jQ33sfJnjIzTOdkZUL0Xj35P4Co2D4OVGOpBqwCu/OMHoD6VG3HB6n1pDUio3DbiBjrUEy/eY4GfUYq/Ig4wCR64xVdlJb5en+12oNYyKhBJ+ZsE9OKdABvCnBPPB6VK8eT2NCRqq5GQaZo56DlKAYA5zz6Yp2eMgkE9DTNu5hz17VKAAp+VetBhJjMEAkHkHOB3qB/mIJ6+uOat+WPmYHCHjrzUYixjnrxz0x607GTZyHiyQtJbw59WIqfSSFgQBcVg6nqkd3rlwjqURW2RsehArY019iqCOB0qpRsRGaZ0FuM9ulX4hkGqNqwYDH6GtGMEjB5GetTyjchV4I61J9446jvS4zSqvHXFFhcwgXrgcU5DkjjgVKEBGM8+4oCrjkYxSKUhqAbjlsntxT+Q2PWmAYpQuVOCQSetFh3HH5myR0pmBnjoTTiApznJ+lOChh1Ab0HeiwrkL8HjHFMYk4C7c+9TPGBjccf0qJgcfKM9uDQguGRjB3Bj2BpjOGkKkZK9dxpdoCDzB1PB7UjhiOTyfQ0wGSSGJvkVQByGzmgSM7Yd39tvOKgdkBI2nnqQMn8qkA4wUdFODuHGfwqtQdrFjzSoI81wPVQMH61TuDuy/mAgk9OBx7elOXaMdQDzjpkVFJsBACkD36VW5CdjOunxA+7IA6AdKyPKEmt2MJGViTzPxrbvMtEQArAHrnuTWRaEPr9y3QKgQce9bw0pyZhUlzVYnQ52457cms3VoFuISNo3HvjrVpnzjOdp6+1U5ptpIGdoJ69q5eVnXFmNZ5Iltn6jkZq/DcsYApOCDtaqUzbLyNwMgHB+hp1wRDcOGxhwCB7+1dPLz0dehgn7PEeUvzLUs4IILe+ao3Fzgk84qC6ulUja3y47Vn26z6jOY7fIAOWcjha4+RneqiRZEs93IIrZSSerdlrc0vSEtslv3kx6ueo9hVqxtUtLdY0UlujE9//AK9acEWMHnPXIpeQ7t6sWGEqoyqgdvUVaiQK/wAxAPTFSIq7DgfN29qtxRHACjJPQ1SRLkPCRg7RgAdQR2qMhVy27nrxzirJiLRnfgluoNVmLL0xgdPSqZCdyCdt4HC4Hp3rNkkdeB/kVbuD6nLHstUJnYnAXHHSsmax0M+ffjC8AdQTxWZOxYMATx3x0rYfHl/N07cZrNu497Hdk9hQbJmZIVBwW5Pt3qo4Hp8xPSrF1EEGR+FUZTxncfoauOpnNyWqZNHLLGrxI7KjkBlX+LHTPrXU3M0dpOIZvEN8sgADDZkJkdDz1riROykFm6HIPpXXra/2lGL270iVp3AY7blYxN/tbTzz7VtyGH1jXX9CHW7HAuJlv5LqaDZ53mrg7W+6wPcUVm3+qSAX0U1qYbqdljk5wI40xtQL/WiolHU6YVmlqzq7uAEHAyPT0rLtbu78P6pFqumNtuIjgqejr3UjuDXVTQjLDHy1jajbLggAc1kpcrucsoqasZWratFrOv3mo26NHFcSb9rdVOOn51btmyFHfvmsCxUQ308B+7nK8Vs23y++OlVPV3LorljymgQMk9s9asR9Bjk+3aq0RBbOfzqymBznj0FJG5ahJQEN83uetWYSGPTjvVcZZsjBGOTmpouJT82cHk9qZEkW09BgjP4inyBc52ZPcVXib59xycnqOKlwSQRkDPRu9BhJaki5PBHHr0qF2wQSelTE5TGc+/rUfAbBVvbApEjWIIJycjnrUDMcE5Y561NzvPr0z6Ux49wJ70FJkYCsvGemTmgjYBt596l2BQME4JGakKheCdue1AuYgwSQeDjjpUgViTgZAGOe1WYVUclSB9P1p3ljk9AO2atRM5VCpHHzvxxnsMAn0qlrlwLPT3ZuGb5UGa1JSFHPA46DpXAeJdVN9fssKnyYvkX3960iramEpNlD7HFcDGwfWp7SKWzYAfvYx2702x3swByK9N8F+HYNRt2NyhKnoR1rWykc7n7M5nS3EqAr+PtWzAfl9qva/wCCZ7Fmm05mK9QR1H4Vz0eoyW0mzUISu3jzEH6kVMo2NY1VI2hhj7+9PAPYjFQ2s0NzGJIHV4/VTU2M9D+FQ0api87jg0A85J4PakVOecinBcNgdKhxKTsIwyamTC9Mc8ZpgVh0ANAXKkZI4z60rDuKVyMZppAwB/EO9SYJwc0oi6k9T+VFhXIym5CFzxyP61GSVztYBfUVZCHaOePXOKgnUBPmKEHjPGarlDmKcjbm9D9e1Rn51ZRyO3PIqchc8L071SuBhsnI2/r9aXKVzAZMN8yrjpz1+tRSyEszFic/nUEsg8zB28VAzhcEEfQ1UUxORfjkBG4sNx6c81DM4ZyAclfxzUBlUgA8OehIoRzI5wAG6fKc5rRRM3IW7lxEmSCM9vasbSWxNcSsSWkc47d63fFGn3GlWNpJdoEaWNnVP4go7muh8FeEbCyiFxq0X2h5YlYKWJC5Gelb8v7tI5HUSqORyM9wGAAYAnPU9Krys3AxkHvx0+tetaneeH9FhEkmnWoY/cUoCWrynVJlvr6e5iiigWV9wijGFT2FRyWR0U6sp9DMuEDqWJwR/Caj1bmKF169MirMkA55IIHX3qvqOPs0PPGa1pJcsl5GdZvmg/MyoYJbycRxgADq3XaK6zT7WK2gEMIC4H3u7H1rM0Xa8RMagHPzH1rpLZCVCjgE9cVwzlfY9KEerHQQlmz2I7960Y4AuCvJ7E9KbBEDgdCDjIq1H3HvwT3rJFthFHh9zAdACMVfjwATsxjnnjNQRckcgdjVrGIepY9MDkCtIoymxsmASynjHA9KoSuJFweOf4RWg2GQngH2PFUpmUA7AaJBEoTYAYKCKz5l/eFmHy47HpWhM5PYYqjMgJyD71kdMNSncZCgKOMflVG5JPAyTV+V1Kheeh/GqzRg5JGeetI15bGPdxHGTgr9az5I9uRit2dVYncB19aoyIM8jrVRdiZvTUxJIAfmwSRyQe9bepWh1C9kvIb+zFvLhgZpdjwcAbcdcD2qP7HJOx+zRSOw6hFLYqpNpd4QT9hnJx/zyb/CumEtDzqsU3dEHiTUYrrVmkhk82NURPNIx5hVQC340VB40UW3iBI1TaWgh2Iq99gzx9aKbQoVLKx7RPFwTgkmsu8gJJLD6V0MoAUk/j7ms26j+RvTnn05rjkjaMjz3Vofs2pwyLwCSvHatGEdGPII5p3ii0Z4JCB868gj86XTMTW8T9Qwpp3RtHRkyZzgDn1q0hAIPNRLERnuM59qtQoSTwCcetNG19CeLnJI6DOOlTxDgcfnUSe+Dn27VPGQT0APbPSmZNkg3A7tqt6Y/wAKsbQfrnA+tQFSwxnnPWplQnB+bOcelBnJoIk575B4p8gJJBJx0wacy8KDlh9aDliBnb/WgybK5UkBRnd2NIFJbHPHepiMkFs+vHemE7AG4x/KgLgF3qeef5UNjcFJB9eKRGyS2Mg0ZBYn16DpQiWycEkF92cdc8cUx8sBhidv40x9wAO0DP3eadlmIGeAPu9K1WpkzL128Wz0yWTcQXPlqR2JrnbDT1mAKEOK3dYBuLhIsZjQcrjqaLDS3hlV4Mqjc8dM+laJGEpFvRfC5vJRgYA5Nek6JYjToFiUnA9aoeGIp4ogZVA/CuiChhzitUkjlnJydiYvvQgLnPUmsnUPD1lfbvOgXeedwrQ8sjo2BTwH6luKHqJNo4298Kvao32FFPfAHNcxO19bSlZbRpFB5wMEV60CR0pZIIpoisiKw75FQ4m0KrW55dBcRuACSj/3XGCKnC56YIrq9S8LWtwpMB2N6HpXL3nhzVrIlrUsyjsOR+VQ0bxqpgFHpThHxWS2p3dnJs1CwfA6tGMfoau2mq2VyQBOEY9pPlNKxd2W1jO4ADNP8vA4q3BbXE64tYHkPcjp+dSfYrtBh7SccdcZqlEhzM1oyrAlQQeKqzgAn5UB6e1akqmPgo6t7oayr1ucLkk9cimogp6lC4YZKqNpz81Z1y+5sLzn+9VybfuwpJ5xnb1osdFvNQunhigfjq7fKPzp8qG5+ZjhjuHAPP60jqWz8u3vxxmvRNN8CxhQby7bJ/hiX+prYi8K6JZx7pLdWI6vcPn8apLoZOsjx5VaW6ihiQyTSNtRFGSSa9Q0Hw/aaDGt3qG2W/x8qdRGf6n3p2peIPD+ijNqLd7kDCmJQAPxrDHivSrhDNfahFEeuHYdKuML6mU6rlojB+IN5Jq3iOOEnJ/dwgemTk1reKvGNloX+hW5We/AxsUbhF6Z9/auQvdVs4/Eq6jeOxslnMm5BkkAHbj9KdD4n8PpcNJHplzLuJJOOpraS2RFNdzNfU77Urlpfst3cSv1Ow/p6VtaVoOu3udulzBCP48Cuj0nxkJFA07w1csPUYFdRYa1rc4BXw9PGD6yisHB9Td1ZLZHDN4J17Bb7F25G8VyGpQlvLiI5O78MV7Hr+reJYNOnkg0qOFFQ75ZJs7B6gCvMLm2db8xsMNHCpJPq3NUvdhJiUpVKkUzA8PuUunhY4AOPmrs7dQCMkMcgHn+lcPC7W+tjsCcZFdzZAbT0O4YyRXA0ewaEfqRjnpUitywI6nqO1QBSRwcgdgKmiGW6Ej0z0osSWYhhQRg+x7e9W4ixhYZ59D0/SoLVOo3AgnAyK0reDKhucZz71cUZTlYrtFuXaF4HJHoapTQ5X5RyOa6I26oOHAIwSD2z/Wqd3bGPn5FY5OAeT7fWqcSIVDmpY8ZOeegqpNEq55yDwAP61rzwMjHpycD3z3rPuYxyF47ZB61jKJ205LqY8/lq/yjGKrSMGP933q3NCSeevXr1qubf5euO4rOx0tqxRnLDkAEDjpVN5AWDDHHWr08ZGcMRWTezxwHLsFHXk1pCNzkqVLE8dzNblmtZ5Id3DbGxmm3Gp6gG5vrkfSQ1Hpt7YeTfXVxiZLVFbyt2ASxwCcdqiur3TdQs5rnTlMV1bqXms1beWX+8ncgdxW6jZHDKSbI7SQ3HiGF7lzNMYj8znLAcd6K1dM08P4jnvFhCW5ghWJR2ygJP50UtS7I9TCLjI6+me9QyIrAZHbv3qVgflXcM4AzUbknrjpz61zlo53WIN0cmRnPH1rB8O/u3ntnA/dOSPoa6+8jDRFfxrkNv2TXkcjCyqVP17VKN4vQ2hGd2COvf3pRGw6AY64qyAM4BwOvFKAVGD0wAcjoao0TIVB3ZBwP0qTB4IzmpEi3DoAB+FPCYHfPpQS5CwsBgEkH36VYSQBwCOc421UClmB5474qzFGS27HGKZlKxIeh+bAzzxyTTxnnaduOuacV2gBucVE7ZT5MZzzk0zK9xGAPPAB7DvUUoB7DI5J60MM89Of1pOBxnj0NIpKwzdgDI59M0H5lPUY5FN2sVLKcMDxS7i5PHXg5poUiRRkbjk8cD0qQ8KSSMAZOO1RqgYj0HXmrsUAbCnAzgkD0raKOecrFGwsWuJdxUsWOa7bSdISCAb0DbhyMUaHp6DDlenFdEqgDAGK22OKTcmQRxhFGOMVKOPanlBjpRtNNslRBf0px5+9zSL6dD+lBYrzjNSOw00qZU9aYz89DQZgOxoDQnINKMjtUayg4AzzTuTQPciurW3uo9lxEjqezCuV1XwFpN+xMayQknqp4H4V2IxQOtFik2tjDnudV0/bFb6ZFcW0ahUdZMEgDuKIdY1R8BtFlHuJBW7S5poRiahrV3ZWMlw2jXs2wZKQ4ZseoFcFL8ZtCBYSWFzkHDKYuQfQ16xnB964Tx58ONJ8UP9sRTZ6oOs0PyiX2cevvTVhHLt8adEGDBo88n/fIqtcfGxmyLTQwvo0kv88VlXfwvFoWaUPMqnBZfX6is6XwfZxkbZp4cdQ/zA/jWygieZGd4i+OPiYu0VlFa26ZxuRSf1rkpfiBrmqYW9u5nlc7QQ+Ac0viPQTY6jLCoJiJJR/WuVurRY7lcM2VHQDv71fKFxdZur2e/eO6nk8xDtK78jiui8Jac+oSBMqwRdzB+SAOv4VgPE8t0zCIADByehNdn4btXS9hkLRqBGwaNDhh2G765p2Ffqei+D/Cq+Kry586RorW1CZwOpboPyFdXqXg/StMe3t7SLMzsOTzWj8IYUh8L3F1uUtcXLE46gKMAH071btJP7U8UytnMUHT61m5XbHG6VjptKs47S0jjjRVCgdBirwfLbT1HtTM4AApQfzrBsaMjxfMi6XHbyfduZ44Wyf4S2T+gryS+nivfEOrz2/+pknZYxn+FeB+Fdj8VNRMEljArYMaNO316CvPNMPkxLu272Gee3eqqK1P1NsMr1G+xhagSutqwUZzjNdnA4IVQMAAZrktTAfVIyBnnpiuosRiNeD0riZ6+6RoISWDHIK8A96uQxE8jJU8Z/xqtb7SxO7g8Gr8LADqB6EU0RJl6BMFc8Dp061owjGTwSOmeKzonQkNuPrz2q1HPgEDjPIzWq0OWd2bUc0asAw3BSWP+8R29aqyR5AbCsU+X27/AJGsxrsr1Yb85GeKjN4DHjnvnB6k9/rVXIUGPubbzULI2cYLyDHGeiisi8iKyMoQLt4wegP+Na8FyiKCqMuFJx/CxPU4+lR+WLhT5zKqrHuAx1+lS0bxlbc5p4ycqwyQe1UrjEeQRn+lb1yqRk42nthe1YGpNtUvtyhrGUbHRGXMcrqV1LLcm2szsYj5nI4X/wCvVI6HCcvPuncjkyHP6VrW0RKmWTG6RifoO1WH4GMDpmkpWG4XMXS9Pkt7mR9NtC7hdj7Yt4ZT2YelXNK0O5tZBNa6ZPb3KsSHSLBH41PazzWl4kttnzM8oP417qaVk1FZpHEV/HC3KgliF9s1tF3OacLMtyXt3BqLPeR7XIXehTacY64orPmaR/mdmYnjcxzRQTynp5f5S+cE8YHcUBshgOn9arMCTkcAdM1MOEwTzXOaledOSAc54ya5bxFGF8qRT+8VgwOPeutlHHqMdPSsfWLNZVycdQPpzStqUpWJLQh1U9QRwfWrOw4Jxx1qvYofIKAcqSp98GrkQ4IP5mqsXzXQ3y9p+6Dx27U9UZsHjHufvVI2Dk4HXIzSqB90gKD1z/OmTJiIigBGHXnA5NSBRkEAjjHJpNqLJ6YGORRI43nk7gBg9zTMncRjjOOucYqJgeA3INSM3IyCeepqKR89eD69qTBKwj4Py5x/Wozgj/ZpyEZzkcetOYKBnjJpA2QhWycn5e3enxKSzbQQB1IPWly4GAvU9qmijKj5yuM8IK1ijKUrBt2xqWyB2AGK1dLtmldfl6mq1raNPIHc57AeldfpVkIEDsPmrZI5Kk76F6ziEUQUDGBVsURrlN3SlFMzQHtikxmloIoGIBxzRgY5FGaCcCgCErkmmkcVJikdeOOtAmiIHDZqypDDIqAjjINOjODQCJ6M+1JRQMXNG6kpDQApbnig9Kac4NJmgBp4P161QvNHsL4fvYAr/wB5ODWiQWBwcH1qIkbgO461SbTJaPnf40aV/ZXinTbOCeKCC5iVjcSrwnJyTj3wK870iJNU8oSxI5Sfy32kgMM9eK95/aE0KbU/DtlqtpbtPNp8hEwUEnyj3wOoBrzj4OWEkOrJPPCUSadTGrLjI7nBreM9LsfLfYtz+ELCBjLbW7Qt2UnepNVIXtnlu5EtFgvI28qdgCM4HT+tfSV7pFheBjPaxlj1ZRtP5ivD/ibZx2OuX1vaAg+WgB7liO5/KrhNSZk01uVvhB4rax/4SiwuAQjMLiFie+NpAHuOa9d8A2rJpf2mX/WTkuTXz0lrIJoL23PlzRqFkTGRJHnnp3Fe+eFvGGl3NrBbS4s5FUKNxzGfx7fjWcou2hbaOyIzgigDmmfKwSUNlRyrA8H+hqh4h1AaXol3eFhlYyE92PArG13Yo808TQSeI/Gn2eN/kkkEY9kTqf51janbmC7ZQu3YSMenauo+FNlLdX95qdwxZYB5MRPPzHlsU7x5ZCPUpHUf6wZI9c1dVX93saYeVpep5a5MmrKHzwccGurhJVQuc4GPrXOi2/4nH7zAGemcV09vtYY6KBiuGSsz1oyVi1EwAA696vqSQpzwOlZLP5bqiKSWB+YDgfWrkZJK53fjQgkuprQFSwB575qd5QV+QqHqjCcAEEe+TRI4LBcgjFaIwaHOzMZPl9topu7Y3zfKe2OlVzcN90yAlPfk0x5Q6YJwaG7Dii2sqqcDG3PzH0p8U7GQEMDg96zfN6gNx1570omVmGeAOtTzFchoSHz1KxqjnBJYDjk1lapAssRG04Kjc3pn/wCvUkU4RSEJK5I+gqC5lMj5dsEDH+BpNpjimmYc8WzAj4AGASOtRGLKDruAyc+tacoIB3AAAEAHpVNk2qW5wBjr1qLGzloSaUSjXSRSRw3bxhYXc4xz8wB7HHeo/sOuiQMs0yHP3muBt+pOaW1hhaK6ubwM8NuoPlg4LEnAB9BTHt4LqFrnT0dGjGZLZm3FR/eU9x/KtY7HNLcZrckcmoSmJwwIUOyj5WfHzEfjRS61BHb3qpCu1PLRwM9yoJorSxKeh2m8cDHbr7+1DP0OQMVAmSc54Pb096c5HbnHpXKakynjknn2qK7jzCz9cc4oibnjI96mPzRspHbj3oEytFGVdyMDc27j86mVhuYdqmSPETHHIP6YqFl5JHB6mgEOZBkg/d9aaobO0nODxmlBDEMOD3FHOcqRg9xQNsGGeuM03YQev1p0hUj5sj60zcFbnp/KmIRgVGT0PH1oYlV/vinFlYZ6n3qPLDqRtPt0oE3YZlSc+4qRJBvyTgj3qMNGGwVB4pzlFG7KBVALM3QD3qokSY9GBzJIAka/MzE9qxptZNxdYt1xEhwpA5aqWpXU+tTLbWEZS03dhzIf8K7jwl4ONsFnvgCeyH+taRv0MJtRWpb8KwXVxtmlXy4vfvXbKi7QAelV1jWLCqOB0HYVKpIrU5G7u5Y7Y7UVEHJPNO3CgY/NITim7sgkdqRj0oAXNITzSf5FHWgBaPY0AcUuB170AIQAabjHIp5GaQ0AKpyKdUanBqSgAxSA4OBRTT1oAcT7U00E+tMLUCHZHTtUZXByOtAIzTgaaQrjCAwYMMgjBB6EelcI/hJ7HxVZ3VgpayaTcR3iPp7iu8Jz0phyoIBOPSqTsK7RYIz1J5rw34hQPeeNr2GPl3mVQPote3xybxz1FeMfEVXs/GdzOvBEkcgPsVxV0t2N7I5AxGAiZDtdTz6bu2fr0Nekx+EbbWdCs9V0N/LM8QYwE9D0IB+vrWa3htZPBEmooMTjLsPVc1v/AAWvDJ4evLJzzbXbbc+jAH+dW5NK6G0mznrPUNa8N3BiJkRR96F1yrD6H+lSeMPFba3YW8AiECxnLAHKs54H4V6F41uLG00SWS+iSZmG2FD94sfT2FeWaT4cv9btZry3i320DYzn/WMOuB3ApxcZLmasZvTRHrXhTS00jw/aWqYYhd7sOjOeTzWf4309rjTjdQqWlt8sVB+8vcVwWn6vqugyFYJnVBy8Ewyh9eO34V3fh/xjpushYLjFndtx5cj5R/8Adb+hqJQafNuWpWPMJbQSTx3EJyrcqRyasxrjgNz79a0PFtn/AMIzrbOQRpl4+7/ri5/oaqTlS6tGylT2H8QrCpTT1O+lUAOWwAQKkEhAzyfeocgnIwpPQHjP+FEgz0zgjrnisOVo6lK5ZS4DNtANTC4Un+LnvjH5Vnxk4IJGeoyOlLvKrgyAgdcGmDS6FudwHyAOfWoA6nJDDIPbiq8js2G5A9Sahkc9EPX071LuUollptzH06cCmySZ4FQqxGQw2+9KjnJBz/SpsUWRLlcDBI7VCJgSOCec/SopS27Hf+dMbtjOByKLBoySQ7yeSQTz71XmK7SB90Hg4pzkgjPpz9Kglfc2M4HrV2uZsbbXctszNGFwy7XDruVx7iobe4kguEmgYK6NkY9PT6VasYVmdndPMVCqLHnG92PAJ9OpNTxzvJcTwMtnKiA7Y1iCiTHUKw5BxnrVJGUminf3bXt15sqqrsAuFHHAxRTL2BIbnbGS0bKroSedpGR+NFWR6HYjcuV5HTJoY4OAOKVeoofqa5TcVVIA7E1OmB1HXn6VA33l+lTtxvx6UAWkP7vA7gVXK84PSn9I+KjPT8aCIjChB+U8d6VSoXnAwaB94VXn6NQUTNhmOT+NJtXHJ/8Ar1ECSq5J70T/AOpH1pkiHKEhV4zRksQuPwHb60q/6n8aij6t/vCmgZIYw2dwUKOp9KoG2n1q7Fvaq32Vew/jPqfar2qf8erDt6V1vghEWzJCqDnqBWsYq5z1JuKuTeHfDUGmxh2VWnP8RH3fpXRqu2j1+tKOlanJdt3Y1x82aAaGoHSgQgz3pc8dKKO9ACjqOaUkk849qZRQBL060ds02g9qBjhTs5phpydKAFPApKX+L8KTt+FADc96cDkUnYUg60AOHf2oJApX6VE/WmgEc8009aQ9qF607EtjjxzQCOv6UHvSL/WgkBnPQUrDqaXvSnpQMgIwwIyCO9cB8StNN9qkToBvurJ0XHeSM7wB+Ga9CfqfrXNeLR+409v4heJg9xnrVQeoLew7w1Gt/wCAI40G4TWzAfUiuE+HeoDRXuXnSRCZMyLjhlxwR+IrufhcT/wisIycCaYD2+c1yGuqqT6gEAUfaZOAMd6uOraG3oJNJe+OvEbW8RMcEOBIR92BP/ij6V6tp9nBp9lDa2ieXBCu1V/qfesD4dRonhGyZEVWkLFyBgsfU+tdMOgqZvWwJdTM1fQ7DVVYXEQ8wj/WqMMP8a818TeDLrTkeaACWAjkgZH4+n1r13+KP60pUMkisAVKnINKE3F2G1fc+bptd1GeGXR9T33lnj5Ul/1sPurfxD2rLtddXQrmOw1SQSWbj9zcbfuH+63pXX+K40GoXOEUbZPlwOn0rivGMaNpy7kU89x710OClG44zcWkjqvtCsFMZyMbvvA8etWPtCkKSVGRkAf/AFq4TwuxOjkknKvhTnoMdq6e34u8Dpn+lcUlqehB6GpJK2Q65K+3ahbgZBGT/X8KoH/Vk981YUnbHyag1WpZlkRhzIRn24HtUAkwQMjHbFK/+sP0FV1H7snvSZaZaHU8Z9ieKHY8Y4GM81Gv3Pypz9G+lStx31ANuOW5x3pHfrgUh/1VI3+qb8KdhMaTgZ4IqvK25hzx61O/3vzqufvU7E3LGnTrCXWV9gfDLIFz5bqflOO49atlUjcylbKEuCDMkxfGeuxOuTWQT976UgA8xeKozcblmeQXNyZI0xGqhEVuqqBgfjRUcPf6UUXJsf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous nodules and plaques in subcutaneous fat necrosis of the newborn.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17635=[""].join("\n");
var outline_f17_14_17635=null;
var title_f17_14_17636="Clomiphene: Patient drug information";
var content_f17_14_17636=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clomiphene: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     see \"Clomiphene: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F153216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Clomid&reg;;",
"     </li>",
"     <li>",
"      Serophene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F153217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Clomid&reg;;",
"     </li>",
"     <li>",
"      Serophene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691380",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help you get pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701837",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clomiphene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703669",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Liver disease, ovarian cysts, pituitary tumor, adrenal gland disease, thyroid gland disease, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697703",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of getting pregnant with more than one baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698156",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hot flashes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698292",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ovarian cyst.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698098",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use carefully.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10855 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17636=[""].join("\n");
var outline_f17_14_17636=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153216\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153217\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025191\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025190\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025195\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025196\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025198\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025193\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025194\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025199\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025200\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=related_link\">",
"      Clomiphene: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17637="Nebivolol: Patient drug information";
var content_f17_14_17637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Nebivolol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/34/32295?source=see_link\">",
"     see \"Nebivolol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5580763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bystolic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10015219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not stop taking this drug all of a sudden. If you do, chest pain that is worse and in some cases heart attack may occur. The risk may be greater if you have certain types of heart disease. To avoid side effects, you will want to slowly stop this drug  as ordered by your doctor. Call your doctor right away if you have new or worse chest pain or if other heart problems occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702579",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to nebivolol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Very bad liver disease, slow heartbeat without a working pacemaker, or very weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 12 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may hide the signs of low blood sugar. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698348",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12038 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17637=[""].join("\n");
var outline_f17_14_17637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5580763\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015219\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015221\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015220\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015225\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015226\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015228\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015223\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015224\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015229\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015230\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/34/32295?source=related_link\">",
"      Nebivolol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17638="Gastrointestinal sarcoidosis";
var content_f17_14_17638=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gastrointestinal sarcoidosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17638/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/14/17638/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis is a systemic granulomatous disease of unknown etiology, characterized by the formation of noncaseating granulomas. Clinically recognizable gastrointestinal (GI) system involvement occurs in 0.1 to 0.9 percent of patients with sarcoidosis, although the incidence of subclinical involvement may be much higher. The stomach is the most commonly involved portion of the GI tract, but sarcoidosis of the esophagus, appendix, colon, rectum, pancreas, and peritoneum has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features and treatment of GI sarcoidosis will be reviewed here. Pathogenesis and other general issues related to sarcoidosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6376?source=see_link\">",
"     \"Pathogenesis of sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GASTRIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 60 cases of symptomatic gastric sarcoidosis have been described in the literature. Of these, 25 patients had well documented histologic evidence of noncaseating granulomas consistent with sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238372\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manifestations of gastric sarcoidosis are usually related either to the presence of peptic ulcerations or to narrowing of the gastric lumen due to granulomatous inflammation and associated fibrosis of the gastric wall; in the latter case diminished peristalsis often results [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/8\">",
"     8",
"    </a>",
"    ]. Epigastric pain is the predominant symptom in either circumstance. Abdominal pain is characteristically dull, burning, or cramping in nature and is often postprandial [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/9\">",
"     9",
"    </a>",
"    ]. Heartburn, generalized abdominal discomfort, and diarrhea may also be reported, and symptom complexes may be influenced by concomitant intestinal or rectal involvement. Nausea and vomiting may occur in the presence of pyloric obstruction. Weight loss is common and can be severe, often raising a suspicion of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/10\">",
"     10",
"    </a>",
"    ]. Upper GI bleeding, although rare, can be the initial presentation and may occasionally be massive and fatal [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Many patients have diminished gastric acid secretion through an unclear mechanism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238523\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper gastrointestinal endoscopy is typically performed in patients with sarcoidosis who have persistent epigastric symptoms. Endoscopic findings in gastric sarcoidosis include nodular changes, gastritis, thickened mucosa, greater or lesser curvature deformities, and benign or malignant-appearing ulcers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/6\">",
"     6",
"    </a>",
"    ]. Nodular mucosal irregularities are common, and mucosal polyps may occasionally be present [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238649\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common abnormalities on upper GI series are segmental mucosal thickening and nondistensibility that mimics the linitis plastica variety of gastric cancer. Deformity of the antrum may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/14\">",
"     14",
"    </a>",
"    ]. Deformity of the antrum may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238801\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of gastric sarcoidosis rests upon histologic evidence of noncaseating granulomas in the biopsy specimens of a patient with clinical and pathologic evidence of sarcoidosis affecting other organ systems. Specimens should be interpreted with care because Crohn's disease, Whipple's disease, tuberculosis, fungal infections, syphilis, and foreign body reactions may yield similar pathology. The diagnosis of gastric sarcoidosis is difficult to establish in the absence of multisystem involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SMALL BOWEL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Very few cases of small bowel sarcoidosis have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1\">",
"     1",
"    </a>",
"    ]. Most cases have occurred in the fifth or sixth decade of life, and evidence of multisystem sarcoidosis is seen in approximately one-half of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238807\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonbloody diarrhea generally is the most common symptom, and colicky, epigastric and periumbilical abdominal pain occurs in approximately one-half of cases. Weight loss, anorexia, low-grade fever, and weakness may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238813\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopy (either esophagogastroduodenoscopy or enteroscopy, depending upon the location of the lesion) with mucosal biopsy is the diagnostic procedure of choice and should be considered in any patient with sarcoidosis who has unexplained epigastric discomfort, nausea, vomiting, or persistent diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H522977882\">",
"    <span class=\"h2\">",
"     Other studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    studies, D-xylose absorption, fecal fat excretion, and Schilling tests are generally normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238824\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of intestinal granulomatosis includes sarcoidosis, Crohn's disease, tuberculous enteritis, and Histoplasma enteritis. The diagnosis of small bowel sarcoidosis rests upon histologic evidence of noncaseating granulomas in the biopsy specimens and negative mycobacterial and fungal cultures, and also clinical and pathologic evidence of sarcoidosis affecting other organ systems [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ]. As part of the evaluation for possible histoplasmosis, a test for urinary histoplasma antigen is obtained when patients have lived in endemic areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     COLONIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis rarely involves the colon and rectum [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1\">",
"     1",
"    </a>",
"    ] and fewer than 20 definite cases have been reported in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1,15,16\">",
"     1,15,16",
"    </a>",
"    ]. In these patients, abdominal pain was the most common symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ]; stool occult blood was present in only one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/17\">",
"     17",
"    </a>",
"    ]. Reported findings include multiple nodules, polyps, stenosis, obstructive lesions, aphthous erosions, and small punctuate bleeding sites [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     APPENDICEAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appendiceal sarcoidosis occurs rarely. As examples, one pathologic series of 71,000 surgically removed appendices found only one case consistent with sarcoidosis, and to date fewer than 10 cases of appendiceal sarcoidosis have been reported in the English language literature. All patients have been less than 30 years of age, and most were men. Two patients had no evidence of systemic sarcoidosis, and their disease would be classified as a \"local sarcoid reaction\" [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1,18\">",
"     1,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with appendiceal sarcoidosis may present with acute right lower quadrant abdominal pain or subacute to chronic pain in association with a right lower quadrant mass. An appendiceal abscess is unusual. Histologic examination of the appendix reveals inflammatory changes and noncaseating granulomas [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/19\">",
"     19",
"    </a>",
"    ]. Negative mycobacterial and fungal stains and cultures and documented sarcoid involvement of another organ are essential to confirming the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     COEXISTENCE WITH INFLAMMATORY BOWEL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis is occasionally reported in association with either Crohn's disease or ulcerative colitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Crohn's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility that a common pathogenetic mechanism links Crohn's disease and sarcoidosis remains to be established [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6376?source=see_link\">",
"     \"Pathogenesis of sarcoidosis\"",
"    </a>",
"    .) The simultaneous occurrence of Crohn's disease and sarcoidosis is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/23\">",
"     23",
"    </a>",
"    ]. Five definite and two possible cases have been reported, but this association may simply be due to chance. The duodenum, jejunum, and ileum are usually involved in Crohn's disease with concurrent sarcoidosis, but an associated case of sarcoidosis with Crohn's disease of the esophagus and mouth has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ulcerative colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concurrence of sarcoidosis and ulcerative colitis is somewhat more common than the concurrence of sarcoidosis and Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/20\">",
"     20",
"    </a>",
"    ]. However, the onset of either condition bears no clear relationship to the activity or the extent of the other, suggesting that the two diseases are independent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gastrointestinal autoimmunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 40 percent of patients with sarcoidosis have serological evidence of gastric autoimmunity and gluten-associated immune reactivity, however, the incidence of pernicious anemia or celiac disease in patients with sarcoidosis remains low [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link\">",
"     \"Diagnosis of celiac disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PANCREATIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;One autopsy series of 92 patients with sarcoidosis documented incidental pancreatic involvement in 5 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/4\">",
"     4",
"    </a>",
"    ]. A different report reviewed nine major series and found pancreatic granulomas in 3 (1 percent) of 287 postmortem examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A literature review in 1996 found only 13 patients with biopsy-proven granulomas in the pancreas or peripancreatic nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/25\">",
"     25",
"    </a>",
"    ]. They added six of their own cases, one involving the body of the pancreas and 5 infiltrating the peripancreatic nodes. A clinically helpful profile of pancreatic sarcoidosis emerged from their limited review of 18 patients.",
"   </p>",
"   <p>",
"    Clinically apparent pancreatic sarcoidosis occurs rarely and appears to be more common in women. Two-thirds of patients have acute abdominal pain, and three-quarters have bilateral hilar adenopathy on chest roentgenogram. Typical findings of acute pancreatitis are uncommon. The diagnosis needs to be confirmed by biopsy because laboratory and radiographic features and nuclear imaging techniques are not definitive. Computed tomography and ultrasound of the abdomen are useful in demonstrating the pancreatic \"mass\"; however, these tests are unable to distinguish the granulomatous involvement from focal pancreatic inflammation or a carcinomatous mass. The prognosis of pancreatic sarcoidosis is good; 80 percent of patients improve either spontaneously or with glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HEPATIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver is almost always involved in patients with gastrointestinal sarcoidosis, although the clinical consequences of the involvement are variable [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ]. Most patients are asymptomatic and have only biochemical abnormalities (usually an elevated alkaline phosphatase and gamma glutamyl transpeptidase). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40406?source=see_link&amp;anchor=H6#H6\">",
"     \"Hepatic granulomas\", section on 'Sarcoidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PERITONEAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peritoneal involvement is an uncommon manifestation of sarcoidosis, especially in the absence of splenic, hepatic, adnexal, or small intestinal involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/28\">",
"     28",
"    </a>",
"    ]. Patients usually complain of abdominal pain. The peritoneal fluid is usually lymphocyte predominant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to treat GI sarcoidosis is based upon the activity and extent of disease. Asymptomatic patients generally do not require treatment. For patients who are symptomatic and have a substantial amount of granulomatous inflammation on tissue biopsy, glucocorticoids are the treatment of choice, based on extrapolation from the treatment of pulmonary sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When therapy is indicated, we typically initiate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    30 to 40 mg given as a single daily dose, and then gradually taper to a maintenance dose of 10 to 15 mg daily, over a period of approximately six months. The proper length of therapy for those who respond to treatment is not known. We usually aim for a duration of therapy of at least one year. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/43/11961?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of pulmonary sarcoidosis with glucocorticoids\", section on 'Dosage and administration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/43/11961?source=see_link&amp;anchor=H110264535#H110264535\">",
"     \"Treatment of pulmonary sarcoidosis with glucocorticoids\", section on 'Duration of therapy'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Alternative or additional agents may be required in patients who do not respond to glucocorticoids alone or who cannot tolerate the side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/11/38074?source=see_link\">",
"     \"Treatment of pulmonary sarcoidosis with alternatives to glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although evidence from clinical trials is lacking, antisecretory therapy or promotility agents may be useful in managing dyspepsia or symptoms related to delayed gastric emptying, respectively, particularly if the disease is minimally active. Surgery frequently is required in patients with pyloric stenosis or GI hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=see_link\">",
"     \"Approach to the patient with dyspepsia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=see_link\">",
"     \"Treatment of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238960\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal sarcoidosis is monitored clinically and radiographically. The role of serum angiotensin converting enzyme levels in monitoring gastrointestinal sarcoidosis is not known. Repeat endoscopy is performed when the response to therapy remains unclear, particularly when intensification of therapy is being considered for persistent symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238966\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sarcoidosis is a systemic granulomatous disease of unknown etiology, characterized by the formation of noncaseating granulomas. The stomach is the most commonly involved portion of the GI tract, but sarcoidosis of the esophagus, appendix, colon, rectum, pancreas, and peritoneum have also been described. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastric involvement with sarcoidosis is typically manifest as peptic ulceration or narrowing of the gastric lumen due to granulomatous inflammation and associated fibrosis of the gastric wall. Patients usually experience dull, burning, or cramping abdominal pain; nausea and vomiting occur when gastric outlet obstruction is present.",
"     </li>",
"     <li>",
"      The differential diagnosis of noncaseating granulomata involving the stomach, small bowel, or colon includes sarcoidosis, Whipple&rsquo;s disease, Crohn&rsquo;s disease, and infection with Mycobacterium tuberculosis, Histoplasmosis capsulatum, or Treponema pallidum.",
"     </li>",
"     <li>",
"      The diagnosis of sarcoidosis of the stomach or intestine is based on the presence of noncaseating granulomas on biopsy, evidence of sarcoidosis involving extraabdominal organs, negative stains and cultures from gastrointestinal biopsy specimens, and exclusion of sarcoid-like reactions to malignancy or foreign bodies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Gastric'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Small bowel'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Colonic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sarcoidosis is rarely reported in association with either Crohn's disease or ulcerative colitis, and the concurrence is rare enough to suggest that the two diseases are independent. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Coexistence with inflammatory bowel disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The liver is almost always involved in patients with gastrointestinal sarcoidosis, but may be affected in the absence of other gastrointestinal involvement. The diagnosis and treatment of hepatic sarcoidosis are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40406?source=see_link&amp;anchor=H6#H6\">",
"       \"Hepatic granulomas\", section on 'Sarcoidosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Asymptomatic patients are typically monitored without initiation of active therapy. For symptomatic patients with substantial organ involvement, we typically initiate therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      0.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day (eg, approximately 30 to 40 mg daily). This dose is continued for six to eight weeks until a response to therapy is noted and then gradually tapered, over a period of approximately six months, to a maintenance dose of 10 to 15 mg daily.",
"     </li>",
"     <li>",
"      Disease activity is monitored clinically and radiographically. The role of serum angiotensin converting enzyme levels in monitoring gastrointestinal sarcoidosis is not known, but appears to be limited. Repeat endoscopy is performed when the response to therapy remains unclear, particularly when intensification of therapy is being considered for persistent symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12084252\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Om Sharma, MD, who passed away in August 2012. UpToDate wishes to acknowledge Dr. Sharma's past work as an author for this topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/1\">",
"      Sharma, A, Kadakia, J, Sharma, O. Gastrointestinal Sarcoidosis. Sem Respir Med 1992; 6:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/2\">",
"      MAYOCK RL, BERTRAND P, MORRISON CE, SCOTT JH. MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE. Am J Med 1963; 35:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/3\">",
"      Sprague R, Harper P, McClain S, et al. Disseminated gastrointestinal sarcoidosis. Case report and review of the literature. Gastroenterology 1984; 87:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/4\">",
"      LONGCOPE WT, FREIMAN DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/5\">",
"      Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 2004; 182:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/6\">",
"      PALMER ED. Note on silent sarcoidosis of the gastric mucosa. J Lab Clin Med 1958; 52:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/7\">",
"      Afshar K, BoydKing A, Sharma OP, Shigemitsu H. Gastric sarcoidosis and review of the literature. J Natl Med Assoc 2010; 102:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/8\">",
"      Fireman Z, Sternberg A, Yarchovsky Y, et al. Multiple antral ulcers in gastric sarcoid. J Clin Gastroenterol 1997; 24:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/9\">",
"      Leeds JS, McAlindon ME, Lorenz E, et al. Gastric sarcoidosis mimicking irritable bowel syndrome--cause not association? World J Gastroenterol 2006; 12:4754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/10\">",
"      Friedman M, Ali MA, Borum ML. Gastric sarcoidosis: a case report and review of the literature. South Med J 2007; 100:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/11\">",
"      Munker M, Sharma OP. Fatal gastrointestinal haemorrhage in sarcoidosis: a previously unreported occurrence. Sarcoidosis 1987; 4:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/12\">",
"      Akinyemi E, Rohewal U, Tangorra M, Abdullah M. Gastric sarcoidosis. J Natl Med Assoc 2006; 98:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/13\">",
"      Farman J, Ramirez G, Rybak B, et al. Gastric sarcoidosis. Abdom Imaging 1997; 22:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/14\">",
"      No&euml;l JM, Katona IM, Pi&ntilde;eiro-Carrero VM. Sarcoidosis resulting in duodenal obstruction in an adolescent. J Pediatr Gastroenterol Nutr 1997; 24:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/15\">",
"      Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103:3184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/16\">",
"      Daldoul S, Triki W, El Jeri K, Zaouche A. Unusual presentation of a colonic sarcoidosis. Case Rep Med 2012; 2012:169760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/17\">",
"      Hilzenrat N, Spanier A, Lamoureux E, et al. Colonic obstruction secondary to sarcoidosis: nonsurgical diagnosis and management. Gastroenterology 1995; 108:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/18\">",
"      Cullinane DC, Schultz SC, Zellos L, Holt RW. Sarcoidosis manifesting as acute appendicitis: report of a case. Dis Colon Rectum 1997; 40:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/19\">",
"      Munt PW. Sarcoidosis of the appendix presenting as appendiceal perforation and abscess. Chest 1974; 66:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/20\">",
"      Fries W, Grassi SA, Leone L, et al. Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol 1995; 30:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/21\">",
"      Bambery P, Kaur U, Bhusnurmath SR, Dilawari JB. Familial idiopathic granulomatosis: sarcoidosis and Crohn's disease in two Indian families. Thorax 1991; 46:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/22\">",
"      Bonniere P, Wallaert B, Cortot A, et al. Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 1986; 27:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/23\">",
"      Dines DE, Green PA, DeRemee RA. Sarcoidosis associated with regional enteritis (Crohn's disease). Minn Med 1971; 54:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/24\">",
"      Papadopoulos KI, Sj&ouml;berg K, Lindgren S, Hallengren B. Evidence of gastrointestinal immune reactivity in patients with sarcoidosis. J Intern Med 1999; 245:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/25\">",
"      Garcia C, Kumar V, Sharma OP. Pancreatic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/26\">",
"      Limaye AP, Paauw D, Raghu G, et al. Sarcoidosis associated with recurrent pancreatitis. South Med J 1997; 90:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/27\">",
"      Bacal D, Hoshal VL Jr, Schaldenbrand JD, Lampman RM. Sarcoidosis of the pancreas: case report and review of the literature. Am Surg 2000; 66:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17638/abstract/28\">",
"      Iyer S, Afshar K, Sharma OP. Peritoneal and pleural sarcoidosis: an unusual association - review and clinical report. Curr Opin Pulm Med 2008; 14:481.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4317 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-3AAB480B33-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17638=[""].join("\n");
var outline_f17_14_17638=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29238966\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GASTRIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238372\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238523\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238649\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238801\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SMALL BOWEL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238807\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238813\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H522977882\">",
"      Other studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29238824\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      COLONIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      APPENDICEAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      COEXISTENCE WITH INFLAMMATORY BOWEL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gastrointestinal autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PANCREATIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HEPATIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PERITONEAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29238960\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29238966\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12084252\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=related_link\">",
"      Approach to the patient with dyspepsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/29/40406?source=related_link\">",
"      Hepatic granulomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6376?source=related_link\">",
"      Pathogenesis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=related_link\">",
"      Treatment of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/11/38074?source=related_link\">",
"      Treatment of pulmonary sarcoidosis with alternatives to glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/43/11961?source=related_link\">",
"      Treatment of pulmonary sarcoidosis with glucocorticoids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17639="Potential spaces for abscess formation on the dorsum of the hand";
var content_f17_14_17639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F79227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F79227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    Potential spaces for abscess formation on the dorsum of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dorsal skin of the hand is loosely anchored to the underlying tissue, allowing the spread of infection into two potential spaces; the dorsal subcutaneous space, which is superficial to the extensor tendons, and the dorsal subaponeurotic space, which is deep to the extensor tendons",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17639=[""].join("\n");
var outline_f17_14_17639=null;
var title_f17_14_17640="Treatment of morphea (localized scleroderma) in adults";
var content_f17_14_17640=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of morphea (localized scleroderma) in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Heidi Jacobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17640/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/14/17640/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H20781856\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morphea, also known as localized scleroderma, is an idiopathic inflammatory disorder that causes fibrotic changes in the skin. Patients present with single or multiple inflammatory or sclerotic plaques. Disease activity typically persists for three to six years, and a minority of patients develop more persistent or recurring involvement.",
"   </p>",
"   <p>",
"    The majority of adults with morphea are managed with observation, topical medications, or phototherapy. The level of disease activity, depth of involvement, body surface area involved, and the potential for functional impairment or cosmetic disfigurement determine the most appropriate approach to treatment. Patients with lesions that are likely to cause significant cosmetic disfigurement, joint contractures, or other functional impairments require aggressive systemic and physical therapy.",
"   </p>",
"   <p>",
"    Pharmacologic therapy, phototherapy, and other interventions for morphea in adults will be reviewed here. The pathogenesis, clinical manifestations, and diagnosis of morphea and the features and management of morphea in children are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40985?source=see_link\">",
"     \"Localized scleroderma in childhood\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781863\">",
"    <span class=\"h1\">",
"     APPROACH TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of treatment options are available for patients with active lesions of morphea; however, evidence in support of many of these therapies is limited. An algorithm for the treatment of patients with morphea is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef63834 \" href=\"UTD.htm?15/33/15888\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The expected outcome of successful therapy for morphea is not the return to completely normal skin, although this may occur in very early inflammatory lesions. Therapeutic success is defined by improvement or resolution of erythema, lesion softening, or local hair regrowth. Successful treatment with systemic therapy in patients with progressive disease arrests the formation of new lesions and limits disease spread. In general, active disease (present &lt;3 months or with clinical signs of inflammation) is most responsive [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/1\">",
"     1",
"    </a>",
"    ]. Sclerotic lesions are less likely to improve, and atrophic lesions rarely respond to therapy. In the office setting, we have found that serial photographs are valuable methods for following the response to treatment.",
"   </p>",
"   <p>",
"    Given the self-limited nature of morphea, therapeutic intervention is optional in patients with uncomplicated, circumscribed morphea. For patients who desire treatment, topical therapies (eg, high potency topical corticosteroids, topical vitamin D, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ) are often used as initial treatments despite the paucity of studies to support their efficacy. There is more evidence for the efficacy of phototherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/2-7\">",
"     2-7",
"    </a>",
"    ], which also can be used as first-line therapy.",
"   </p>",
"   <p>",
"    In patients with generalized morphea, topical therapy is often ineffective, making phototherapy or systemic therapy the preferred initial treatments for these patients.",
"   </p>",
"   <p>",
"    Progressive, deep lesions can result in functional impairments and should be treated aggressively with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    alone or with systemic glucocorticoids. Patients with superficial morphea who fail to improve with phototherapy may also be candidates for systemic treatment. However, the risks and benefits of treatment must be considered carefully. Systemic therapy is not warranted in many patients with nonthreatening, limited disease.",
"   </p>",
"   <p>",
"    Local therapies, phototherapy, and systemic therapies are unlikely to be effective in patients with inactive disease. Treatment should focus on improving functional impairment through physical and occupational therapy and consultations with specialties such as orthotics, orthopedics, podiatry, and rheumatology as needed.",
"   </p>",
"   <p>",
"    In patients with inactive disease but persistent cosmetic disfigurement, injectable cosmetic fillers or surgical intervention may lead to improvement. Surgical intervention is sometimes necessary for patients with persistent, disabling contractures. Of note, we have observed the occurrence of new-onset or worsening morphea in sites of surgical incisions or radiation therapy. Therefore, invasive procedures should be undertaken with caution, and should only be attempted in patients with inactive (atrophic stage) disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781870\">",
"    <span class=\"h1\">",
"     TOPICAL AND INTRALESIONAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the relative safety of these agents, topical or intralesional medications are often used as first line therapies for patients with limited, superficial (dermal) disease. Topical therapies are unlikely to be effective for disease involving the subcutis or deeper tissues, and are not useful for preventing the development of new lesions in patients with rapidly progressive disease. We typically utilize topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    0.1% ointment under occlusion or intralesional corticosteroids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781877\">",
"    <span class=\"h2\">",
"     Topical tacrolimus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    0.1% ointment may be effective for active, inflammatory morphea. In an intraindividual randomized trial of 10 adults with active circumscribed morphea, one lesion on each patient was treated with tacrolimus ointment and a second lesion with petrolatum, both given twice daily for 12 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/8\">",
"     8",
"    </a>",
"    ]. Significantly greater improvement occurred in lesions treated with tacrolimus. Open label studies and a case report also support the use of topical tacrolimus in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781884\">",
"    <span class=\"h2\">",
"     Topical and intralesional corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although high potency topical corticosteroids are widely used by clinicians, including ourselves, for the treatment of morphea, no formal studies have documented efficacy. Topical corticosteroids are usually applied twice daily or once daily with occlusion (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    ). If there is no response after 10 to 12 weeks, treatment should be discontinued.",
"   </p>",
"   <p>",
"    Similarly, there are no formal studies of the efficacy of intralesional corticosteroids for morphea. However, in our clinical experience, intralesional corticosteroids injections have been effective for the treatment of circumscribed morphea or as adjuvant therapy for recalcitrant lesions in patients receiving phototherapy or systemic treatment. We typically use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide at a concentration of 5 to 10",
"    <span class=\"nowrap\">",
"     mg/mL.",
"    </span>",
"    In patients who respond to treatment, we repeat injections every four to six weeks until sufficient improvement is attained. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40660?source=see_link\">",
"     \"Intralesional injection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781891\">",
"    <span class=\"h2\">",
"     Topical vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D may exert inhibitory effects on fibroblast proliferation, collagen synthesis, and T lymphocyte activation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/12\">",
"     12",
"    </a>",
"    ]. In a three-month open-label study, 12 adolescents and adults with morphea that had failed to respond to topical corticosteroids were treated with twice daily application of topical calcipotriene 0.005% ointment under occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/13\">",
"     13",
"    </a>",
"    ]. Clinical improvement was noted in all patients during the study.",
"   </p>",
"   <p>",
"    Improvement after treatment with a combination",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/54/5988?source=see_link\">",
"     calcipotriol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/5/44120?source=see_link\">",
"     betamethasone",
"    </a>",
"    dipropionate ointment has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781898\">",
"    <span class=\"h2\">",
"     Imiquimod",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     Imiquimod",
"    </a>",
"    is a topical immunomodulator that induces interferon (IFN)-gamma, a cytokine that can inhibit TGF-beta and the production of extracellular matrix proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Imiquimod may also downregulate the profibrotic cytokine IL-4 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/15\">",
"     15",
"    </a>",
"    ]. Limited data suggest that imiquimod is effective in morphea [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The largest reported experience comes from a series of 12 adults and children with morphea who were followed for six months; application of imiquimod 5% cream three days per week was associated with improvements in dyspigmentation, induration, and erythema [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/15\">",
"     15",
"    </a>",
"    ]. Successful treatment with imiquimod 5% cream has also been documented in a case report [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/16\">",
"     16",
"    </a>",
"    ]. The author has not had significant success with this therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781905\">",
"    <span class=\"h2\">",
"     Phototherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultraviolet (UV) light therapy has been used for the treatment of a variety of sclerotic diseases of the skin, including morphea. Because longer wavelengths of light are capable of greater depth of penetration into the skin, most studies of UV phototherapy in sclerotic skin disease have focused on the use of UVA light (320 to 400 nm). Less data are available on the use of UVB (290 to 320 nm).",
"   </p>",
"   <p>",
"    UVA1 is a newer form of UVA phototherapy that eliminates the shorter, less deeply penetrating wavelengths of UVA light, and emits only UVA light between 340 and 400 nm. This results in a lower risk of sunburn compared with broad band UVA. However, the availability of UVA1 treatment units remains limited. UVA1 is primarily administered in academic centers.",
"   </p>",
"   <p>",
"    Phototherapy is unlikely to be effective for morphea characterized by deep involvement (subcutis, fascia, or muscle), and should not be considered as primary therapy in such cases.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Mechanism of action",
"      </strong>",
"      &mdash; The mechanisms through which UV light improves sclerotic skin disease are not fully understood. Theories for the efficacy of UVA light have included UV-induced upregulation of fibroblast production of enzymes (matrix metalloproteinases) that stimulate collagen breakdown as well as UV-induced immunomodulation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/17\">",
"       17",
"      </a>",
"      ]. The following observations support these theories:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Exposure of fibroblasts to UVA1 increases fibroblast production of collagenase, and collagenase has been detected at increased levels in lesions of morphea irradiated with UVA1 [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/18-20\">",
"       18-20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IL-6, a cytokine that stimulates collagen production in fibroblasts, and IL-8, a proinflammatory cytokine, have been detected at increased levels in patients with morphea and are decreased following exposure to UVA1 [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      UVA may increase production of IFN-gamma, a cytokine that inhibits collagen synthesis, and may decrease production of the profibrotic cytokine TGF-beta [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      UVA1 stimulates the inhibition of transcription proteins (SMADs) that are involved in TGF-beta signal transduction in fibroblasts [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Efficacy",
"      </strong>",
"      &mdash; Multiple studies have investigated the efficacy of UV light for morphea. Psoralen plus UVA (PUVA) was the first form of phototherapy used; PUVA was effective in a small uncontrolled study and case series [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/5,24\">",
"       5,24",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Broadband UVA without psoralens is easier to administer than PUVA and has also shown efficacy. In a series of 12 patients with morphea treated with broadband UVA (20",
"      <span class=\"nowrap\">",
"       J/cm2)",
"      </span>",
"      three times per week for 20 sessions, all patients exhibited lesion softening. Early lesions responded best to therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/2\">",
"       2",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      One randomized trial and small, open-label studies and case reports have documented improvement with UVA1 phototherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/17\">",
"       17",
"      </a>",
"      ]. UVA1 permits the delivery of higher doses of UVA light with a lower risk of sunburn than occurs with similar doses of broad band UVA. However, no studies have directly compared the efficacies of broad band UVA and UVA1 for morphea.",
"      <br/>",
"      <br/>",
"      The comparative efficacy of some forms of phototherapy was evaluated in a randomized trial in which 64 patients were treated with low dose UVA1 (20",
"      <span class=\"nowrap\">",
"       J/cm2),",
"      </span>",
"      medium dose UVA1 (50",
"      <span class=\"nowrap\">",
"       J/cm2),",
"      </span>",
"      or narrowband UVB five times per week for eight weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/3\">",
"       3",
"      </a>",
"      ]. All patients improved with treatment. Medium dose UVA1 was significantly more effective than narrow band UVB. However, no significant differences in clinical efficacy were detected between medium and low dose UVA1 or between narrow band UVB and low dose UVA1.",
"      <br/>",
"      <br/>",
"      Aside from this randomized trial, there is little other data on the efficacy of narrow band UVB for morphea. In a case report of two sisters with en coup de sabre, narrow band UVB slowed disease progression and reversed hair loss [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/25\">",
"       25",
"      </a>",
"      ]. Advantages of narrow band UVB include its wide availability and ease of administration. In comparison, the time required to administer doses of UVA1 is much longer.",
"     </li>",
"     <li>",
"      <strong>",
"       Choice and administration &mdash;",
"      </strong>",
"      In general, when UVA1 is available, we favor this modality for the treatment of morphea. However, when UVA1 is unavailable or impractical, we consider treatment with broad band UVA or narrow band UVB. Due to the lower depth of penetration of UVB, we usually reserve narrow band UVB for patients with lesions that primarily involve the upper dermis. Improvement, defined as discontinuation of disease progression and reduction in erythema, usually occurs within 10 to 20 treatments with UV light. Most trials do not extend beyond 20 to 40 treatments. &nbsp;",
"      <br/>",
"      <br/>",
"      The optimum dose (low versus medium versus high) and regimen for UVA1 phototherapy have yet to be determined. We treat most patients with a medium (40 to 60",
"      <span class=\"nowrap\">",
"       J/cm",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      or high dose (90",
"      <span class=\"nowrap\">",
"       J/cm",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      dose regimen, with treatments administered three to five times per week for a total of around 40 treatments. The patient&rsquo;s minimal dose to elicit erythema (minimal erythema dose) determines appropriate dosing for broad band UVA and narrow band UVB. Treatments are usually administered three times per week.",
"     </li>",
"     <li>",
"      <strong>",
"       Adverse effects &mdash;",
"      </strong>",
"      Adverse effects of phototherapy include erythema, pruritus, hyperpigmentation, burns, and reactivation of herpes simplex virus infection. Accelerated skin aging and skin cancer are potential long term effects of phototherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781912\">",
"    <span class=\"h1\">",
"     SYSTEMIC THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe, disabling disease require systemic therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    . In addition, methotrexate therapy is an alternative to treatment with phototherapy in patients with generalized disease. The efficacy of oral vitamin D and other systemic medications remains uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781919\">",
"    <span class=\"h2\">",
"     Methotrexate and glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    is the most appropriate systemic therapy for morphea [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/26-30\">",
"     26-30",
"    </a>",
"    ]. In patients with acute generalized or rapidly progressive disease, we combine treatment with systemic glucocorticoids.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Efficacy &ndash;",
"      </strong>",
"      In a pilot study of 15 adults with severe generalized or linear morphea, treatment with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      (initial dose 15",
"      <span class=\"nowrap\">",
"       mg/week)",
"      </span>",
"      and pulsed intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      (1000 mg for three days once monthly) for at least six months led to resolution of inflammation and marked softening of sclerotic skin in all but one patient [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/29\">",
"       29",
"      </a>",
"      ]. Improvement was evident within two months after the start of treatment in most patients.",
"      <br/>",
"      <br/>",
"      Methotrexate may also lead to improvement when used as monotherapy. In a 24-week open label study of nine adults with generalized morphea, treatment with oral methotrexate (15 to 25",
"      <span class=\"nowrap\">",
"       mg/week)",
"      </span>",
"      led to statistically significant improvement [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/28\">",
"       28",
"      </a>",
"      ]. However, three patients discontinued the study due to adverse effects, and two patients required dose reductions due to side effects.",
"      <br/>",
"      <br/>",
"      Some patients treated with methotrexate relapse after the discontinuation of therapy, indicating that therapy likely has a suppressive, rather than curative effect [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/31\">",
"       31",
"      </a>",
"      ]. Patients who relapse may respond to additional treatment courses.",
"      <br/>",
"      <br/>",
"      The efficacy of methotrexate for morphea was also demonstrated in a randomized trial in children [",
"      <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40985?source=see_link&amp;anchor=H19#H19\">",
"       \"Localized scleroderma in childhood\", section on 'Pharmacologic measures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Administration &ndash;",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      is usually given orally or subcutaneously at a dose of 15 to 25",
"      <span class=\"nowrap\">",
"       mg/week.",
"      </span>",
"      The optimum duration of therapy has not been determined, but patients are often treated for one to two years. Systemic glucocorticoids, when given, are started simultaneously with methotrexate. We typically give intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg/day",
"      </span>",
"      for three days per month) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg/day).",
"      </span>",
"      <br/>",
"      <br/>",
"      Improvement with methotrexate or methotrexate plus glucocorticoids is usually noted within two to five months, and is most likely to occur in patients with early disease. In our experience, improvement occurs most rapidly in inflammatory lesions; sclerosis improves more slowly.",
"     </li>",
"     <li>",
"      <strong>",
"       Adverse effects &ndash;",
"      </strong>",
"      The adverse effects of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      and systemic glucocorticoids are reviewed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=see_link\">",
"       \"Major side effects of low-dose methotrexate\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"       \"Major side effects of systemic glucocorticoids\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data are limited on the use of systemic glucocorticoids as monotherapy for morphea. In a series of 17 adults and adolescents treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (initial dose 0.5 to 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) for a mean of 18.3 months, four patients (24 percent) had complete clinical responses and the remainder demonstrated partial improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/33\">",
"     33",
"    </a>",
"    ]. A subsequently published retrospective study found that among 28 adults with severe morphea who were treated with prednisone (initial dose 0.3 to 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) for a mean of 11.5 months, complete or partial responses were attained by 16 (57 percent) and 8 (29 percent) patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Relapse may be common after the discontinuation of systemic glucocorticoid monotherapy; in the retrospective study, 9 of 20 patients (45 percent) who had a favorable response and subsequently discontinued therapy relapsed within follow-up periods ranging 8 to 180 months [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/34\">",
"     34",
"    </a>",
"    ]. The potential for adverse effects due to systemic glucocorticoids are an additional concern. Further studies are necessary to determine the role of systemic glucocorticoid monotherapy for the treatment of adults with morphea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781926\">",
"    <span class=\"h2\">",
"     Oral vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D may exert inhibitory effects on fibroblast proliferation, collagen synthesis, and T lymphocyte activation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/12\">",
"     12",
"    </a>",
"    ]. Both oral and topical forms of vitamin D have been studied for the treatment of morphea with variable results. Although improvement with oral calcitriol has been reported in case reports and a small uncontrolled study [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/35-37\">",
"     35-37",
"    </a>",
"    ], there was no benefit of calcitriol (0.75",
"    <span class=\"nowrap\">",
"     &micro;g/day",
"    </span>",
"    for six months plus 1.25",
"    <span class=\"nowrap\">",
"     &micro;g/day",
"    </span>",
"    for three months) when compared with placebo in a randomized trial that included 20 patients with morphea [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/38\">",
"     38",
"    </a>",
"    ]. We do",
"    <strong>",
"     not",
"    </strong>",
"    use oral vitamin D for the treatment of morphea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781933\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of morphea with penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/16/40200?source=see_link\">",
"     bosentan",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , extracorporeal phototherapy has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/12,39-51\">",
"     12,39-51",
"    </a>",
"    ]. There is little evidence to support the efficacies of these treatments. Procedural treatments that have been reported to be effective in a few patients include photodynamic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/52\">",
"     52",
"    </a>",
"    ] and pulsed dye laser [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781940\">",
"    <span class=\"h1\">",
"     OTHER INTERVENTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781947\">",
"    <span class=\"h2\">",
"     Functional impairments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional impairments secondary to active or previously active disease can have significant effects on quality of life of patients with morphea. All patients should be clinically examined for contractures, limb length discrepancy, reduced range of motion, and other functional impairments. In patients with functional impairments, consultation as appropriate with physical therapy, occupational therapy, physical medicine and rehabilitation, rheumatology, plastic surgery, orthopedics, or oral maxillofacial surgery should be requested to maximize function and minimize further damage. Patients with lesions in locations that are at risk for disabling contractures should be referred to physical and occupational therapy",
"    <strong>",
"     before",
"    </strong>",
"    the development of movement deficits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781954\">",
"    <span class=\"h2\">",
"     Extracutaneous disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with morphea can develop extracutaneous complications that require additional evaluation (",
"    <a class=\"graphic graphic_algorithm graphicRef62195 \" href=\"UTD.htm?24/20/24911\">",
"     algorithm 2",
"    </a>",
"    ) (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=see_link&amp;anchor=H1477951#H1477951\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\", section on 'Extracutaneous manifestations'",
"    </a>",
"    ). Rheumatologic evaluation is indicated in patients with symptoms suggestive of arthritis. Patients with lesions involving the head or face should be referred to ophthalmology to evaluate for the presence of ocular complications. Some authors also have recommended repeating ophthalmologic examinations every three to four months during the first three years of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with head or face involvement who have neurologic symptoms (eg, seizures, headaches, focal neurologic deficits, or neuropsychiatric abnormalities) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/55\">",
"     55",
"    </a>",
"    ]should be referred to neurology for evaluation. The most common findings on magnetic resonance imaging (MRI) in patients with neurologic involvement include hyperintensities in the subcortical white matter or other sites, focal tissue atrophy, and calcifications [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/55\">",
"     55",
"    </a>",
"    ]. Routine radiologic imaging is not indicated in asymptomatic patients.",
"   </p>",
"   <p>",
"    Referral to dentistry or oromaxillofacial surgery is beneficial for patients with evidence for dental or jaw dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781961\">",
"    <span class=\"h1\">",
"     COSMESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hypopigmented or hyperpigmented lesions in cosmetically sensitive areas can benefit from the use of topical camouflage agents (eg, Dermablend&trade;, Covermark&reg;). Atrophic changes in inactive lesions may be managed by injection of autologous fat transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/56\">",
"     56",
"    </a>",
"    ], injectable cosmetic fillers, or surgical excision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20781968\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periods of disease activity vary from three to six years, but reactivation after periods of remission can occur. In one retrospective study of 113 adults with morphea, the mean duration of disease was 5.8 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/57\">",
"     57",
"    </a>",
"    ]. A minority of patients experience chronic, relapsing disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17640/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The prognostic markers for recurrent or chronic disease have yet to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20783239\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Morphea, also known as localized scleroderma, is a relatively uncommon idiopathic inflammatory disorder that leads to the development of sclerotic plaques in the skin. The disorder occurs in both adults and children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=see_link&amp;anchor=H16539049#H16539049\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Because of the self-limited nature of morphea, some patients with limited plaque disease may elect to defer therapy. For patients with superficial (dermal) circumscribed disease who desire treatment, but do not have access to or prefer to avoid the frequent visits required for phototherapy, we suggest treatment with high potency topical corticosteroids, intralesional corticosteroids, a topical vitamin D analog, topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"       imiquimod",
"      </a>",
"      (",
"      <a class=\"graphic graphic_algorithm graphicRef63834 \" href=\"UTD.htm?15/33/15888\">",
"       algorithm 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We typically use topical tacrolimus 0.1% ointment under occlusion or intralesional corticosteroids.",
"     </li>",
"     <li>",
"      For patients with superficial (dermal) forms of morphea who are able and willing to receive phototherapy, we suggest treatment with UVA1 (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If UVA1 is not available, other options for phototherapy include broad band UVA, narrow band UVB, and PUVA. Phototherapy is unlikely to be effective for morphea involving the subcutaneous tissue, muscle, or bone. (See",
"      <a class=\"local\" href=\"#H20781856\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapidly progressive, severe, disabling disease requires treatment with systemic therapy. For patients in this category, we suggest treatment with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      and systemic glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20781912\">",
"       'Systemic therapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Morphea may cause joint contractures and other functional impairments secondary to tissue sclerosis. All patients should be clinically assessed for the development of these findings. Physical therapy is essential for patients who are at risk for or who show evidence for functional impairments. (See",
"      <a class=\"local\" href=\"#H20781940\">",
"       'Other interventions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/1\">",
"      Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011; 65:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/2\">",
"      El-Mofty M, Zaher H, Bosseila M, et al. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/3\">",
"      Kreuter A, Hyun J, St&uuml;cker M, et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/4\">",
"      de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003; 207:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/5\">",
"      Kerscher M, Meurer M, Sander C, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996; 132:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/6\">",
"      Grundmann-Kollmann M, Behrens S, Gruss C, et al. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000; 42:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/7\">",
"      El-Mofty M, Mostafa W, Esmat S, et al. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study. Photodermatol Photoimmunol Photomed 2004; 20:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/8\">",
"      Kroft EB, Groeneveld TJ, Seyger MM, de Jong EM. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. Am J Clin Dermatol 2009; 10:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/9\">",
"      Mancuso G, Berdondini RM. Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br J Dermatol 2005; 152:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/10\">",
"      Stefanaki C, Stefanaki K, Kontochristopoulos G, et al. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study. J Dermatol 2008; 35:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/11\">",
"      Mancuso G, Berdondini RM. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003; 13:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/12\">",
"      Vilela FA, Carneiro S, Ramos-e-Silva M. Treatment of morphea or localized scleroderma: review of the literature. J Drugs Dermatol 2010; 9:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/13\">",
"      Cunningham BB, Landells ID, Langman C, et al. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998; 39:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/14\">",
"      Dytoc MT, Kossintseva I, Ting PT. First case series on the use of calcipotriol-betamethasone dipropionate for morphoea. Br J Dermatol 2007; 157:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/15\">",
"      Dytoc M, Ting PT, Man J, et al. First case series on the use of imiquimod for morphoea. Br J Dermatol 2005; 153:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/16\">",
"      Man J, Dytoc MT. Use of imiquimod cream 5% in the treatment of localized morphea. J Cutan Med Surg 2004; 8:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/17\">",
"      Kroft EB, Berkhof NJ, van de Kerkhof PC, et al. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008; 59:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/18\">",
"      Gruss C, Reed JA, Altmeyer P, et al. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/19\">",
"      Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/20\">",
"      Petersen MJ, Hansen C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/21\">",
"      Kreuter A, Hyun J, Skrygan M, et al. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol 2006; 155:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/22\">",
"      Kreuter A, Hyun J, Skrygan M, et al. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma. Arch Dermatol Res 2006; 298:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/23\">",
"      Gambichler T, Skrygan M, Tomi NS, et al. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation. Br J Dermatol 2007; 156:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/24\">",
"      Usmani N, Murphy A, Veale D, et al. Photochemotherapy for localized morphoea: effect on clinical and molecular markers. Clin Exp Dermatol 2008; 33:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/25\">",
"      Brownell I, Soter NA, Franks AG Jr. Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy. Dermatol Online J 2007; 13:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/26\">",
"      Tollefson MM, Witman PM. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007; 56:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/27\">",
"      Uziel Y, Feldman BM, Krafchik BR, et al. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000; 136:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/28\">",
"      Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998; 39:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/29\">",
"      Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005; 141:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/30\">",
"      Weibel L, Sampaio MC, Visentin MT, et al. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 2006; 155:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/31\">",
"      Kroft EB, Creemers MC, van den Hoogen FH, et al. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol 2009; 160:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/32\">",
"      Zulian F, Martini G, Vallongo C, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2011; 63:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/33\">",
"      Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994; 130:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/34\">",
"      Amy de la Bret&egrave;que M, Rybojad M, Cordoliani F, et al. Relapse of severe forms of adult morphea after oral corticosteroid treatment. J Eur Acad Dermatol Venereol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/35\">",
"      Hulshof MM, Pavel S, Breedveld FC, et al. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994; 130:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/36\">",
"      Caca-Biljanovska NG, Vlckova-Laskoska MT, Dervendi DV, et al. Treatment of generalized morphea with oral 1,25-dihydroxyvitamin D3. Adv Exp Med Biol 1999; 455:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/37\">",
"      Humbert PG, Dupond JL, Rochefort A, et al. Localized scleroderma--response to 1,25-dihydroxyvitamin D3. Clin Exp Dermatol 1990; 15:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/38\">",
"      Hulshof MM, Bouwes Bavinck JN, Bergman W, et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000; 43:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/39\">",
"      Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 2008; 59:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/40\">",
"      Maragh SH, Davis MD, Bruce AJ, Nelson AM. Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol 2005; 53:S115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/41\">",
"      Schlaak M, Friedlein H, Kauer F, et al. Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil. J Eur Acad Dermatol Venereol 2008; 22:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/42\">",
"      Rose RF, Goodfield MJ. Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea. Clin Exp Dermatol 2005; 30:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/43\">",
"      M&ouml;hrenschlager M, Jung C, Ring J, Abeck D. Effect of penicillin G on corium thickness in linear morphea of childhood: An analysis using ultrasound technique. Pediatr Dermatol 1999; 16:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/44\">",
"      Roldan R, Morote G, Castro Mdel C, et al. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children. J Rheumatol 2006; 33:2538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/45\">",
"      Diab M, Coloe JR, Magro C, Bechtel MA. Treatment of recalcitrant generalized morphea with infliximab. Arch Dermatol 2010; 146:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/46\">",
"      Alarcon-Segovia D, Ramos-Niembro F, Ibanez de Kasep G, et al. Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 1979; 6:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/47\">",
"      van Bergen BH, van Dooren-Greebe RJ, Fiselier TJ, Koopman RJ. [D-penicillamine in treatment of scleroderma \"en coup de sabre\"]. Hautarzt 1997; 48:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/48\">",
"      P&eacute;rez Crespo M, Betlloch Mas I, Mataix D&iacute;az J, et al. Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl. Pediatr Dermatol 2009; 26:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/49\">",
"      Strauss RM, Bhushan M, Goodfield MJ. Good response of linear scleroderma in a child to ciclosporin. Br J Dermatol 2004; 150:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/50\">",
"      Neustadter JH, Samarin F, Carlson KR, Girardi M. Extracorporeal photochemotherapy for generalized deep morphea. Arch Dermatol 2009; 145:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/51\">",
"      Cribier B, Faradji T, Le Coz C, et al. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 1995; 191:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/52\">",
"      Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000; 80:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/53\">",
"      Eisen D, Alster TS. Use of a 585 nm pulsed dye laser for the treatment of morphea. Dermatol Surg 2002; 28:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/54\">",
"      Zannin ME, Martini G, Athreya BH, et al. Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 2007; 91:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/55\">",
"      Kister I, Inglese M, Laxer RM, Herbert J. Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology 2008; 71:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/56\">",
"      Roh MR, Jung JY, Chung KY. Autologous fat transplantation for depressed linear scleroderma-induced facial atrophic scars. Dermatol Surg 2008; 34:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/57\">",
"      Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003; 13:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17640/abstract/58\">",
"      Saxton-Daniels S, Jacobe HT. An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol 2010; 146:1044.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16150 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-71122602D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17640=[""].join("\n");
var outline_f17_14_17640=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20783239\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781856\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781863\">",
"      APPROACH TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781870\">",
"      TOPICAL AND INTRALESIONAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781877\">",
"      Topical tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781884\">",
"      Topical and intralesional corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781891\">",
"      Topical vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781898\">",
"      Imiquimod",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781905\">",
"      Phototherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781912\">",
"      SYSTEMIC THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781919\">",
"      Methotrexate and glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781926\">",
"      Oral vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781933\">",
"      OTHER THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781940\">",
"      OTHER INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781947\">",
"      Functional impairments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20781954\">",
"      Extracutaneous disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781961\">",
"      COSMESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20781968\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20783239\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/16150\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16150|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?15/33/15888\" title=\"algorithm 1\">",
"      Morphea treatment algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?24/20/24911\" title=\"algorithm 2\">",
"      Evaluation algorithm for morphea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16150|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40660?source=related_link\">",
"      Intralesional injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/1/40985?source=related_link\">",
"      Localized scleroderma in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=related_link\">",
"      Major side effects of low-dose methotrexate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/133?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17641="Approach to the patient with night sweats";
var content_f17_14_17641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with night sweats",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Gerald W Smetana, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/14/17641/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/14/17641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Night sweats are a common symptom in ambulatory primary care practice. While the cause may be evident after straightforward history taking, often no cause is immediately apparent. In these cases, clinicians face the challenge of determining a thoughtful, cost effective, yet comprehensive evaluation.",
"   </p>",
"   <p>",
"    The definition and epidemiology of night sweats, differential diagnosis, approach to history taking and physical examination, and suggested evaluation of the patient with night sweats are discussed here. The management of benign excessive sweating (idiopathic hyperhidrosis) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1257?source=see_link\">",
"     \"Primary focal hyperhidrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Night sweats must be distinguished from other disorders of sweating. For the purposes of this discussion, night sweats are drenching sweats that require changing bedclothes. This more strict definition excludes patients with a benign increase in sweating, or hyperhidrosis. An overheated room or too many bed coverings may be a simple cause for an increase in sweating at night.",
"   </p>",
"   <p>",
"    Hot flashes are often difficult to distinguish from night sweats, although the former have several distinctive features. Hot flashes may begin with an unpleasant sensation in the chest, breasts, or abdomen. A sudden warmth, and visible skin redness in the chest, head, and neck follows, which may be apparent to observers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/1\">",
"     1",
"    </a>",
"    ]. The warmth lasts for three to four minutes and is followed by sweating in the same areas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Flushing, a feature of carcinoid and an adverse effect of certain medications, is a warmth and redness of the face and occasionally the trunk. In practice, it may be difficult to distinguish flushing or increased sweating from night sweats. Thus, the conditions associated with any of these symptoms are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few series of patients with night sweats exist in the literature. Several small series have reported descriptive epidemiology and the ultimate diagnoses of patients with night sweats [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. These series are limited by selection bias, lack of standardization of evaluation, and variable follow-up.",
"   </p>",
"   <p>",
"    In the largest study examining the prevalence of night sweats in ambulatory patients presenting to primary care clinicians, 41 percent of the 2267 participating patients reported experiencing night sweats within the last month, including 23 percent with pure night sweats only and 18 percent with both day and night sweats [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/5\">",
"     5",
"    </a>",
"    ]. A night sweat in this study was defined as \"sweating at night even when it isn't excessively hot in your bedroom.\" In multivariate analysis, the factors associated with pure night sweats in women were hot flashes and panic attacks, and in men, sleep problems. However, the study was not designed to establish the true causes of night sweats.",
"   </p>",
"   <p>",
"    In a second report, a random sample of 174 inpatients on medical, surgical, obstetric, and gynecologic services were asked whether they had had night sweating in the previous three months; a standardized questionnaire was given to all those with positive responses [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/2\">",
"     2",
"    </a>",
"    ]. Thirty-two percent of non-obstetric patients and 60 percent of obstetric patients reported a history of night sweats. Only 11 percent of all patients reported severe night sweats (bath or clothing change required). Obstetric patients, who presumably were otherwise healthy, had the highest frequency of night sweats. Underlying disease did not predict the likelihood of night sweats, although there were few patients included who had those diseases known to be associated with night sweats. The authors did not follow their subjects after hospital discharge to learn of subsequent diagnoses.",
"   </p>",
"   <p>",
"    In a third study conducted in 100 hospice patients with cancer, 16 voluntarily reported sweating [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/3\">",
"     3",
"    </a>",
"    ]. The sweating was predominantly at night in one-half of these patients. In this highly selected population, no clinical factors predicted night sweats. Sweating did not correlate with tumor type, pain, or medication use.",
"   </p>",
"   <p>",
"    The only study that specifically addressed the causes of night sweats in an ambulatory population interviewed 200 sequential patients in an office practice [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/4\">",
"     4",
"    </a>",
"    ]. Seventy percent of these patients were from a primary care practice; the remainder were from a gastroenterology specialty practice. Eighty-one patients reported at least one night sweat within the previous year. A subsequent chart review determined the cause to be gastroesophageal reflux in 36 patients, menopause in 21, external overheating in 14, multifactorial in 6, and unknown in 4. Eighty percent of the 24 patients with frequent night sweats reported symptoms of gastroesophageal reflux. In the 12 patients with night sweats and gastroesophageal reflux for whom results of treatment were available, all had relief of night sweats with treatment of the reflux. However, it may not be easy to generalize these results, due to the variable follow up, imprecise diagnostic categories, lack of a clear definition, and referral bias.",
"   </p>",
"   <p>",
"    One study suggested that night sweats do not portend a poor prognosis. In a cohort study of 1534 patients &gt;65 years old attending a geriatric primary care clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/6\">",
"     6",
"    </a>",
"    ], patients who reported night sweats at baseline were no more likely to die over 7 years of follow-up than those without night sweats. This finding does not diminish the importance or need for a careful evaluation of patients with night sweats. However, it does suggest that at least a subset of patients that defy a specific diagnosis, and who do not develop any other localizing symptoms over time to suggest a specific diagnosis, may have a benign course in follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of night sweats is large. The available literature consists primarily of case series and symptom surveys of collected patients with a particular diagnosis. Broad categories include malignancy, infection, medications, endocrine causes, neurologic disease, menopause, and idiopathic hyperhidrosis (",
"    <a class=\"graphic graphic_table graphicRef58031 \" href=\"UTD.htm?16/31/16893\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Night sweats may be an early feature of many different cancers. Malignancy should always be considered in the evaluation of a patient with night sweats.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The malignancy most commonly associated with night sweats is lymphoma; low grade fever and drenching night sweats are found in approximately 25 percent of patients with Hodgkin lymphoma. Night sweats is one of the \"B\" symptoms in the commonly used Cotswolds staging classification for Hodgkin lymphoma; the others are significant fever and unintentional loss of at least 10 percent of body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/7\">",
"     7",
"    </a>",
"    ]. Night sweats by themselves, in contrast to the other B symptoms, do not appear to adversely affect the prognosis of patients with Hodgkin lymphoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=see_link\">",
"     \"Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional symptoms that may suggest Hodgkin lymphoma as the cause for night sweats include fatigue, pruritus, and pain after alcohol consumption. The physical examination may be normal or may reveal lymphadenopathy or splenomegaly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with non-Hodgkin lymphoma may also report night sweats as an early constitutional symptom. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Systemic complaints (B symptoms)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Solid tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with nonhematologic malignancies may also experience night sweats. Reports exist of night sweats among patients with most types of solid tumors. Common malignancies include prostate cancer, renal cell cancer, and germ cell tumors. Advanced medullary carcinoma of the thyroid may cause flushing due to calcitonin secretion. Insulinoma may cause night sweats because of nocturnal hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic and indolent infections often cause night sweats. While other typical clinical features are usually present, in some cases night sweats are the sole initial symptom.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disease most commonly associated with night sweats in medical lore is tuberculosis (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=see_link\">",
"     \"Clinical manifestations and evaluation of pulmonary tuberculosis\"",
"    </a>",
"    ). In contrast to many other etiologies of night sweats, large case series exist that cite the frequency of clinical features of tuberculosis. In one prospective study of 313 adults with confirmed cases of tuberculosis, 48 percent of patients reported sweats; 29 percent of patients had sweats of at least two weeks in duration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/8\">",
"     8",
"    </a>",
"    ]. Sweats were more common among patients with extrapulmonary disease than among those with pulmonary disease (54 versus 46 percent). Cough, fatigue, and fever were each more common than sweats and occurred in 73, 60, and 52 percent of patients, respectively. Other symptoms occurring less often than sweats included weight loss, anorexia, chest pain, diarrhea, and hemoptysis.",
"   </p>",
"   <p>",
"    These results were similar to the finding of night sweats in 62 percent of 5480 inpatients with active pulmonary or pleural tuberculosis in a second report [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/9\">",
"     9",
"    </a>",
"    ]. Only cough, anorexia or weight loss, and sputum were more common than night sweats in this report. In another study, night sweats in patients with tuberculosis were more common among patients under age 60 years than among older individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/10\">",
"     10",
"    </a>",
"    ]. This was the only feature that was more common in younger patients.",
"   </p>",
"   <p>",
"    While night sweats are sensitive, they are not specific for the diagnosis of tuberculosis. This was illustrated in a study comparing the clinical features in 101 patients with suspected tuberculosis who ultimately did or did not have the disease after evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/11\">",
"     11",
"    </a>",
"    ]. While cough and sputum each predicted tuberculosis, no difference existed in the incidence of night sweats between patients with and without tuberculosis. However, only one patient with tuberculosis had no weight loss, cough, or sputum. Even among patients with HIV infection, who may be expected to have more baseline constitutional symptoms than non-HIV infected individuals, night sweats remain an independent predictor of tuberculosis among patients suspected of having the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/12\">",
"     12",
"    </a>",
"    ]. Night sweats appear to be less common among patients with culture proven tuberculosis who are smear negative (three negative sputum smears for acid-fast bacilli). In a study that included 52 such patients, only 33 percent reported night sweats [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Brucellosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellosis is a zoonotic disease that mainly affects people who work with domestic animals or animal products, or people whose diet includes raw milk or unpasteurized cheese. Four Brucella species are pathogenic to humans. Brucella melitensis, B. abortus, B. suis and B. canis. Brucellosis is a well-documented cause of fever of unknown origin with varied and nonspecific symptoms. Common clinical symptoms include night sweats and joint pains; other prominent symptoms are malaise, anorexia, fatigue, weight loss, malodorous perspiration, and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/14\">",
"     14",
"    </a>",
"    ]. Multiple organ systems (liver, heart, central nervous system) may also be involved. The onset of symptoms of brucellosis may be abrupt or insidious, developing over several days to weeks.",
"   </p>",
"   <p>",
"    There are few objective findings, other than fever. Physical findings, when present, are usually limited to minimal lymphadenopathy and occasionally hepatosplenomegaly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Bacterial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute bacterial infections may lead to night sweats. Most common are endocarditis, osteomyelitis, and pyogenic abscess. Fever will also be present in many of these instances. Localizing symptoms or signs can also suggest one of these diagnoses. As an example, back pain and a new heart murmur may suggest endocarditis; localized mouth pain raises the possibility of a dental abscess. Thus, these diagnoses less often present as \"night sweats of unknown origin\" than other diagnoses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with symptomatic HIV infection often experience night sweats. One group studied constitutional symptoms among 205 patients with HIV infection and at least one of fever, diarrhea, or weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/15\">",
"     15",
"    </a>",
"    ]. In this highly selected cohort, 70 percent of patients experienced night sweats; the mean frequency was once per week. Patients with acute exposure to HIV and seroconversion may also report night sweats; the incidence was 9 percent in two separate studies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. However, fever, lymphadenopathy, and joint pain were each more common in newly HIV-infected individuals than were night sweats.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications are a common cause of increased sweating or frank night sweats. The exact incidence cannot be determined given the lack of published epidemiologic data, although medications are a frequent cause of night sweats when the etiology is not immediately apparent after clinical evaluation. The mechanism by which sweats develop differs across drug classes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/18\">",
"     18",
"    </a>",
"    ]. The list of medications known to cause increased sweating or flushing is extensive (",
"    <a class=\"graphic graphic_table graphicRef56351 \" href=\"UTD.htm?33/32/34317\">",
"     table 2",
"    </a>",
"    ). In an individual patient, it may be difficult to confidently distinguish between flushing, increased sweating, and night sweats. The listed medications, therefore, include those that may cause any of these side effects. The evaluation of a patient with night sweats is not complete until a careful history of all prescribed and over the counter medications is taken.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidepressants are perhaps the most common medication-related cause of sweating. These cause a generalized increase in sweating, but patients may be more aware of episodes at night and seek medical attention for night sweats. All antidepressants have been implicated, including tricyclic antidepressants, selective serotonin reuptake inhibitors, and the newer agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    . Sweating occurs in approximately 10 to 15 percent of patients taking antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/18\">",
"     18",
"    </a>",
"    ]. Bupropion and venlafaxine more frequently cause sweating than the selective serotonin reuptake inhibitors. In a meta-analysis, 14 percent of patients taking tricyclic antidepressants reported sweating, compared to 10 percent of patients taking selective serotonin reuptake inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Sweating is occasionally sufficient to lead to patient discontinuation of the offending medication. (For further information on individual medications please refer to the Lexicomp program provided with UpToDate.)",
"   </p>",
"   <p>",
"    Other psychiatric medications that may cause sweating include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Antipyretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any medicine that lowers body temperature may cause sweats. Clinicians should inquire about a history of frequent use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , or nonsteroidal antiinflammatory medication as these over-the-counter medications can occasionally cause sweating episodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Cholinergic agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholinergic agonists cause sweating through direct stimulation of peripheral muscarinic receptors in the sweat glands. Though not used as commonly as in the past,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/36/33344?source=see_link\">",
"     pilocarpine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25476?source=see_link\">",
"     bethanechol",
"    </a>",
"    are two examples of cholinergic agents in clinical practice. Cholinesterase inhibitors, such as organophosphate pesticides, cause prominent sweating after accidental poisoning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hypoglycemic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally sweats are the most prominent clinical feature of hypoglycemia. While other typical symptoms of hypoglycemia are usually present, clinicians should still consider the possibility of medication-induced hypoglycemia in insulin or sulfonylurea-treated patients with diabetes who report nocturnal episodes of sweating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Hormonal agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;All medications that modulate estrogen or androgen levels, or receptor binding, have the potential to cause night sweats. GnRH agonists induce a state of hypogonadism when used chronically in the treatment of men (eg, for prostate cancer) or women (eg, for endometriosis). This pharmacologic castrate state commonly produces hot flashes. Aromatase inhibitors cause hot flashes by decreasing the conversion of androgens to estrogens, resulting in a fall in circulating estrogen levels.",
"   </p>",
"   <p>",
"    Hot flashes are the most common side effect of the antiestrogenic drug",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , affecting 64 percent of treated patients.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6390?source=see_link\">",
"     Raloxifene",
"    </a>",
"    , another selective estrogen receptor modulator (SERM), causes hot flashes in 10 to 25 percent of patients.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     Flutamide",
"    </a>",
"    , an androgen receptor blocker, causes hot flashes in men treated for prostate cancer. The incidence of hot flashes due to flutamide is unknown as studies have evaluated its adverse effects only in combination with GnRH agonists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Other medications causing flushing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other medications may cause flushing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Niacin predictably causes flushing in the higher pharmacologic doses used to treat lipid disorders. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link\">",
"       \"Lipid lowering with drugs other than statins and fibrates\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Flushing occurs in 10 percent of men using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      for the treatment of erectile dysfunction.",
"     </li>",
"     <li>",
"      Direct vasodilators, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      , may also produce flushing.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"       Bromocriptine",
"      </a>",
"      occasionally causes flushing.",
"     </li>",
"     <li>",
"      Alcohol may provoke a flushing reaction in susceptible individuals. The association is usually immediately apparent to the patient and is rarely a diagnostic challenge.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Other medications causing sweating",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sweating is a less common side effect of a number of other drugs. These include the \"triptans\" used in the treatment of migraine, beta-blockers, calcium channel blockers,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      , sympathomimetic agents,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"       theophylline",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"       tramadol",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Withdrawal from alcohol, opioids, and cocaine may cause sweating.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Endocrine disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sweating or flushing is a central feature of several endocrine disorders, including pheochromocytoma, carcinoid syndrome, and hyperthyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pheochromocytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic triad of symptoms in patients with a pheochromocytoma consists of episodic headache, sweating, and tachycardia in a patient with sustained or intermittent hypertension (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    ). In a series of 108 pheochromocytomas in 104 patients, sweating was present in 37 percent of patients, flushing in 18 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/20\">",
"     20",
"    </a>",
"    ]. Hypertension, headache, and palpitations were each more common, with a prevalence of 82 percent, 58 percent, and 48 percent, respectively. In a single institution review of 95 patients, sweating was similarly present in 52 percent of patients; 88 percent of affected patients were hypertensive [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/21\">",
"     21",
"    </a>",
"    ]. Clinicians should consider this diagnosis when sweating spells or night sweats occur in a hypertensive patient with other typical features of pheochromocytoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Carcinoid syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flushing is the hallmark of the carcinoid syndrome, occurring in 84 percent of affected patients. Other classic symptoms are diarrhea and wheezing. Right-sided cardiac valvular disease occurs in up to one-half of patients (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    ). Flushing rarely occurs alone. Diarrhea occurs in 70 percent of patients, and only 5 percent of patients experience flushing without diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/22\">",
"     22",
"    </a>",
"    ]. This suggests that clinicians may defer evaluation for possible carcinoid as an initial diagnostic strategy when flushing occurs as an isolated symptom.",
"   </p>",
"   <p>",
"    Patients with intestinal carcinoids do not develop the carcinoid syndrome unless liver metastases are present. In contrast, patients with bronchial carcinoids may develop the carcinoid syndrome with localized disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased sweating and heat intolerance are prominent features of hyperthyroidism. In one review, sweating occurred in 50 to 91 percent of patients, and heat intolerance in 41 to 89 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/23\">",
"     23",
"    </a>",
"    ]. The sweating is usually persistent and is not paroxysmal. In most patients, other clinical features of hyperthyroidism will alert the clinician to this diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Neurologic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic conditions that may cause increased sweating and potentially night sweats include autonomic dysreflexia, post-traumatic syringomyelia, stroke, and autonomic neuropathy. While no good epidemiologic data exist, these are likely considerably less common causes of night sweats in a primary care setting than the diagnoses already discussed.",
"   </p>",
"   <p>",
"    Autonomic dysreflexia is a syndrome of acute autonomic instability that occurs in patients with cervical or high thoracic spinal cord injuries above the T8 level. The most common precipitant is bladder distension; it may also occur after rectal distension, urologic or rectal procedures, or any painful stimulus [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/24\">",
"     24",
"    </a>",
"    ]. Common clinical features include sweating of the forehead or generalized sweating along with headache, gooseflesh, cutaneous vasodilation, increased muscle spasticity, an acute rise in blood pressure, and a desire to void. This distinctive constellation, in the context of a patient with a spinal cord injury, is not easily confused with other causes of sweating spells. Other authors have reported the differential diagnosis to include migraine, cluster headache, essential hypertension, posterior fossa tumors, pheochromocytoma, and toxemia of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Posttraumatic or idiopathic syringomyelia can cause spells of generalized increase in sweating. The sweating may be affected by posture and may be generalized or segmental [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A unilateral increase in sweating can occur after acute hemispheric brain infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/27\">",
"     27",
"    </a>",
"    ], and segmental hyperhidrosis may result from a spinal or paraspinal lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distinction between perimenopausal hot flashes and night sweats is not always clear. As an example, in a recall questionnaire study of postmenopausal women, 35 percent of subjects recalled night sweats due to menopause while 74 percent recalled hot flashes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/29\">",
"     29",
"    </a>",
"    ]. Similarly, in a large questionnaire study of US women (n = 14,906), the number of women who reported night sweats due to menopause was nearly equal to the number of those who reported hot flashes (23.6 percent versus 27.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/30\">",
"     30",
"    </a>",
"    ]. Daily alcohol use increases the likelihood of hot flashes and night sweats in perimenopausal women, compared to women who drink &le;one drink a month [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/31\">",
"     31",
"    </a>",
"    ]. Prior hysterectomy, depressed mood, and anxiety also correlated with the likelihood of experiencing hot flashes in another large cross-sectional study of women aged 54 to 65 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The median age of menopause in the United States is 51 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/33\">",
"     33",
"    </a>",
"    ]. The first menopausal symptoms, usually hot flashes, occur a median of 3.8 years earlier and often precede a change in the menstrual pattern. The peak occurrence is during the year before the final menstrual period, although women may experience hot flashes for more than 10 years after menopause (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=see_link\">",
"     \"Clinical manifestations and diagnosis of menopause\"",
"    </a>",
"    ). Clinicians should also consider the possibility of hot flashes in younger women after bilateral oophorectomy or chemotherapy-induced amenorrhea.",
"   </p>",
"   <p>",
"    Clinicians should not immediately conclude that sweating or flushing episodes in women of typical perimenopausal age are hot flashes. If atypical or localizing symptoms are present, one should obtain a more complete history, perform a directed physical examination, and consider further study before assigning the symptoms to menopause. Similarly, based upon the epidemiology of menopause, other diagnostic possibilities should be entertained if flushing occurs in a woman with normal menstrual cycles before the age of 45.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Idiopathic hyperhidrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic hyperhidrosis is a benign increase in eccrine sweating without pathologic cause (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1257?source=see_link\">",
"     \"Primary focal hyperhidrosis\"",
"    </a>",
"    ). One percent of the general population experiences excessive sweating beyond that needed to cool the body [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/34\">",
"     34",
"    </a>",
"    ]. Anxiety may precipitate episodes. Generalized hyperhidrosis is episodic. It may be either localized or generalized and usually involves the palms, soles, and axillae. The consequences of this condition primarily involve social embarrassment. Its importance in this discussion is to differentiate this benign increase in sweating from pathologic causes of night sweats or flushing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4204654\">",
"    <span class=\"h2\">",
"     Sleep disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, night sweats disrupt sleep. Sleep disorders are more common among patients with night sweats, though it is unclear if sleep disorders are a cause of night sweats, or if sleep disorders are reported more commonly in patients who awaken because of night sweats. A cross-sectional study of 363 patients attending a clinician office visit found that 24 percent of patients experienced night sweats in the previous month [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/35\">",
"     35",
"    </a>",
"    ]. Significant predictors of night sweats included daytime tiredness (OR 1.99, CI 1.12-3.53), legs jerking during sleep (OR 1.78, CI 1.05-3.00), and awakening with pain (OR 1.87, CI 1.16-2.99).",
"   </p>",
"   <p>",
"    One chart review study evaluated 282 sequential patients who had undergone formal polysomnography, most of whom were referred for suspected sleep apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/36\">",
"     36",
"    </a>",
"    ]. Night sweats were reported in 28 percent of patients. There was discordance between patient-reported symptoms and the findings on polysomnography. Patients who reported night sweats were more likely to also report breathing trouble at night, daytime fatigue, snoring, morning headaches, and kicking during sleep. However, there was no difference in the apnea hypopnea index (API), sleep onset latency, or total sleep time when compared to patients without night sweats.",
"   </p>",
"   <p>",
"    The available data are not sufficient to confirm that primary sleep disorders are a direct cause of night sweats.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4204711\">",
"    <span class=\"h2\">",
"     Miscellaneous causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other less common diagnoses may result in night sweats. The association between night sweats, increased sweating, or flushing and these diagnoses is less well established. Gastroesophageal reflux can cause night sweats [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/35\">",
"     35",
"    </a>",
"    ]. Case reports exist of temporal arteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/37\">",
"     37",
"    </a>",
"    ] and diabetes insipidus [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/38\">",
"     38",
"    </a>",
"    ] as causes for night sweats. Night sweats occur in 30 to 40 percent of patients with chronic fatigue syndrome, but other clinical features predominate in this condition [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/39\">",
"     39",
"    </a>",
"    ]. Men whose prostate cancer has been treated with orchiectomy will usually experience hypogonadal hot flashes.",
"   </p>",
"   <p>",
"    Flushing is a common feature of the systemic mastocytosis syndrome. Common blushing is not easily confused with night sweats. Facial flushing is a feature of rosacea; this does not commonly occur at night. Food additives may cause flushing in some patients. Gustatory sweating is facial sweating after food or drink. It may occur in patients with diabetic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/40\">",
"     40",
"    </a>",
"    ], after parotidectomy, parotid trauma, or neck dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/41\">",
"     41",
"    </a>",
"    ]. Clinicians would be unlikely to confuse this with night sweats.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the extensive list of possible causes of night sweats, the challenge for clinicians is to correctly identify patients with a serious cause while minimizing unnecessary diagnostic evaluations that are costly and may carry some risk for the patient. It is not possible to construct an evidence-based approach based upon the available literature. Published recommendations for the approach to patients with night sweats have been mostly experiential and opinion. The few epidemiologic surveys are subject to selection bias, and no comprehensive studies report the frequency of the ultimate diagnosis among unselected series of patients with night sweats.",
"   </p>",
"   <p>",
"    Thus, the ideal approach is a matter of opinion, and reasonable clinicians may reach different conclusions. The following approach takes into account the likelihood of certain conditions in a primary care setting, the diagnostic value of associated symptoms, the benefit of physical examination in suggesting a cause, and the tradeoff between delay of diagnosis with a conservative approach versus the cost and risk of diagnostic evaluations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history is the most important element in the evaluation of a patient with night sweats. It is unlikely that further evaluation will prove fruitful if no cause is apparent after taking a complete history. A rational approach to taking a history follows from the potential diagnoses outlined above.",
"   </p>",
"   <p>",
"    First, it is particularly important for clinicians to exclude fever with certainty when evaluating patients with night sweats. The presence of fever greatly expands the diagnostic possibilities. When doubt exists, patients should keep a diary and take their temperature during and after a sweat to exclude fever more thoroughly. If present, the cause for fever must be determined.",
"   </p>",
"   <p>",
"    Associated symptoms that make a particular cause more likely should be sought. These include unintentional weight loss, fatigue, and pruritus that may suggest lymphoma. Localized pain may suggest cancer, abscess, or osteomyelitis. Back pain and fever suggest endocarditis or localized infection in the epidural space or vertebral body. Frank rigors favor a bacterial infection.",
"   </p>",
"   <p>",
"    Risk factors for tuberculosis include a prior positive PPD test, HIV infection, hemodialysis, gastrectomy, solid organ transplantation, exposure to an individual with tuberculosis, being homeless or living in an institutionalized setting, immigration from an endemic area, or working in a healthcare setting. Cough, sputum, fatigue, and weight loss also suggest this diagnosis.",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on targeted tuberculin testing and the treatment of latent tuberculosis, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Risk factors for HIV infection, including injection drug use, men who have sex with men, sexual activity with multiple partners or commercial sex workers, and blood transfusions before 1985 should be evaluated. Other suggestive historical features include thrush, diarrhea, unintentional weight loss, or a patient report of enlarged lymph nodes.",
"   </p>",
"   <p>",
"    The medication history should include both prescription and over-the-counter medications with attention toward the use of any medication known to cause sweating or flushing as detailed above. Medication-induced sweating is usually a diagnosis of exclusion once other causes appear unlikely after obtaining a directed history. A temporal relationship between the initiation of a new medication and the onset of sweating increases the likelihood of the medication as the cause.",
"   </p>",
"   <p>",
"    Flushing, diarrhea, wheezing, palpitations, headache, heat intolerance, skin changes, and tremor may suggest an endocrine cause. The presence of a spinal cord injury, recent stroke, or regional or segmental sweating will suggest a possible neurologic cause. Characteristic hot flashes should be distinguished from less specific night sweats in a woman of perimenopausal age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should be thorough unless the cause is certain after taking the patient's history. One should measure temperature, heart rate (pheochromocytoma or hyperthyroidism), blood pressure (pheochromocytoma), and weight. The skin examination should include attention to the sweating pattern, flushing, peripheral stigmata of endocarditis, and changes of hyperthyroidism. All lymph node chains should be examined in search of any pathologically enlarged nodes; an abnormal lymph node should be biopsied (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=see_link\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\"",
"    </a>",
"    ). Lid lag or exophthalmos may suggest hyperthyroidism. One should exclude thrush in the oropharynx and evaluate for a goiter or thyroid nodule. The chest examination may rarely reveal findings suggestive of tuberculous pneumonia; a new or changed murmur may suggest endocarditis. The abdomen should be assessed for splenomegaly that may suggest lymphoma. Clinicians should seek evidence for myelopathy or dermatomal sensory abnormalities if a neurologic cause is suggested by the history.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Diagnostic strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment should be directed at the presumed cause if one is apparent after a complete history and physical examination. If a patient is taking a medication known to cause flushing or excessive sweating, the medication should be withdrawn, if possible, as a diagnostic trial (",
"    <a class=\"graphic graphic_table graphicRef58031 \" href=\"UTD.htm?16/31/16893\">",
"     table 1",
"    </a>",
"    ). If this is not possible, a change to a lower dose, an extended release formulation of the medication, or a drug less likely to cause sweating is another potential strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/14/17641/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If no cause is found, the patient should keep a daily diary of temperature readings at random times and during and after a sweating episode. Once fever is excluded, the next strategy depends upon the character of the sweating episodes. If the history is one of mild focal increases in sweating, clinicians may establish a tentative diagnosis of idiopathic hyperhidrosis (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1257?source=see_link\">",
"     \"Primary focal hyperhidrosis\"",
"    </a>",
"    ). Other than for symptom control, these patients require no additional treatment or evaluation. They should be counseled to report any fever, change in their sweating pattern, or new symptoms that might suggest an additional diagnosis.",
"   </p>",
"   <p>",
"    Further evaluation is warranted if the history is that of drenching night sweats that require changing bedclothes. A chest radiograph and PPD are appropriate for all such patients as an initial evaluation for possible tuberculosis, in addition to a complete blood count, TSH, and blood cultures. If these are normal, and drenching night sweats persist, clinicians should obtain a torso computed tomography (CT) scan to evaluate for lymphoma, solid tumor, or abscess. If no diagnosis is apparent and severe night sweats persist, additional evaluation may include HIV serology and a bone marrow biopsy.",
"   </p>",
"   <p>",
"    Menopause and the endocrine causes of night sweats are sufficiently characteristic that, in general, clinicians may limit directed evaluations for these diagnoses to patients with flushing or increased sweating and typical associated clinical features. When night sweats remain a puzzle, a broad diagnostic approach including a 24-hour urine collection for 5-HIAA, metanephrine, and catecholamines is reasonable, in addition to a serum FSH measurement for women who may be menopausal. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"     \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At each step of this evaluation, it is important to repeat a careful history as new diagnostic symptoms often emerge over time. Empiric treatment is likely to be confusing and is not recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complaint of night sweats is common in primary care practice and may be due to a variety of serious and benign causes (",
"    <a class=\"graphic graphic_table graphicRef58031 \" href=\"UTD.htm?16/31/16893\">",
"     table 1",
"    </a>",
"    ). A detailed history is the most important element in the evaluation; further evaluation is unlikely to be helpful if no cause is apparent after taking a complete history. The history should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The certain exclusion fever as a cause",
"     </li>",
"     <li>",
"      The presence of associated symptoms (eg, unintentional weight loss, fatigue, pruritus, pain, rigors) that may suggest the etiology",
"     </li>",
"     <li>",
"      Risk factors for tuberculosis and HIV infection",
"     </li>",
"     <li>",
"      A careful medication history (including over-the-counter medications) (",
"      <a class=\"graphic graphic_table graphicRef56351 \" href=\"UTD.htm?33/32/34317\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A thorough physical examination is also important and should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Temperature, heart rate, blood pressure, and weight",
"     </li>",
"     <li>",
"      Skin examination (sweating pattern, flushing, stigmata of endocarditis, changes of hyperthyroidism)",
"     </li>",
"     <li>",
"      Examination of the heart (murmurs) and chest (findings of tuberculosis)",
"     </li>",
"     <li>",
"      Complete lymph node and spleen exams",
"     </li>",
"     <li>",
"      Examination of the thyroid and for presence of lid lag",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinicians should obtain specific diagnostic studies based upon clues available from the history and physical examination. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Diagnostic strategies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If no cause is found, further evaluation should proceed in a stepwise fashion. Only proceed to the next step if no diagnosis is apparent, and at each additional step repeat a careful history:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When possible, discontinue medications known to cause sweating.",
"     </li>",
"     <li>",
"      Exclude fever by having the patient keep a daily diary of temperature readings at random times and during and after a sweating episode.",
"     </li>",
"     <li>",
"      If the history is one of a mild increase in focal sweating, patients can be tentatively diagnosed with idiopathic hyperhidrosis, managed for this condition, and counseled to report any change in symptoms (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1257?source=see_link\">",
"       \"Primary focal hyperhidrosis\"",
"      </a>",
"      ). No further evaluation is required. If the history is of persistent drenching night sweats that require changing bed clothes, proceed with the sequential evaluation below.",
"     </li>",
"     <li>",
"      Obtain a chest radiograph and perform a PPD test. Check a complete blood count, TSH, and blood cultures.",
"     </li>",
"     <li>",
"      Perform a CT scan of the torso.",
"     </li>",
"     <li>",
"      Perform HIV serology.",
"     </li>",
"     <li>",
"      Perform a bone marrow biopsy.",
"     </li>",
"     <li>",
"      If the diagnosis remains elusive, obtain a 24-hour urine collection for 5-HIAA, metanephrines, and catecholamines. Also obtain a serum FSH measurement in women who could be menopausal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We do not recommend empiric treatment of night sweats.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/1\">",
"      Kenemans P. Menopause, HRT and menopausal symptoms. J Epidemiol Biostat 1999; 4:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/2\">",
"      Lea MJ, Aber RC. Descriptive epidemiology of night sweats upon admission to a university hospital. South Med J 1985; 78:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/3\">",
"      Quigley CS, Baines M. Descriptive epidemiology of sweating in a hospice population. J Palliat Care 1997; 13:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/4\">",
"      Reynolds WA. Are night sweats a sign of esophageal reflux? J Clin Gastroenterol 1989; 11:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/5\">",
"      Mold JW, Mathew MK, Belgore S, DeHaven M. Prevalence of night sweats in primary care patients: an OKPRN and TAFP-Net collaborative study. J Fam Pract 2002; 51:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/6\">",
"      Mold JW, Lawler F. The prognostic implications of night sweats in two cohorts of older patients. J Am Board Fam Med 2010; 23:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/7\">",
"      Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/8\">",
"      Miller LG, Asch SM, Yu EI, et al. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000; 30:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/9\">",
"      Aktou S, Yorgancioglu A, Cirak K, et al. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J 1996; 9:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/10\">",
"      Van den Brande P, Vijgen J, Demedts M. Clinical spectrum of pulmonary tuberculosis in older patients: comparison with younger patients. J Gerontol 1991; 46:M204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/11\">",
"      Cohen R, Muzaffar S, Capellan J, et al. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996; 109:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/12\">",
"      Corbett EL, Zezai A, Cheung YB, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ 2010; 88:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/13\">",
"      Alavi-Naini R, Cuevas LE, Squire SB, et al. Clinical and laboratory diagnosis of the patients with sputum smear-negative pulmonary tuberculosis. Arch Iran Med 2012; 15:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/14\">",
"      Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/15\">",
"      Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998; 104:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/16\">",
"      Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997; 278:2085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/17\">",
"      Hofer CB, Harrison LH, Struchiner CJ, et al. Acute retrovirus syndrome among prospectively identified homosexual men with incident HIV infection in Brazil. Projecto Pra&ccedil;a Onze Study Group. J Acquir Immune Defic Syndr 2000; 25:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/18\">",
"      Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf 2008; 31:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/19\">",
"      Trindade E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 1998; 159:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/20\">",
"      Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999; 229:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/21\">",
"      Noshiro T, Shimizu K, Watanabe T, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am J Hypertens 2000; 13:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/22\">",
"      Vinik AI, McLeod MK, Fig LM, et al. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989; 18:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/23\">",
"      Spaulding SW, Lippes H. Hyperthyroidism. Causes, clinical features, and diagnosis. Med Clin North Am 1985; 69:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/24\">",
"      Trop CS, Bennett CJ. The evaluation of autonomic dysreflexia. Semin Urol 1992; 10:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/25\">",
"      Lee BY, Karmakar MG, Herz BL, Sturgill RA. Autonomic dysreflexia revisited. J Spinal Cord Med 1995; 18:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/26\">",
"      Glasauer FE, Czyrny JJ. Hyperhidrosis as the presenting symptom in post-traumatic syringomyelia. Paraplegia 1994; 32:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/27\">",
"      Korpelainen JT, Sotaniemi KA, Myllyl&auml; VV. Hyperhidrosis as a reflection of autonomic failure in patients with acute hemispheral brain infarction. An evaporimetric study. Stroke 1992; 23:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/28\">",
"      Schulz V, Ward D, Moulin DE. Segmental hyperhidrosis as a manifestation of spinal and paraspinal disease. Can J Neurol Sci 1998; 25:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/29\">",
"      von M&uuml;hlen DG, Kritz-Silverstein D, Barrett-Connor E. A community-based study of menopause symptoms and estrogen replacement in older women. Maturitas 1995; 22:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/30\">",
"      Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001; 52:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/31\">",
"      Sievert LL, Obermeyer CM, Price K. Determinants of hot flashes and night sweats. Ann Hum Biol 2006; 33:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/32\">",
"      Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65. BJOG 2012; 119:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/33\">",
"      Avis NE, McKinlay SM. The Massachusetts Women's Health Study: an epidemiologic investigation of the menopause. J Am Med Womens Assoc 1995; 50:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/34\">",
"      Leung AK, Chan PY, Choi MC. Hyperhidrosis. Int J Dermatol 1999; 38:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/35\">",
"      Mold JW, Woolley JH, Nagykaldi Z. Associations between night sweats and other sleep disturbances: An OKPRN study. Ann Fam Med 2006; 4:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/36\">",
"      Mold JW, Goodrich S, Orr W. Associations between subjective night sweats and sleep study findings. J Am Board Fam Med 2008; 21:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/37\">",
"      Morris GC, Thomas TP. Night sweats--presentation of an often forgotten diagnosis. Br J Clin Pract 1991; 45:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/38\">",
"      Raff SB, Gershberg H. Night sweats. A dominant symptom in diabetes insipidus. JAMA 1975; 234:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/39\">",
"      Komaroff AL. Clinical presentation of chronic fatigue syndrome. Ciba Found Symp 1993; 173:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/40\">",
"      Sheehy TW. Diabetic gustatory sweating. Am J Gastroenterol 1991; 86:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/14/17641/abstract/41\">",
"      Laskawi R, Ellies M, R&ouml;del R, Schoenebeck C. Gustatory sweating: clinical implications and etiologic aspects. J Oral Maxillofac Surg 1999; 57:642.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2768 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-50DD9E1A11-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17641=[""].join("\n");
var outline_f17_14_17641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Solid tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Brucellosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Antidepressants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Antipyretics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Cholinergic agonists",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hypoglycemic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Hormonal agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Other medications causing flushing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Other medications causing sweating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Endocrine disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Neurologic disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Idiopathic hyperhidrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4204654\">",
"      Sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4204711\">",
"      Miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Diagnostic strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2768\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2768|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/31/16893\" title=\"table 1\">",
"      Differential DX night sweats",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/32/34317\" title=\"table 2\">",
"      Medications causing sweating",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=related_link\">",
"      Clinical manifestations and diagnosis of menopause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=related_link\">",
"      Clinical manifestations and evaluation of pulmonary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of brucellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10711?source=related_link\">",
"      Definition of favorable and unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=related_link\">",
"      Evaluation of peripheral lymphadenopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=related_link\">",
"      Menopausal hot flashes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=related_link\">",
"      Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1257?source=related_link\">",
"      Primary focal hyperhidrosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_14_17642="Pemphigus vulgaris bullae and erosions";
var content_f17_14_17642=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53425%7EDERM%2F63170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53425%7EDERM%2F63170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flaccid bullae and erosions on the skin of a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the trunk skin of this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17642=[""].join("\n");
var outline_f17_14_17642=null;
var title_f17_14_17643="Prognostic factors AML";
var content_f17_14_17643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for outcome in adults with acute myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Favorable factors",
"       </td>",
"       <td class=\"subtitle1\">",
"        Unfavorable factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &lt;50",
"       </td>",
"       <td>",
"        Age &gt;60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Karnofsky score &gt;60 percent",
"       </td>",
"       <td>",
"        Karnofsky score &lt;60 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MDR 1-negative phenotype",
"       </td>",
"       <td>",
"        MDR 1-positive phenotype",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No antecedent hematologic disorder or prior chemo/radiotherapy",
"       </td>",
"       <td>",
"        Therapy-related AML, prior myelodysplastic syndrome, myeloproliferative or other hematologic disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        t(8;21), inv(16)/t(16;16), t(15;17)",
"       </td>",
"       <td>",
"        Complex karyotypic abnormalities, -5, -7, 3q26 aberrations, t(6;9), 11q23 aberrations except for t(9;11), \"monosomal karyotype\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NPM1 mutation, CEBPA mutation",
"       </td>",
"       <td>",
"        FLT3/ITD mutation, MLL partial tandem duplication, BAALC overexpression, mutations in IDH1 and/or IDH2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17643=[""].join("\n");
var outline_f17_14_17643=null;
var title_f17_14_17644="Nomenclature and classification for neuroendocrine tumors";
var content_f17_14_17644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ENETS/WHO Nomenclature and classification for digestive system neuroendocrine tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Differentiation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mitotic count*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ki-67 index",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Traditional",
"       </td>",
"       <td class=\"subtitle1\">",
"        ENETS, WHO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Well differentiated",
"       </td>",
"       <td>",
"        Low grade (G1)",
"       </td>",
"       <td>",
"        &lt;2 per 10 HPF",
"       </td>",
"       <td>",
"        &lt;3 percent",
"       </td>",
"       <td>",
"        Carcinoid, islet cell, pancreatic (neuro)endocrine tumor",
"       </td>",
"       <td>",
"        Neuroendocrine tumor, Grade 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intermediate grade (G2)",
"       </td>",
"       <td>",
"        2-20 per 10 HPF",
"       </td>",
"       <td>",
"        3-20 percent",
"       </td>",
"       <td>",
"        Carcinoid, atypical carcinoid",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , islet cell, pancreatic (neuro)endocrine tumor",
"       </td>",
"       <td>",
"        Neuroendocrine tumor, Grade 2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Poorly differentiated",
"       </td>",
"       <td rowspan=\"2\">",
"        High grade (G3)",
"       </td>",
"       <td rowspan=\"2\">",
"        &gt;20 per 10 HPF",
"       </td>",
"       <td rowspan=\"2\">",
"        &gt;20 percent",
"       </td>",
"       <td>",
"        Small cell carcinoma",
"       </td>",
"       <td>",
"        Neuroendocrine carcinoma, Grade 3, small cell",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large cell neuroendocrine carcinoma",
"       </td>",
"       <td>",
"        Neuroendocrine carcinoma, Grade 3, large cell",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ENETS: European Neuroendocrine Tumor Society; WHO: World Health Organization.",
"     <br>",
"      * Counted in 10 high power fields (HPF). 10 HPF = 2 mm",
"      <sup>",
"       2",
"      </sup>",
"      , at least 40 fields (at 400x magnification) evaluated in areas of highest mitotic density. Cut-offs per American Joint Commission on Cancer Staging Manual, 7th edition.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Ki-67 index as assessed by MIB1 antibody staining: percent positive after count of 2000 cells in area of highest nuclear labeling. Cut-offs per American Joint Commission on Cancer Staging Manual, 7th edition.",
"       <br>",
"        &Delta; The term \"atypical carcinoid\" only applies to intermediate grade NETs of the lung.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17644=[""].join("\n");
var outline_f17_14_17644=null;
var title_f17_14_17645="Short acting nifedipine in CHD";
var content_f17_14_17645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Association of high-dose short-acting nifedipine with increased mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 248px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relative risk of mortality in patients with underlying coronary heart disease (CHD) treated with a short-acting preparation of oral nifedipine. Doses of 80 mg/day and above were associated with a relative risk of mortality of 2.83.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Furberg CD, Psaty BM, Meyer JV. Circulation 1995; 92:1326.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17645=[""].join("\n");
var outline_f17_14_17645=null;
var title_f17_14_17646="RCC incidence mortality trends";
var content_f17_14_17646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Temporal trends in renal cell cancer incidence and mortality in the United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 303px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As noted, incidence rates are rising three times faster than mortality rates, suggesting an improvement in overall survival in patients with renal cell cancer over the last 25 years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Pantuck, AJ, et al, J Urology 2001; 166:1612.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17646=[""].join("\n");
var outline_f17_14_17646=null;
var title_f17_14_17647="Evaluation patients DCM";
var content_f17_14_17647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flow diagram for the work-up of patients with dilated cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 551px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ECG: electrocardiography; echo: echocardiography.",
"     <br>",
"      * The timing of endomyocardial biopsy in patients who fail to improve on medical therapy is controversial. If the patient's left ventricular function and symptoms are not stable after one week of treatment, additional time before endomyocardial biopsy could be considered, if appropriate in the treating physician's clinical judgment, to allow for delayed recovery to occur.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wu, LA, Lapeyre, AC 3rd, Cooper, LT. Mayo Clin Proc 2001; 76:1030. Copyright &copy; 2001 Mayo Clinic Proceedings.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_14_17647=[""].join("\n");
var outline_f17_14_17647=null;
           